| 0藥品編碼 |
通用名稱 |
收費類別 |
處方藥標志 |
收費項目等級 |
拼音助記碼 |
藥品劑量單位 |
最高價格 |
門診自付比例 |
住院自付比例 |
劑型 |
每次用量 |
使用頻次 |
用法 |
單位 |
規(guī)格 |
限定天數 |
藥品商品名 |
商品名價格 |
商品名拼音碼 |
藥廠名稱 |
自制藥品標志 |
離休自付比例 |
工傷自付比例 |
開始時間 |
終止時間 |
備注 |
居民住院比例 |
居民門診比例 |
談判藥品標識 |
| XJ05ABG075A006 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
更昔洛韋分散片 |
|
GXLWFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ABG075E001 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
更昔洛韋硬膠囊 |
|
GXLWYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ABG075B001 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
更昔洛韋注射劑 |
|
GXLWZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XJ05ABG075B002 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
更昔洛韋注射液 |
|
GXLWZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XJ05ABG075B003 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
更昔洛韋注射用無菌粉末 |
|
GXLWZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XJ05ABG075B014 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
更昔洛韋凍干粉針 |
|
GXLWDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XJ05ABA063B001 |
阿糖腺苷 |
01 |
|
2 |
ATXG |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
阿糖腺苷注射劑 |
|
ATXGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ05APL052X001 |
利巴韋林 |
01 |
|
2 |
LBWL |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
利巴韋林口服溶液劑 |
|
LBWLKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ05ACJ120A001 |
金剛乙胺 |
01 |
|
2 |
JGYA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
金剛乙胺片劑 |
|
JGYAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ACJ120K001 |
金剛乙胺 |
01 |
|
2 |
JGYA |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
金剛乙胺糖漿劑 |
|
JGYATJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ACJ120X001 |
金剛乙胺 |
01 |
|
2 |
JGYA |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
金剛乙胺口服溶液劑 |
|
JGYAKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ACJ120N001 |
金剛乙胺 |
01 |
|
2 |
JGYA |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
金剛乙胺顆粒劑 |
|
JGYAKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ADL116B001 |
膦甲酸鈉 |
01 |
|
2 |
LJSN |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
膦甲酸鈉注射劑 |
|
LJSNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ADL290B002 |
膦甲酸鈉氯化鈉 |
01 |
|
2 |
LJSNLHN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
膦甲酸鈉氯化鈉注射液 |
|
LJSNLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05ADL294B002 |
膦甲酸鈉葡萄糖 |
01 |
|
2 |
LJSNPTT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
膦甲酸鈉葡萄糖注射液 |
|
LJSNPTTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ05AES051W001 |
沙奎那韋 |
01 |
|
2 |
SKNW |
|
40000 |
0.1 |
0.1 |
W001 |
|
|
|
|
|
|
沙奎那韋口服常釋劑型 |
|
SKNWKFCSJX |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.1 |
0.1 |
|
| XJ05AFA014A001 |
阿德福韋酯 |
01 |
|
2 |
ADFWZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
阿德福韋酯片劑 |
|
ADFWZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據 |
0.1 |
0.1 |
|
| XJ05AFA014A006 |
阿德福韋酯 |
01 |
|
2 |
ADFWZ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
阿德福韋酯分散片 |
|
ADFWZFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據 |
0.1 |
0.1 |
|
| XJ05AFA014E001 |
阿德福韋酯 |
01 |
|
2 |
ADFWZ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
阿德福韋酯硬膠囊 |
|
ADFWZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據 |
0.1 |
0.1 |
|
| XJ05AFE009B001 |
恩夫韋肽 |
01 |
|
2 |
EFWT |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
恩夫韋肽注射劑 |
|
EFWTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05AFE011A001 |
恩曲他濱 |
01 |
|
2 |
EQTB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩曲他濱片劑 |
|
EQTBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.1 |
0.1 |
|
| XJ05AFE011E001 |
恩曲他濱 |
01 |
|
2 |
EQTB |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
恩曲他濱硬膠囊 |
|
EQTBYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.1 |
0.1 |
|
| XJ05AFE070A001 |
恩曲他濱替諾福韋 |
01 |
|
2 |
EQTBTNFW |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
恩曲他濱替諾福韋片劑 |
|
EQTBTNFWPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0 |
0 |
|
| XJ05AFE013A001 |
恩替卡韋 |
01 |
|
2 |
ETKW |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩替卡韋片劑 |
|
ETKWPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據 |
0.1 |
0.1 |
|
| XJ05AFE013A006 |
恩替卡韋 |
01 |
|
2 |
ETKW |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
恩替卡韋分散片 |
|
ETKWFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據 |
0.1 |
0.1 |
|
| XJ05AFE013E001 |
恩替卡韋 |
01 |
|
2 |
ETKW |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
恩替卡韋硬膠囊 |
|
ETKWYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據 |
0.1 |
0.1 |
|
| XJ05AFL008A001 |
拉米夫定 |
01 |
|
2 |
LMFD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
拉米夫定片劑 |
|
LMFDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據或母嬰乙肝傳播阻斷 |
0.1 |
0.1 |
|
| XJ05AFL008A017 |
拉米夫定 |
01 |
|
2 |
LMFD |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
拉米夫定薄膜衣片 |
|
LMFDBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據或母嬰乙肝傳播阻斷 |
0.1 |
0.1 |
|
| XJ05AFL008E001 |
拉米夫定 |
01 |
|
2 |
LMFD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
拉米夫定硬膠囊 |
|
LMFDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據或母嬰乙肝傳播阻斷 |
0.1 |
0.1 |
|
| XJ05AFQ008K001 |
齊多夫定 |
01 |
|
2 |
QDFD |
|
40000 |
0.2 |
0.2 |
K001 |
|
|
|
|
|
|
齊多夫定糖漿劑 |
|
QDFDTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05AFQ008X001 |
齊多夫定 |
01 |
|
2 |
QDFD |
|
40000 |
0.2 |
0.2 |
X001 |
|
|
|
|
|
|
齊多夫定口服溶液劑 |
|
QDFDKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05AFQ008B001 |
齊多夫定 |
01 |
|
2 |
QDFD |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
齊多夫定注射劑 |
|
QDFDZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05AFQ008B002 |
齊多夫定 |
01 |
|
2 |
QDFD |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
齊多夫定注射液 |
|
QDFDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05AFT031A001 |
替比夫定 |
01 |
|
2 |
TBFD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
替比夫定片劑 |
|
TBFDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據或母嬰乙肝傳播阻斷 |
0.1 |
0.1 |
|
| XJ05AFT043A001 |
替諾福韋二吡呋酯 |
01 |
|
2 |
TNFWEBFZ |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
替諾福韋二吡呋酯片劑 |
|
TNFWEBFZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據或母嬰乙肝傳播阻斷 |
0.2 |
0.2 |
|
| XJ05AFT043E001 |
替諾福韋二吡呋酯 |
01 |
|
2 |
TNFWEBFZ |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
替諾福韋二吡呋酯硬膠囊 |
|
TNFWEBFZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限有活動性乙型肝炎的明確診斷及檢驗證據或母嬰乙肝傳播阻斷 |
0.2 |
0.2 |
|
| XJ05AGL341A001 |
利匹韋林 |
01 |
|
2 |
LPWL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
利匹韋林片劑 |
|
LPWLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0 |
0 |
|
| XJ05AHA218E001 |
奧司他韋 |
01 |
|
2 |
ASTW |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
奧司他韋硬膠囊 |
|
ASTWYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥流感高危人群及重癥患者的抗流感病毒治療 |
0.1 |
0.1 |
|
| XJ05AHA218N001 |
奧司他韋 |
01 |
|
2 |
ASTW |
|
40000 |
0.2 |
0.2 |
N001 |
|
|
|
|
|
|
奧司他韋顆粒劑 |
|
ASTWKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限不宜使用奧司他韋口服常釋劑型的兒童或吞咽困難患者 |
0.2 |
0.2 |
|
| XJ05AHP119B002 |
帕拉米韋氯化鈉 |
01 |
|
2 |
PLMWLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
帕拉米韋氯化鈉注射液 |
|
PLMWLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥流感高危人群及重癥患者的抗流感病毒治療 |
0.2 |
0.2 |
|
| XJ05ARQ009A001 |
齊多拉米雙夫定 |
01 |
|
2 |
QDLMSFD |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
齊多拉米雙夫定片劑 |
|
QDLMSFDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05ARL282A001 |
洛匹那韋利托那韋 |
01 |
|
2 |
LPNWLTNW |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
洛匹那韋利托那韋片劑 |
|
LPNWLTNWPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限艾滋病病毒感染 |
0.2 |
0.2 |
|
| XJ05AXA011A001 |
阿比多爾 |
01 |
|
2 |
ABDE |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
阿比多爾片劑 |
|
ABDEPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥流感高危人群及重癥患者的抗流感病毒治療 |
0.1 |
0.1 |
|
| XJ05AXA011A006 |
阿比多爾 |
01 |
|
2 |
ABDE |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
阿比多爾分散片 |
|
ABDEFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥流感高危人群及重癥患者的抗流感病毒治療 |
0.1 |
0.1 |
|
| XJ05AXA011E001 |
阿比多爾 |
01 |
|
2 |
ABDE |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
阿比多爾硬膠囊 |
|
ABDEYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥流感高危人群及重癥患者的抗流感病毒治療 |
0.1 |
0.1 |
|
| XJ05AXC047B001 |
穿琥寧 |
01 |
|
2 |
CHN |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
穿琥寧注射劑 |
|
CHNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XJ05AXC047B002 |
穿琥寧 |
01 |
|
2 |
CHN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
穿琥寧注射液 |
|
CHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XJ05AXC047B003 |
穿琥寧 |
01 |
|
2 |
CHN |
|
40000 |
0 |
0 |
B003 |
|
|
|
|
|
|
穿琥寧注射用無菌粉末 |
|
CHNZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XJ05AXC047B014 |
穿琥寧 |
01 |
|
2 |
CHN |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
穿琥寧凍干粉針 |
|
CHNDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XJ06AAB010B001 |
白喉抗毒素 |
01 |
|
1 |
BHKDS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
白喉抗毒素注射劑 |
|
BHKDSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAB010B002 |
白喉抗毒素 |
01 |
|
1 |
BHKDS |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
白喉抗毒素注射液 |
|
BHKDSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAD166B002 |
多價氣性壞疽抗毒素 |
01 |
|
1 |
DJQXHJKDS |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
多價氣性壞疽抗毒素注射液 |
|
DJQXHJKDSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAD166B014 |
多價氣性壞疽抗毒素 |
01 |
|
1 |
DJQXHJKDS |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
多價氣性壞疽抗毒素凍干粉針 |
|
DJQXHJKDSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAK041B001 |
抗狂犬病血清 |
01 |
|
1 |
KKQBXQ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
抗狂犬病血清注射劑 |
|
KKQBXQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAK041B002 |
抗狂犬病血清 |
01 |
|
1 |
KKQBXQ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
抗狂犬病血清注射液 |
|
KKQBXQZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAK040B001 |
抗蝮蛇毒血清 |
01 |
|
1 |
KFSDXQ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
抗蝮蛇毒血清注射劑 |
|
KFSDXQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAK048B001 |
抗五步蛇毒血清 |
01 |
|
1 |
KWBSDXQ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
抗五步蛇毒血清注射劑 |
|
KWBSDXQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAK050B001 |
抗眼鏡蛇毒血清 |
01 |
|
1 |
KYJSDXQ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
抗眼鏡蛇毒血清注射劑 |
|
KYJSDXQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAK054B001 |
抗銀環(huán)蛇毒血清 |
01 |
|
1 |
KYHSDXQ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
抗銀環(huán)蛇毒血清注射劑 |
|
KYHSDXQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAP062B001 |
破傷風抗毒素 |
01 |
|
1 |
PSFKDS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
破傷風抗毒素注射劑 |
|
PSFKDSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAP062B002 |
破傷風抗毒素 |
01 |
|
1 |
PSFKDS |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
破傷風抗毒素注射液 |
|
PSFKDSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAR047B002 |
肉毒抗毒素 |
01 |
|
1 |
RDKDS |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
肉毒抗毒素注射液 |
|
RDKDSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06AAA006B001 |
A型肉毒毒素 |
01 |
|
2 |
AXRDDS |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
A型肉毒毒素注射劑 |
|
AXRDDSZSJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ06AAA006B014 |
A型肉毒毒素 |
01 |
|
2 |
AXRDDS |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
A型肉毒毒素凍干粉針 |
|
AXRDDSDGFZ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ06AAA224B001 |
A型肉毒抗毒素 |
01 |
|
2 |
AXRDKDS |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
A型肉毒抗毒素注射劑 |
|
AXRDKDSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ06BAJ215B001 |
靜注人免疫球蛋白（pH4） |
01 |
|
2 |
JZRMYQDB(PH4) |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射劑 |
|
JZRMYQDB(PH4)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性免疫球蛋白缺乏癥；新生兒敗血癥；重型原發(fā)性免疫性血小板減少癥；川崎??；全身型重癥肌無力；急性格林巴利綜合征 |
0.1 |
0.1 |
|
| XJ06BAJ215B002 |
靜注人免疫球蛋白（pH4） |
01 |
|
2 |
JZRMYQDB(PH4) |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射液 |
|
JZRMYQDB(PH4)ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性免疫球蛋白缺乏癥；新生兒敗血癥；重型原發(fā)性免疫性血小板減少癥；川崎??；全身型重癥肌無力；急性格林巴利綜合征 |
0.1 |
0.1 |
|
| XJ06BAJ215B003 |
靜注人免疫球蛋白（pH4） |
01 |
|
2 |
JZRMYQDB(PH4) |
|
40000 |
0.1 |
0.1 |
B003 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射用無菌粉末 |
|
JZRMYQDB(PH4)ZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性免疫球蛋白缺乏癥；新生兒敗血癥；重型原發(fā)性免疫性血小板減少癥；川崎??；全身型重癥肌無力；急性格林巴利綜合征 |
0.1 |
0.1 |
|
| XJ06BAJ215B005 |
靜注人免疫球蛋白（pH4） |
01 |
|
2 |
JZRMYQDB(PH4) |
|
40000 |
0.1 |
0.1 |
B005 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射用溶液劑 |
|
JZRMYQDB(PH4)ZSYRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性免疫球蛋白缺乏癥；新生兒敗血癥；重型原發(fā)性免疫性血小板減少癥；川崎病；全身型重癥肌無力；急性格林巴利綜合征 |
0.1 |
0.1 |
|
| XJ06BAJ215B014 |
靜注人免疫球蛋白（pH4） |
01 |
|
2 |
JZRMYQDB(PH4) |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）凍干粉針 |
|
JZRMYQDB(PH4)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性免疫球蛋白缺乏癥；新生兒敗血癥；重型原發(fā)性免疫性血小板減少癥；川崎??；全身型重癥肌無力；急性格林巴利綜合征 |
0.1 |
0.1 |
|
| XJ06BAR008B001 |
人免疫球蛋白 |
01 |
|
2 |
RMYQDB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
人免疫球蛋白注射劑 |
|
RMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限麻疹和傳染性肝炎接觸者的預防治療 |
0.1 |
0.1 |
|
| XJ06BAR008B002 |
人免疫球蛋白 |
01 |
|
2 |
RMYQDB |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
人免疫球蛋白注射液 |
|
RMYQDBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限麻疹和傳染性肝炎接觸者的預防治療 |
0.1 |
0.1 |
|
| XJ06BBP063B001 |
破傷風人免疫球蛋白 |
01 |
|
2 |
PSFRMYQDB |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
破傷風人免疫球蛋白注射劑 |
|
PSFRMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06BBP063B002 |
破傷風人免疫球蛋白 |
01 |
|
2 |
PSFRMYQDB |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
破傷風人免疫球蛋白注射液 |
|
PSFRMYQDBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06BBM149B001 |
馬破傷風免疫球蛋白 |
01 |
|
2 |
MPSFMYQDB |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
馬破傷風免疫球蛋白注射劑 |
|
MPSFMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ06BBR006B001 |
人狂犬病免疫球蛋白 |
01 |
|
2 |
RKQBMYQDB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
人狂犬病免疫球蛋白注射劑 |
|
RKQBMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ06BBR006B002 |
人狂犬病免疫球蛋白 |
01 |
|
2 |
RKQBMYQDB |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
人狂犬病免疫球蛋白注射液 |
|
RKQBMYQDBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XJ07ACK047B002 |
抗炭疽血清 |
01 |
|
1 |
KTJXQ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
抗炭疽血清注射液 |
|
KTJXQZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XJ07BGR030B001 |
人用狂犬病疫苗（Vero細胞） |
01 |
|
2 |
RYKQBYM(EROXB) |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（Vero細胞）注射劑 |
|
RYKQBYM(EROXB)ZSJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR030B002 |
人用狂犬病疫苗（Vero細胞） |
01 |
|
2 |
RYKQBYM(EROXB) |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
人用狂犬病疫苗（Vero細胞）注射液 |
|
RYKQBYM(EROXB)ZSY |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR030B014 |
人用狂犬病疫苗（Vero細胞） |
01 |
|
2 |
RYKQBYM(EROXB) |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人用狂犬病疫苗（Vero細胞）凍干粉針 |
|
RYKQBYM(EROXB)DGFZ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR032B001 |
人用狂犬病疫苗（地鼠腎細胞） |
01 |
|
2 |
RYKQBYM(DSSXB) |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（地鼠腎細胞）注射劑 |
|
RYKQBYM(DSSXB)ZSJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR032B002 |
人用狂犬病疫苗（地鼠腎細胞） |
01 |
|
2 |
RYKQBYM(DSSXB) |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
人用狂犬病疫苗（地鼠腎細胞）注射液 |
|
RYKQBYM(DSSXB)ZSY |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR032B014 |
人用狂犬病疫苗（地鼠腎細胞） |
01 |
|
2 |
RYKQBYM(DSSXB) |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人用狂犬病疫苗（地鼠腎細胞）凍干粉針 |
|
RYKQBYM(DSSXB)DGFZ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR033B001 |
人用狂犬病疫苗（雞胚細胞） |
01 |
|
2 |
RYKQBYM(JPXB) |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（雞胚細胞）注射劑 |
|
RYKQBYM(JPXB)ZSJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XJ07BGR077B001 |
人用狂犬病疫苗（人二倍體細胞） |
01 |
|
2 |
RYKQBYM(REBTXB) |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（人二倍體細胞）注射劑 |
|
RYKQBYM(REBTXB)ZSJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XL01AAD040B002 |
氮芥 |
01 |
|
1 |
DJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氮芥注射液 |
|
DJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01AAH040A001 |
環(huán)磷酰胺 |
01 |
|
1 |
HLXA |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
環(huán)磷酰胺片劑 |
|
HLXAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01AAH040B001 |
環(huán)磷酰胺 |
01 |
|
1 |
HLXA |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
環(huán)磷酰胺注射劑 |
|
HLXAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01AAB055A001 |
苯丁酸氮芥 |
01 |
|
2 |
BDSDJ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
苯丁酸氮芥片劑 |
|
BDSDJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AAM042A001 |
美法侖 |
01 |
|
2 |
MFL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
美法侖片劑 |
|
MFLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AAX069B001 |
硝卡芥 |
01 |
|
2 |
XKJ |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
硝卡芥注射劑 |
|
XKJZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AAY145B001 |
異環(huán)磷酰胺 |
01 |
|
2 |
YHLXA |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
異環(huán)磷酰胺注射劑 |
|
YHLXAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AAY145B014 |
異環(huán)磷酰胺 |
01 |
|
2 |
YHLXA |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
異環(huán)磷酰胺凍干粉針 |
|
YHLXADGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AAF306A001 |
復方環(huán)磷酰胺 |
01 |
|
2 |
FFHLXA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
復方環(huán)磷酰胺片劑 |
|
FFHLXAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ABB014A001 |
白消安 |
01 |
|
1 |
BXA |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
白消安片劑 |
|
BXAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01ABB014B002 |
白消安 |
01 |
|
2 |
BXA |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
白消安注射液 |
|
BXAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ADS171E001 |
司莫司汀 |
01 |
|
1 |
SMST |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
司莫司汀硬膠囊 |
|
SMSTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01ADF103B001 |
福莫司汀 |
01 |
|
2 |
FMST |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
福莫司汀注射劑 |
|
FMSTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ADF103B014 |
福莫司汀 |
01 |
|
2 |
FMST |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
福莫司汀凍干粉針 |
|
FMSTDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ADK021B002 |
卡莫司汀 |
01 |
|
2 |
KMST |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
卡莫司汀注射液 |
|
KMSTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ADL280E001 |
洛莫司汀 |
01 |
|
2 |
LMST |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
洛莫司汀硬膠囊 |
|
LMSTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ADN044B001 |
尼莫司汀 |
01 |
|
2 |
NMST |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
尼莫司汀注射劑 |
|
NMSTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01ADN044B014 |
尼莫司汀 |
01 |
|
2 |
NMST |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
尼莫司汀凍干粉針 |
|
NMSTDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AXS005B002 |
塞替派 |
01 |
|
1 |
STP |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
塞替派注射液 |
|
STPZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01AXD002B001 |
達卡巴嗪 |
01 |
|
2 |
DKBQ |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
達卡巴嗪注射劑 |
|
DKBQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AXD002B014 |
達卡巴嗪 |
01 |
|
2 |
DKBQ |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
達卡巴嗪凍干粉針 |
|
DKBQDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01AXT041E001 |
替莫唑胺 |
01 |
|
2 |
TMZA |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
替莫唑胺硬膠囊 |
|
TMZAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限多形性膠質母細胞瘤、間變性星形細胞瘤 |
0.1 |
0.1 |
|
| XL01BAJ025B001 |
甲氨蝶呤 |
01 |
|
1 |
JADL |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
甲氨蝶呤注射劑 |
|
JADLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BAJ025B002 |
甲氨蝶呤 |
01 |
|
1 |
JADL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
甲氨蝶呤注射液 |
|
JADLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BAJ025B003 |
甲氨蝶呤 |
01 |
|
1 |
JADL |
|
40000 |
0 |
0 |
B003 |
|
|
|
|
|
|
甲氨蝶呤注射用無菌粉末 |
|
JADLZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BAJ025B014 |
甲氨蝶呤 |
01 |
|
1 |
JADL |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
甲氨蝶呤凍干粉針 |
|
JADLDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BAP030B001 |
培美曲塞 |
01 |
|
2 |
PMQS |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
培美曲塞注射劑 |
|
PMQSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限局部晚期或轉移性非鱗狀細胞型非小細胞肺癌；惡性胸膜間皮瘤 |
0.2 |
0.2 |
|
| XL01BAP030B014 |
培美曲塞 |
01 |
|
2 |
PMQS |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
培美曲塞凍干粉針 |
|
PMQSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限局部晚期或轉移性非鱗狀細胞型非小細胞肺癌；惡性胸膜間皮瘤 |
0.2 |
0.2 |
|
| XL01BBQ080A001 |
巰嘌呤 |
01 |
|
1 |
QPL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
巰嘌呤片劑 |
|
QPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BBF066A001 |
氟達拉濱 |
01 |
|
2 |
FDLB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氟達拉濱片劑 |
|
FDLBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限B細胞慢性淋巴細胞白血病或濾泡淋巴瘤 |
0.1 |
0.1 |
|
| XL01BBF066B001 |
氟達拉濱 |
01 |
|
2 |
FDLB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
氟達拉濱注射劑 |
|
FDLBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限B細胞慢性淋巴細胞白血病或濾泡淋巴瘤 |
0.1 |
0.1 |
|
| XL01BBL137A001 |
硫鳥嘌呤 |
01 |
|
2 |
LNPL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
硫鳥嘌呤片劑 |
|
LNPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCA062B001 |
阿糖胞苷 |
01 |
|
1 |
ATBG |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
阿糖胞苷注射劑 |
|
ATBGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BCA062B002 |
阿糖胞苷 |
01 |
|
1 |
ATBG |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
阿糖胞苷注射液 |
|
ATBGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BCF082A001 |
氟尿嘧啶 |
01 |
|
1 |
FNMD |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氟尿嘧啶片劑 |
|
FNMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BCF082B001 |
氟尿嘧啶 |
01 |
|
1 |
FNMD |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
氟尿嘧啶注射劑 |
|
FNMDZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BCF082B002 |
氟尿嘧啶 |
01 |
|
1 |
FNMD |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氟尿嘧啶注射液 |
|
FNMDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BCF082B014 |
氟尿嘧啶 |
01 |
|
1 |
FNMD |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
氟尿嘧啶凍干粉針 |
|
FNMDDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01BCD089B001 |
地西他濱 |
01 |
|
2 |
DXTB |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
地西他濱注射劑 |
|
DXTBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限高危的骨髓增生異常綜合征患者 |
0.2 |
0.2 |
|
| XL01BCF619B002 |
氟尿嘧啶氯化鈉 |
01 |
|
2 |
FNMDLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
氟尿嘧啶氯化鈉注射液 |
|
FNMDLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01BCF620B002 |
氟尿嘧啶葡萄糖 |
01 |
|
2 |
FNMDPTT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
氟尿嘧啶葡萄糖注射液 |
|
FNMDPTTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01BCJ011B001 |
吉西他濱 |
01 |
|
2 |
JXTB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
吉西他濱注射劑 |
|
JXTBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCJ011B011 |
吉西他濱 |
01 |
|
2 |
JXTB |
|
40000 |
0.1 |
0.1 |
B011 |
|
|
|
|
|
|
吉西他濱粉針劑 |
|
JXTBFZJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCJ011B014 |
吉西他濱 |
01 |
|
2 |
JXTB |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
吉西他濱凍干粉針 |
|
JXTBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCK020A001 |
卡莫氟 |
01 |
|
2 |
KMF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
卡莫氟片劑 |
|
KMFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCK020A017 |
卡莫氟 |
01 |
|
2 |
KMF |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
卡莫氟薄膜衣片 |
|
KMFBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCK023A001 |
卡培他濱 |
01 |
|
2 |
KPTB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
卡培他濱片劑 |
|
KPTBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCQ129A001 |
去氧氟尿苷 |
01 |
|
2 |
QYFNG |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
去氧氟尿苷片劑 |
|
QYFNGPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCQ129A006 |
去氧氟尿苷 |
01 |
|
2 |
QYFNG |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
去氧氟尿苷分散片 |
|
QYFNGFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCQ129E001 |
去氧氟尿苷 |
01 |
|
2 |
QYFNG |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
去氧氟尿苷硬膠囊 |
|
QYFNGYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCT033A001 |
替吉奧 |
01 |
|
2 |
TJA |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
替吉奧片劑 |
|
TJAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01BCT033E001 |
替吉奧 |
01 |
|
2 |
TJA |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
替吉奧硬膠囊 |
|
TJAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01BCT034D001 |
替加氟 |
01 |
|
2 |
TJF |
|
40000 |
0.2 |
0.2 |
D001 |
|
|
|
|
|
|
替加氟栓劑 |
|
TJFSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01BCT034B002 |
替加氟 |
01 |
|
2 |
TJF |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
替加氟注射液 |
|
TJFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCT134B002 |
替加氟氯化鈉 |
01 |
|
2 |
TJFLHN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
替加氟氯化鈉注射液 |
|
TJFLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01BCF082J001 |
氟尿嘧啶 |
01 |
|
2 |
FNMD |
|
40000 |
0.2 |
0.2 |
J001 |
|
|
|
|
|
|
氟尿嘧啶植入劑 |
|
FNMDZRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01CAC022B001 |
長春新堿 |
01 |
|
1 |
CCXJ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
長春新堿注射劑 |
|
CCXJZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CAC022B014 |
長春新堿 |
01 |
|
1 |
CCXJ |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
長春新堿凍干粉針 |
|
CCXJDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CAC018B001 |
長春地辛 |
01 |
|
2 |
CCDX |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
長春地辛注射劑 |
|
CCDXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CAC018B014 |
長春地辛 |
01 |
|
2 |
CCDX |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
長春地辛凍干粉針 |
|
CCDXDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CAC020E002 |
長春瑞濱 |
01 |
|
2 |
CCRB |
|
40000 |
0.1 |
0.1 |
E002 |
|
|
|
|
|
|
長春瑞濱軟膠囊 |
|
CCRBRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CAC020B001 |
長春瑞濱 |
01 |
|
2 |
CCRB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
長春瑞濱注射劑 |
|
CCRBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CAC020B002 |
長春瑞濱 |
01 |
|
2 |
CCRB |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
長春瑞濱注射液 |
|
CCRBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CAC020B014 |
長春瑞濱 |
01 |
|
2 |
CCRB |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
長春瑞濱凍干粉針 |
|
CCRBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBY090B001 |
依托泊苷 |
01 |
|
1 |
YTBG |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
依托泊苷注射劑 |
|
YTBGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CBY090B002 |
依托泊苷 |
01 |
|
1 |
YTBG |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
依托泊苷注射液 |
|
YTBGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CBT042B002 |
替尼泊苷 |
01 |
|
2 |
TNBG |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
替尼泊苷注射液 |
|
TNBGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBT111E001 |
托泊替康 |
01 |
|
2 |
TBTK |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
托泊替康硬膠囊 |
|
TBTKYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBT111B001 |
托泊替康 |
01 |
|
2 |
TBTK |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
托泊替康注射劑 |
|
TBTKZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBY057B001 |
伊立替康 |
01 |
|
2 |
YLTK |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
伊立替康注射劑 |
|
YLTKZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBY057B002 |
伊立替康 |
01 |
|
2 |
YLTK |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
伊立替康注射液 |
|
YLTKZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBY090E001 |
依托泊苷 |
01 |
|
2 |
YTBG |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
依托泊苷硬膠囊 |
|
YTBGYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CBY090E002 |
依托泊苷 |
01 |
|
2 |
YTBG |
|
40000 |
0.1 |
0.1 |
E002 |
|
|
|
|
|
|
依托泊苷軟膠囊 |
|
YTBGRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CDZ046B002 |
紫杉醇 |
01 |
|
1 |
ZSC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
紫杉醇注射液 |
|
ZSCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CDD194B002 |
多西他賽 |
01 |
|
2 |
DXTS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
多西他賽注射液 |
|
DXTSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CXG054B002 |
高三尖杉酯堿 |
01 |
|
1 |
GSJSZJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
高三尖杉酯堿注射液 |
|
GSJSZJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CXG054B014 |
高三尖杉酯堿 |
01 |
|
1 |
GSJSZJ |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
高三尖杉酯堿凍干粉針 |
|
GSJSZJDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CXQ038B001 |
羥喜樹堿 |
01 |
|
1 |
QXSJ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
羥喜樹堿注射劑 |
|
QXSJZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CXQ038B002 |
羥喜樹堿 |
01 |
|
1 |
QXSJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
羥喜樹堿注射液 |
|
QXSJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CXQ038B014 |
羥喜樹堿 |
01 |
|
1 |
QXSJ |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
羥喜樹堿凍干粉針 |
|
QXSJDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01CXB019B002 |
斑蝥酸鈉維生素B6 |
01 |
|
2 |
BMSNWSSB6 |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
斑蝥酸鈉維生素B6注射液 |
|
BMSNWSSB6ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限晚期原發(fā)性肝癌、晚期肺癌 |
0.1 |
0.1 |
|
| XL01CXG139B002 |
高三尖杉酯堿氯化鈉 |
01 |
|
2 |
GSJSZJLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
高三尖杉酯堿氯化鈉注射液 |
|
GSJSZJLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01CXL035X003 |
欖香烯 |
01 |
|
2 |
LXX |
|
40000 |
0.3 |
0.3 |
X003 |
|
|
|
|
|
|
欖香烯口服乳劑 |
|
LXXKFRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限晚期食管癌或晚期胃癌改善癥狀的輔助治療 |
0.3 |
0.3 |
|
| XL01CXL035B002 |
欖香烯 |
01 |
|
2 |
LXX |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
欖香烯注射液 |
|
LXXZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌性胸腹水的胸腔內或腹腔內注射治療 |
0.1 |
0.1 |
|
| XL01CXL035B022 |
欖香烯 |
01 |
|
2 |
LXX |
|
40000 |
0.1 |
0.1 |
B022 |
|
|
|
|
|
|
欖香烯乳狀注射液 |
|
LXXRZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌性胸腹水的胸腔內或腹腔內注射治療 |
0.1 |
0.1 |
|
| XL01CXQ143B002 |
羥基喜樹堿氯化鈉 |
01 |
|
2 |
QJXSJLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
羥基喜樹堿氯化鈉注射液 |
|
QJXSJLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01CXS023B002 |
三尖杉酯堿 |
01 |
|
2 |
SJSZJ |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
三尖杉酯堿注射液 |
|
SJSZJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01CXB018B002 |
斑蝥酸鈉 |
01 |
|
2 |
BMSN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
斑蝥酸鈉注射液 |
|
BMSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性肝癌 |
0.1 |
0.1 |
|
| XL01DAF015B001 |
放線菌素D |
01 |
|
1 |
FXJSD |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
放線菌素D注射劑 |
|
FXJSDZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DBD174B001 |
多柔比星 |
01 |
|
1 |
DRBX |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
多柔比星注射劑 |
|
DRBXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DBD174B002 |
多柔比星 |
01 |
|
1 |
DRBX |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
多柔比星注射液 |
|
DRBXZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DBD174B014 |
多柔比星 |
01 |
|
1 |
DRBX |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
多柔比星凍干粉針 |
|
DRBXDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DBR040B001 |
柔紅霉素 |
01 |
|
1 |
RHMS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
柔紅霉素注射劑 |
|
RHMSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DBR040B014 |
柔紅霉素 |
01 |
|
1 |
RHMS |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
柔紅霉素凍干粉針 |
|
RHMSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DBA053B001 |
阿柔比星 |
01 |
|
2 |
ARBX |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
阿柔比星注射劑 |
|
ARBXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBA053B014 |
阿柔比星 |
01 |
|
2 |
ARBX |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
阿柔比星凍干粉針 |
|
ARBXDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBB104B001 |
吡柔比星 |
01 |
|
2 |
BRBX |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
吡柔比星注射劑 |
|
BRBXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBB104B014 |
吡柔比星 |
01 |
|
2 |
BRBX |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
吡柔比星凍干粉針 |
|
BRBXDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBB116B001 |
表柔比星 |
01 |
|
2 |
BRBX |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
表柔比星注射劑 |
|
BRBXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBB116B002 |
表柔比星 |
01 |
|
2 |
BRBX |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
表柔比星注射液 |
|
BRBXZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBM109B001 |
米托蒽醌 |
01 |
|
2 |
MTEK |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
米托蒽醌注射劑 |
|
MTEKZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBM109B002 |
米托蒽醌 |
01 |
|
2 |
MTEK |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
米托蒽醌注射液 |
|
MTEKZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBM109B014 |
米托蒽醌 |
01 |
|
2 |
MTEK |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
米托蒽醌凍干粉針 |
|
MTEKDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBM158B002 |
米托蒽醌葡萄糖 |
01 |
|
2 |
MTEKPTT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
米托蒽醌葡萄糖注射液 |
|
MTEKPTTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBM150B002 |
米托蒽醌氯化鈉 |
01 |
|
2 |
MTEKLHN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
米托蒽醌氯化鈉注射液 |
|
MTEKLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01DBY055B001 |
伊達比星 |
01 |
|
2 |
YDBX |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
伊達比星注射劑 |
|
YDBXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XL01DCP056B001 |
平陽霉素 |
01 |
|
1 |
PYMS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
平陽霉素注射劑 |
|
PYMSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DCS167B001 |
絲裂霉素 |
01 |
|
1 |
SLMS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
絲裂霉素注射劑 |
|
SLMSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DCS167B014 |
絲裂霉素 |
01 |
|
1 |
SLMS |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
絲裂霉素凍干粉針 |
|
SLMSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01DCB150B001 |
博來霉素 |
01 |
|
2 |
BLMS |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
博來霉素注射劑 |
|
BLMSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAK014B001 |
卡鉑 |
01 |
|
1 |
KB |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
卡鉑注射劑 |
|
KBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAK014B002 |
卡鉑 |
01 |
|
1 |
KB |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
卡鉑注射液 |
|
KBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAK014B014 |
卡鉑 |
01 |
|
1 |
KB |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
卡鉑凍干粉針 |
|
KBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAS166B001 |
順鉑 |
01 |
|
1 |
SB |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
順鉑注射劑 |
|
SBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAS166B002 |
順鉑 |
01 |
|
1 |
SB |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
順鉑注射液 |
|
SBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAS166B013 |
順鉑 |
01 |
|
1 |
SB |
|
40000 |
0 |
0 |
B013 |
|
|
|
|
|
|
順鉑無菌粉針 |
|
SBWJFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAS166B014 |
順鉑 |
01 |
|
1 |
SB |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
順鉑凍干粉針 |
|
SBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XAA215B001 |
奧沙利鉑 |
01 |
|
2 |
ASLB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
奧沙利鉑注射劑 |
|
ASLBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAA215B002 |
奧沙利鉑 |
01 |
|
2 |
ASLB |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
奧沙利鉑注射液 |
|
ASLBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAA215B003 |
奧沙利鉑 |
01 |
|
2 |
ASLB |
|
40000 |
0.1 |
0.1 |
B003 |
|
|
|
|
|
|
奧沙利鉑注射用無菌粉末 |
|
ASLBZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAA215B014 |
奧沙利鉑 |
01 |
|
2 |
ASLB |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
奧沙利鉑凍干粉針 |
|
ASLBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAL272B001 |
洛鉑 |
01 |
|
2 |
LB |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
洛鉑注射劑 |
|
LBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01XAN014B001 |
奈達鉑 |
01 |
|
2 |
NDB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
奈達鉑注射劑 |
|
NDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAN014B014 |
奈達鉑 |
01 |
|
2 |
NDB |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
奈達鉑凍干粉針 |
|
NDBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XAS199B002 |
順鉑氯化鈉 |
01 |
|
2 |
SBLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
順鉑氯化鈉注射液 |
|
SBLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01XAA254B002 |
奧沙利鉑甘露醇 |
01 |
|
2 |
ASLBGLC |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
奧沙利鉑甘露醇注射液 |
|
ASLBGLCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01XXM078B001 |
門冬酰胺酶 |
01 |
|
1 |
MDXAM |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
門冬酰胺酶注射劑 |
|
MDXAMZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XXM078B014 |
門冬酰胺酶 |
01 |
|
1 |
MDXAM |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
門冬酰胺酶凍干粉針 |
|
MDXAMDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XXQ027A001 |
羥基脲 |
01 |
|
1 |
QJN |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
羥基脲片劑 |
|
QJNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XXQ027E001 |
羥基脲 |
01 |
|
1 |
QJN |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
羥基脲硬膠囊 |
|
QJNYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XXW004A001 |
維A酸 |
01 |
|
1 |
WAS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
維A酸片劑 |
|
WASPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XXW004E001 |
維A酸 |
01 |
|
1 |
WAS |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
維A酸硬膠囊 |
|
WASYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL01XXA089B002 |
安吖啶 |
01 |
|
2 |
AD |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
安吖啶注射液 |
|
ADZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXC054E001 |
雌莫司汀 |
01 |
|
2 |
CMST |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
雌莫司汀硬膠囊 |
|
CMSTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXG011B001 |
甘氨雙唑鈉 |
01 |
|
2 |
GASZN |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
甘氨雙唑鈉注射劑 |
|
GASZNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限頭頸部惡性腫瘤 |
0.2 |
0.2 |
|
| XL01XXG011B014 |
甘氨雙唑鈉 |
01 |
|
2 |
GASZN |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
甘氨雙唑鈉凍干粉針 |
|
GASZNDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限頭頸部惡性腫瘤 |
0.2 |
0.2 |
|
| XL01XXJ090A001 |
甲異靛 |
01 |
|
2 |
JYD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
甲異靛片劑 |
|
JYDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXL165A001 |
六甲蜜胺 |
01 |
|
2 |
LJMA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
六甲蜜胺片劑 |
|
LJMAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXL165A012 |
六甲蜜胺 |
01 |
|
2 |
LJMA |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
六甲蜜胺腸溶片 |
|
LJMACRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXL165E001 |
六甲蜜胺 |
01 |
|
2 |
LJMA |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
六甲蜜胺硬膠囊 |
|
LJMAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXY005B014 |
亞砷酸（三氧化二砷） |
01 |
|
2 |
YSS(SYHES) |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
亞砷酸（三氧化二砷）凍干粉針 |
|
YSS(SYHES)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL01XXY229B002 |
亞砷酸氯化鈉 |
01 |
|
2 |
YSSLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
亞砷酸氯化鈉注射液 |
|
YSSLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL01XXT165B002 |
銅綠假單胞菌 |
01 |
|
2 |
TLJDBJ |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
銅綠假單胞菌注射液 |
|
TLJDBJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限惡性腫瘤輔助治療 |
0.1 |
0.1 |
|
| XL01XXX138B002 |
小牛脾提取物 |
01 |
|
2 |
XNPTQW |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
小牛脾提取物注射液 |
|
XNPTQWZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限再生障礙性貧血、惡性腫瘤放化療引起的白細胞減少 |
0.2 |
0.2 |
|
| XL01XXC073B001 |
重組改構人腫瘤壞死因子 |
01 |
|
2 |
CZGGRZLHSYZ |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組改構人腫瘤壞死因子注射劑 |
|
CZGGRZLHSYZZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限非小細胞肺癌、非霍奇金氏淋巴瘤患者化療輔助治療 |
0.2 |
0.2 |
|
| XL02AEB119B001 |
丙氨瑞林 |
01 |
|
2 |
BARL |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
丙氨瑞林注射劑 |
|
BARLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02AEG062B014 |
戈那瑞林 |
01 |
|
2 |
GNRL |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
戈那瑞林凍干粉針 |
|
GNRLDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02AEG063J004 |
戈舍瑞林 |
01 |
|
2 |
GSRL |
|
40000 |
0.1 |
0.1 |
J004 |
|
|
|
|
|
|
戈舍瑞林緩釋植入劑 |
|
GSRLHSZRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02AEL086B015 |
亮丙瑞林 |
01 |
|
2 |
LBRL |
|
40000 |
0.1 |
0.1 |
B015 |
|
|
|
|
|
|
亮丙瑞林微球注射劑 |
|
LBRLWQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02AEL086B024 |
亮丙瑞林 |
01 |
|
2 |
LBRL |
|
40000 |
0.1 |
0.1 |
B024 |
|
|
|
|
|
|
亮丙瑞林緩釋微球注射劑 |
|
LBRLHSWQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02AEQ108B001 |
曲普瑞林 |
01 |
|
2 |
QPRL |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
曲普瑞林注射劑 |
|
QPRLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02AEQ108B002 |
曲普瑞林 |
01 |
|
2 |
QPRL |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
曲普瑞林注射液 |
|
QPRLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BAT003A001 |
他莫昔芬 |
01 |
|
1 |
TMXF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
他莫昔芬片劑 |
|
TMXFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL02BGA045A001 |
阿那曲唑 |
01 |
|
2 |
ANQZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
阿那曲唑片劑 |
|
ANQZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BBB085A001 |
比卡魯胺 |
01 |
|
2 |
BKLA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
比卡魯胺片劑 |
|
BKLAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BBB085E001 |
比卡魯胺 |
01 |
|
2 |
BKLA |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
比卡魯胺硬膠囊 |
|
BKLAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BBF094A001 |
氟他胺 |
01 |
|
2 |
FTA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氟他胺片劑 |
|
FTAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BBF094E001 |
氟他胺 |
01 |
|
2 |
FTA |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氟他胺硬膠囊 |
|
FTAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BGL020A001 |
來曲唑 |
01 |
|
2 |
LQZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
來曲唑片劑 |
|
LQZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BAT120A001 |
托瑞米芬 |
01 |
|
2 |
TRMF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
托瑞米芬片劑 |
|
TRMFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BGY096A001 |
依西美坦 |
01 |
|
2 |
YXMT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
依西美坦片劑 |
|
YXMTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL02BGY096E001 |
依西美坦 |
01 |
|
2 |
YXMT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
依西美坦硬膠囊 |
|
YXMTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL03AAJ213B002 |
聚乙二醇化重組人粒細胞刺激因子 |
01 |
|
2 |
JYECHCZRLXBCJYZ |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
聚乙二醇化重組人粒細胞刺激因子注射液 |
|
JYECHCZRLXBCJYZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限前次化療曾發(fā)生重度中性粒細胞減少合并發(fā)熱的患者 |
0.2 |
0.2 |
|
| XL03AAC106B002 |
重組人粒細胞刺激因子 |
01 |
|
2 |
CZRLXBCJYZ |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
重組人粒細胞刺激因子注射液 |
|
CZRLXBCJYZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療后的骨髓抑制 |
0.1 |
0.1 |
|
| XL03AAC146B001 |
重組人粒細胞刺激因子（CHO細胞） |
01 |
|
2 |
CZRLXBCJYZ(CHOXB) |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
重組人粒細胞刺激因子（CHO細胞）注射劑 |
|
CZRLXBCJYZ(CHOXB)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療后的骨髓抑制 |
0.1 |
0.1 |
|
| XL03AAC108B001 |
重組人粒細胞巨噬細胞刺激因子 |
01 |
|
2 |
CZRLXBJSXBCJYZ |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
重組人粒細胞巨噬細胞刺激因子注射劑 |
|
CZRLXBJSXBCJYZZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療后的骨髓抑制 |
0.1 |
0.1 |
|
| XL03AAC108B014 |
重組人粒細胞巨噬細胞刺激因子 |
01 |
|
2 |
CZRLXBJSXBCJYZ |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
重組人粒細胞巨噬細胞刺激因子凍干粉針 |
|
CZRLXBJSXBCJYZDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療后的骨髓抑制 |
0.1 |
0.1 |
|
| XL03ABJ163B002 |
聚乙二醇干擾素α2a |
01 |
|
2 |
JYECGRS2A |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
聚乙二醇干擾素α2a注射液 |
|
JYECGRS2AZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限丙肝、慢性活動性乙肝，連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.1 |
0.1 |
|
| XL03ABJ164B001 |
聚乙二醇干擾素α2b |
01 |
|
2 |
JYECGRS2B |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
聚乙二醇干擾素α2b注射劑 |
|
JYECGRS2BZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限丙肝、慢性活動性乙肝，連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.1 |
0.1 |
|
| XL03ABJ164B002 |
聚乙二醇干擾素α2b |
01 |
|
2 |
JYECGRS2B |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
聚乙二醇干擾素α2b注射液 |
|
JYECGRS2BZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限丙肝、慢性活動性乙肝，連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.1 |
0.1 |
|
| XL03ABC094B001 |
重組人干擾素α1b |
01 |
|
2 |
CZRGRS1B |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人干擾素α1b注射劑 |
|
CZRGRS1BZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC094B002 |
重組人干擾素α1b |
01 |
|
2 |
CZRGRS1B |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
重組人干擾素α1b注射液 |
|
CZRGRS1BZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC094B014 |
重組人干擾素α1b |
01 |
|
2 |
CZRGRS1B |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人干擾素α1b凍干粉針 |
|
CZRGRS1BDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC095B001 |
重組人干擾素α2a |
01 |
|
2 |
CZRGRS2A |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人干擾素α2a注射劑 |
|
CZRGRS2AZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC095B002 |
重組人干擾素α2a |
01 |
|
2 |
CZRGRS2A |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
重組人干擾素α2a注射液 |
|
CZRGRS2AZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC095B014 |
重組人干擾素α2a |
01 |
|
2 |
CZRGRS2A |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人干擾素α2a凍干粉針 |
|
CZRGRS2ADGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC096B001 |
重組人干擾素α2a（酵母） |
01 |
|
2 |
CZRGRS2A(JM) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人干擾素α2a（酵母）注射劑 |
|
CZRGRS2A(JM)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC096B014 |
重組人干擾素α2a（酵母） |
01 |
|
2 |
CZRGRS2A(JM) |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人干擾素α2a（酵母）凍干粉針 |
|
CZRGRS2A(JM)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC097B001 |
重組人干擾素α2b |
01 |
|
2 |
CZRGRS2B |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人干擾素α2b注射劑 |
|
CZRGRS2BZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC097B002 |
重組人干擾素α2b |
01 |
|
2 |
CZRGRS2B |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
重組人干擾素α2b注射液 |
|
CZRGRS2BZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC097B014 |
重組人干擾素α2b |
01 |
|
2 |
CZRGRS2B |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人干擾素α2b凍干粉針 |
|
CZRGRS2BDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC098B001 |
重組人干擾素α2b（假單胞菌） |
01 |
|
2 |
CZRGRS2B(JDBJ) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人干擾素α2b（假單胞菌）注射劑 |
|
CZRGRS2B(JDBJ)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC098B002 |
重組人干擾素α2b（假單胞菌） |
01 |
|
2 |
CZRGRS2B(JDBJ) |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
重組人干擾素α2b（假單胞菌）注射液 |
|
CZRGRS2B(JDBJ)ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC098B003 |
重組人干擾素α2b（假單胞菌） |
01 |
|
2 |
CZRGRS2B(JDBJ) |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
重組人干擾素α2b（假單胞菌）注射用無菌粉末 |
|
CZRGRS2B(JDBJ)ZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC099B001 |
重組人干擾素α2b（酵母） |
01 |
|
2 |
CZRGRS2B(JM) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人干擾素α2b（酵母）注射劑 |
|
CZRGRS2B(JM)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ABC099B014 |
重組人干擾素α2b（酵母） |
01 |
|
2 |
CZRGRS2B(JM) |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人干擾素α2b（酵母）凍干粉針 |
|
CZRGRS2B(JM)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限白血病、淋巴瘤、黑色素瘤、腎癌、多發(fā)性骨髓瘤、丙肝、慢性活動性乙肝。丙肝、慢性活動性乙肝連續(xù)使用6個月無效時停藥，連續(xù)使用不超過12個月 |
0.2 |
0.2 |
|
| XL03ACC084B001 |
重組人白介素-11 |
01 |
|
2 |
CZRBJS-11 |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人白介素-11注射劑 |
|
CZRBJS-11ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療引起的嚴重血小板減少患者 |
0.2 |
0.2 |
|
| XL03ACC084B003 |
重組人白介素-11 |
01 |
|
2 |
CZRBJS-11 |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
重組人白介素-11注射用無菌粉末 |
|
CZRBJS-11ZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療引起的嚴重血小板減少患者 |
0.2 |
0.2 |
|
| XL03ACC084B014 |
重組人白介素-11 |
01 |
|
2 |
CZRBJS-11 |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人白介素-11凍干粉針 |
|
CZRBJS-11DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療引起的嚴重血小板減少患者 |
0.2 |
0.2 |
|
| XL03ACC085B001 |
重組人白介素-11（Ⅰ） |
01 |
|
2 |
CZRBJS-11() |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人白介素-11（Ⅰ）注射劑 |
|
CZRBJS-11()ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療引起的嚴重血小板減少患者 |
0.2 |
0.2 |
|
| XL03ACC158B001 |
重組人白介素-11（酵母） |
01 |
|
2 |
CZRBJS-11(JM) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人白介素-11（酵母）注射劑 |
|
CZRBJS-11(JM)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限放化療引起的嚴重血小板減少患者 |
0.2 |
0.2 |
|
| XL03ACC086B001 |
重組人白介素-2 |
01 |
|
2 |
CZRBJS-2 |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人白介素-2注射劑 |
|
CZRBJS-2ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC086B002 |
重組人白介素-2 |
01 |
|
2 |
CZRBJS-2 |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
重組人白介素-2注射液 |
|
CZRBJS-2ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC086B013 |
重組人白介素-2 |
01 |
|
2 |
CZRBJS-2 |
|
40000 |
0.2 |
0.2 |
B013 |
|
|
|
|
|
|
重組人白介素-2無菌粉針 |
|
CZRBJS-2WJFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC086B014 |
重組人白介素-2 |
01 |
|
2 |
CZRBJS-2 |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人白介素-2凍干粉針 |
|
CZRBJS-2DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC128B001 |
重組人白介素-2（Ⅰ） |
01 |
|
2 |
CZRBJS-2() |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人白介素-2（Ⅰ）注射劑 |
|
CZRBJS-2()ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC087B002 |
重組人白介素-2（125Ala） |
01 |
|
2 |
CZRBJS-2(125ALA) |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
重組人白介素-2（125Ala）注射液 |
|
CZRBJS-2(125ALA)ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC087B014 |
重組人白介素-2（125Ala） |
01 |
|
2 |
CZRBJS-2(125ALA) |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人白介素-2（125Ala）凍干粉針 |
|
CZRBJS-2(125ALA)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC088B001 |
重組人白介素-2（125Ser） |
01 |
|
2 |
CZRBJS-2(125SER) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人白介素-2（125Ser）注射劑 |
|
CZRBJS-2(125SER)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03ACC088B014 |
重組人白介素-2（125Ser） |
01 |
|
2 |
CZRBJS-2(125SER) |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
重組人白介素-2（125Ser）凍干粉針 |
|
CZRBJS-2(125SER)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎細胞癌、黑色素瘤、癌性胸腹腔積液 |
0.2 |
0.2 |
|
| XL03AXJ004B001 |
肌苷 |
01 |
|
1 |
JG |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
肌苷注射劑 |
|
JGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXJ004B002 |
肌苷 |
01 |
|
1 |
JG |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
肌苷注射液 |
|
JGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXJ004B014 |
肌苷 |
01 |
|
1 |
JG |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
肌苷凍干粉針 |
|
JGDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXA195A001 |
氨肽素 |
01 |
|
2 |
ATS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氨肽素片劑 |
|
ATSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXA195A018 |
氨肽素 |
01 |
|
2 |
ATS |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
氨肽素糖衣片 |
|
ATSTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXC006B002 |
草分枝桿菌F.U.36 |
01 |
|
2 |
CFZGJF..36 |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
草分枝桿菌F.U.36注射液 |
|
CFZGJF..36ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL03AXS055A001 |
鯊肝醇 |
01 |
|
2 |
SGC |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
鯊肝醇片劑 |
|
SGCPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXW040A001 |
維生素B4（腺嘌呤） |
01 |
|
2 |
WSSB4(XPL) |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
維生素B4（腺嘌呤）片劑 |
|
WSSB4(XPL)PJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL03AXX234B001 |
胸腺法新 |
01 |
|
2 |
XXFX |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
胸腺法新注射劑 |
|
XXFXZSJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XL03AXX234B003 |
胸腺法新 |
01 |
|
2 |
XXFX |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
胸腺法新注射用無菌粉末 |
|
XXFXZSYWJFM |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XL03AXB158B002 |
薄芝糖肽 |
01 |
|
2 |
BZTT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
薄芝糖肽注射液 |
|
BZTTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限進行性肌營養(yǎng)不良、萎縮性肌強直 |
0.2 |
0.2 |
|
| XL03AXG029A001 |
甘露聚糖肽 |
01 |
|
2 |
GLJTT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
甘露聚糖肽片劑 |
|
GLJTTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限免疫功能低下、再生障礙性貧血、惡性腫瘤放化療引起的白細胞減少 |
0.1 |
0.1 |
|
| XL03AXG029E001 |
甘露聚糖肽 |
01 |
|
2 |
GLJTT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
甘露聚糖肽硬膠囊 |
|
GLJTTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限免疫功能低下、再生障礙性貧血、惡性腫瘤放化療引起的白細胞減少 |
0.1 |
0.1 |
|
| XL03AXG029B001 |
甘露聚糖肽 |
01 |
|
2 |
GLJTT |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
甘露聚糖肽注射劑 |
|
GLJTTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限再生障礙性貧血、惡性腫瘤放化療引起的白細胞減少 |
0.1 |
0.1 |
|
| XL03AXG029B002 |
甘露聚糖肽 |
01 |
|
2 |
GLJTT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
甘露聚糖肽注射液 |
|
GLJTTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限再生障礙性貧血、惡性腫瘤放化療引起的白細胞減少 |
0.1 |
0.1 |
|
| XL03AXK015B002 |
卡介菌多糖核酸 |
01 |
|
2 |
KJJDTHS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
卡介菌多糖核酸注射液 |
|
KJJDTHSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL03AXP048B002 |
脾多肽 |
01 |
|
2 |
PDT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
脾多肽注射液 |
|
PDTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限惡性腫瘤放化療引起的白細胞減少 |
0.2 |
0.2 |
|
| XL03AXP050X001 |
匹多莫德 |
01 |
|
2 |
PDMD |
|
40000 |
0.2 |
0.2 |
X001 |
|
|
|
|
|
|
匹多莫德口服溶液劑 |
|
PDMDKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL03AXP050X008 |
匹多莫德 |
01 |
|
2 |
PDMD |
|
40000 |
0.2 |
0.2 |
X008 |
|
|
|
|
|
|
匹多莫德口服液 |
|
PDMDKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL03AXT124B001 |
脫氧核苷酸 |
01 |
|
2 |
TYHGS |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
脫氧核苷酸注射劑 |
|
TYHGSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限惡性腫瘤放化療引起的白細胞減少 |
0.1 |
0.1 |
|
| XL03AXT124B002 |
脫氧核苷酸 |
01 |
|
2 |
TYHGS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
脫氧核苷酸注射液 |
|
TYHGSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限惡性腫瘤放化療引起的白細胞減少 |
0.1 |
0.1 |
|
| XL03AXX056A001 |
香菇菌多糖 |
01 |
|
2 |
XGJDT |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
香菇菌多糖片劑 |
|
XGJDTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限免疫功能低下 |
0.2 |
0.2 |
|
| XL03AXX056A017 |
香菇菌多糖 |
01 |
|
2 |
XGJDT |
|
40000 |
0.2 |
0.2 |
A017 |
|
|
|
|
|
|
香菇菌多糖薄膜衣片 |
|
XGJDTBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
限免疫功能低下 |
0.2 |
0.2 |
|
| XL03AXX056A018 |
香菇菌多糖 |
01 |
|
2 |
XGJDT |
|
40000 |
0.2 |
0.2 |
A018 |
|
|
|
|
|
|
香菇菌多糖糖衣片 |
|
XGJDTTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
限免疫功能低下 |
0.2 |
0.2 |
|
| XL03AXX160A012 |
胸腺肽 |
01 |
|
2 |
XXT |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
胸腺肽腸溶片 |
|
XXTCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性或繼發(fā)性T細胞缺陷導致免疫功能低下的患者 |
0.1 |
0.1 |
|
| XL03AXX160E005 |
胸腺肽 |
01 |
|
2 |
XXT |
|
40000 |
0.1 |
0.1 |
E005 |
|
|
|
|
|
|
胸腺肽腸溶膠囊 |
|
XXTCRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性或繼發(fā)性T細胞缺陷導致免疫功能低下的患者 |
0.1 |
0.1 |
|
| XL03AXX160B001 |
胸腺肽 |
01 |
|
2 |
XXT |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
胸腺肽注射劑 |
|
XXTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性或繼發(fā)性T細胞缺陷導致免疫功能低下的患者 |
0.1 |
0.1 |
|
| XL03AXX160B002 |
胸腺肽 |
01 |
|
2 |
XXT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
胸腺肽注射液 |
|
XXTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性或繼發(fā)性T細胞缺陷導致免疫功能低下的患者 |
0.1 |
0.1 |
|
| XL03AXX160B014 |
胸腺肽 |
01 |
|
2 |
XXT |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
胸腺肽凍干粉針 |
|
XXTDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限原發(fā)性或繼發(fā)性T細胞缺陷導致免疫功能低下的患者 |
0.1 |
0.1 |
|
| XL04AAL019A001 |
來氟米特 |
01 |
|
2 |
LFMT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
來氟米特片劑 |
|
LFMTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL04AAL019A017 |
來氟米特 |
01 |
|
2 |
LFMT |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
來氟米特薄膜衣片 |
|
LFMTBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL04AAL019E001 |
來氟米特 |
01 |
|
2 |
LFMT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
來氟米特硬膠囊 |
|
LFMTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL04AAM026A001 |
嗎替麥考酚酯 |
01 |
|
2 |
MTMKFZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
嗎替麥考酚酯片劑 |
|
MTMKFZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAM026A006 |
嗎替麥考酚酯 |
01 |
|
2 |
MTMKFZ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
嗎替麥考酚酯分散片 |
|
MTMKFZFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAM026E001 |
嗎替麥考酚酯 |
01 |
|
2 |
MTMKFZ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
嗎替麥考酚酯硬膠囊 |
|
MTMKFZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAM026X006 |
嗎替麥考酚酯 |
01 |
|
2 |
MTMKFZ |
|
40000 |
0.1 |
0.1 |
X006 |
|
|
|
|
|
|
嗎替麥考酚酯干混懸劑 |
|
MTMKFZGHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限口服吞咽困難的器官移植后抗排異反應 |
0.1 |
0.1 |
|
| XL04AAM033A012 |
麥考酚鈉 |
01 |
|
2 |
MKFN |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
麥考酚鈉腸溶片 |
|
MKFNCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAX009A001 |
西羅莫司 |
01 |
|
2 |
XLMS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
西羅莫司片劑 |
|
XLMSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAX009E001 |
西羅莫司 |
01 |
|
2 |
XLMS |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
西羅莫司硬膠囊 |
|
XLMSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAX009X001 |
西羅莫司 |
01 |
|
2 |
XLMS |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
西羅莫司口服溶液劑 |
|
XLMSKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的抗排異反應 |
0.1 |
0.1 |
|
| XL04AAK112B001 |
抗人T細胞兔免疫球蛋白 |
01 |
|
2 |
KRTXBTMYQDB |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
抗人T細胞兔免疫球蛋白注射劑 |
|
KRTXBTMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植排斥反應高危人群的誘導治療；急性排斥反應的治療；重型再生障礙性貧血 |
0.2 |
0.2 |
|
| XL04AAK112B014 |
抗人T細胞兔免疫球蛋白 |
01 |
|
2 |
KRTXBTMYQDB |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
抗人T細胞兔免疫球蛋白凍干粉針 |
|
KRTXBTMYQDBDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植排斥反應高危人群的誘導治療；急性排斥反應的治療；重型再生障礙性貧血 |
0.2 |
0.2 |
|
| XL04AAT108B001 |
兔抗人胸腺細胞免疫球蛋白 |
01 |
|
2 |
TKRXXXBMYQDB |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
兔抗人胸腺細胞免疫球蛋白注射劑 |
|
TKRXXXBMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植排斥反應高危人群的誘導治療；急性排斥反應的治療；重型再生障礙性貧血 |
0.2 |
0.2 |
|
| XL04AAK113B001 |
抗人T細胞豬免疫球蛋白 |
01 |
|
2 |
KRTXBZMYQDB |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
抗人T細胞豬免疫球蛋白注射劑 |
|
KRTXBZMYQDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植排斥反應高危人群的誘導治療；急性排斥反應的治療；重型再生障礙性貧血；原發(fā)性血小板減少性紫癜。 |
0.2 |
0.2 |
|
| XL04ACB003B001 |
巴利昔單抗 |
01 |
|
2 |
BLXDK |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
巴利昔單抗注射劑 |
|
BLXDKZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植的誘導治療 |
0.2 |
0.2 |
|
| XL04ABC082B001 |
重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白 |
01 |
|
2 |
CZRXZLHSYZST-KTRHDB |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白注射劑 |
|
CZRXZLHSYZST-KTRHDBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限診斷明確的類風濕關節(jié)炎經傳統(tǒng)DMARDs治療3-6個月疾病活動度下降低于50%者；診斷明確的強直性脊柱炎（不含放射學前期中軸性脊柱關節(jié)炎）NSAIDs充分治療3個月疾病活動度下降低于50%者；并需風濕病?？漆t(yī)師處方。限成人重度斑塊狀銀屑病。 |
0.2 |
0.2 |
|
| XL04ABC082B003 |
重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白 |
01 |
|
2 |
CZRXZLHSYZST-KTRHDB |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白注射用無菌粉末 |
|
CZRXZLHSYZST-KTRHDBZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限診斷明確的類風濕關節(jié)炎經傳統(tǒng)DMARDs治療3-6個月疾病活動度下降低于50%者；診斷明確的強直性脊柱炎（不含放射學前期中軸性脊柱關節(jié)炎）NSAIDs充分治療3個月疾病活動度下降低于50%者；并需風濕病?？漆t(yī)師處方。限成人重度斑塊狀銀屑病。 |
0.2 |
0.2 |
|
| XL04ABG180B002 |
戈利木單抗 |
01 |
|
2 |
GLMDK |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
戈利木單抗注射液 |
|
GLMDKZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限診斷明確的類風濕關節(jié)炎經傳統(tǒng)DMARDs治療3-6個月疾病活動度下降低于50%者；診斷明確的強直性脊柱炎（不含放射學前期中軸性脊柱關節(jié)炎）NSAIDs充分治療3個月疾病活動度下降低于50%者；并需風濕病?？漆t(yī)師處方。 |
0.2 |
0.2 |
|
| XL04ACT156B002 |
托珠單抗 |
01 |
|
2 |
TZDK |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
托珠單抗注射液 |
|
TZDKZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限全身型幼年特發(fā)性關節(jié)炎的二線治療；限診斷明確的類風濕關節(jié)炎經傳統(tǒng)DMARDs治療3-6個月疾病活動度下降低于50%者。 |
0.2 |
0.2 |
|
| XL04ADH033E001 |
環(huán)孢素 |
01 |
|
1 |
HBS |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
環(huán)孢素硬膠囊 |
|
HBSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL04ADH033E002 |
環(huán)孢素 |
01 |
|
1 |
HBS |
|
40000 |
0 |
0 |
E002 |
|
|
|
|
|
|
環(huán)孢素軟膠囊 |
|
HBSRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL04ADH033X001 |
環(huán)孢素 |
01 |
|
1 |
HBS |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
環(huán)孢素口服溶液劑 |
|
HBSKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL04ADH033B002 |
環(huán)孢素 |
01 |
|
1 |
HBS |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
環(huán)孢素注射液 |
|
HBSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL04ADT002E001 |
他克莫司 |
01 |
|
2 |
TKMS |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
他克莫司硬膠囊 |
|
TKMSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL04ADT002E003 |
他克莫司 |
01 |
|
2 |
TKMS |
|
40000 |
0.2 |
0.2 |
E003 |
|
|
|
|
|
|
他克莫司緩釋膠囊 |
|
TKMSHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XL04AXJ025A001 |
甲氨蝶呤 |
01 |
|
1 |
JADL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
甲氨蝶呤片劑 |
|
JADLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL04AXL155A001 |
硫唑嘌呤 |
01 |
|
1 |
LZPL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
硫唑嘌呤片劑 |
|
LZPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XL04AXB209E001 |
吡非尼酮 |
01 |
|
2 |
BFNT |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
吡非尼酮硬膠囊 |
|
BFNTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限特發(fā)性肺纖維化 |
0.2 |
0.2 |
|
| XL04AXM088A001 |
咪唑立賓 |
01 |
|
2 |
MZLB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
咪唑立賓片劑 |
|
MZLBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限器官移植后的排異反應 |
0.1 |
0.1 |
|
| XL04AXS052A001 |
沙利度胺 |
01 |
|
2 |
SLDA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
沙利度胺片劑 |
|
SLDAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL04AXS052E001 |
沙利度胺 |
01 |
|
2 |
SLDA |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
沙利度胺硬膠囊 |
|
SLDAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XL04AXL344E001 |
來那度胺 |
01 |
|
2 |
LNDA |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
來那度胺硬膠囊 |
|
LNDAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限曾接受過至少一種療法的多發(fā)性骨髓瘤的成年患者，并滿足以下條件：1、每2個療程需提供治療有效的證據后方可繼續(xù)支付；2、由三級醫(yī)院血液專科或血液?？漆t(yī)院醫(yī)師處方。 |
0.2 |
0.2 |
|
| XM01ABS120A001 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
雙氯芬酸片劑 |
|
SLFSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120A006 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
雙氯芬酸分散片 |
|
SLFSFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120A012 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A012 |
|
|
|
|
|
|
雙氯芬酸腸溶片 |
|
SLFSCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120A017 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
雙氯芬酸薄膜衣片 |
|
SLFSBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120E001 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
雙氯芬酸硬膠囊 |
|
SLFSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120E005 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
E005 |
|
|
|
|
|
|
雙氯芬酸腸溶膠囊 |
|
SLFSCRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120A010 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
雙氯芬酸緩釋片 |
|
SLFSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120E003 |
雙氯芬酸 |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
雙氯芬酸緩釋膠囊 |
|
SLFSHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS213A010 |
雙氯芬酸Ⅰ |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
雙氯芬酸Ⅰ緩釋片 |
|
SLFSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS213E003 |
雙氯芬酸Ⅰ |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
雙氯芬酸Ⅰ緩釋膠囊 |
|
SLFSHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS236E003 |
雙氯芬酸Ⅲ |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
雙氯芬酸Ⅲ緩釋膠囊 |
|
SLFSHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS214A010 |
雙氯芬酸Ⅳ |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
雙氯芬酸Ⅳ緩釋片 |
|
SLFSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS221A010 |
雙氯芬酸Ⅴ |
01 |
|
1 |
SLFS |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
雙氯芬酸Ⅴ緩釋片 |
|
SLFSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABY174D001 |
吲哚美辛 |
01 |
|
1 |
YDMX |
|
40000 |
0 |
0 |
D001 |
|
|
|
|
|
|
吲哚美辛栓劑 |
|
YDMXSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABS120E007 |
雙氯芬酸 |
01 |
|
2 |
SLFS |
|
40000 |
0.1 |
0.1 |
E007 |
|
|
|
|
|
|
雙氯芬酸雙釋放腸溶膠囊 |
|
SLFSSSFCRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABS120E013 |
雙氯芬酸 |
01 |
|
2 |
SLFS |
|
40000 |
0.1 |
0.1 |
E013 |
|
|
|
|
|
|
雙氯芬酸腸溶緩釋膠囊 |
|
SLFSCRHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM02AAS120D001 |
雙氯芬酸 |
01 |
|
2 |
SLFS |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
雙氯芬酸栓劑 |
|
SLFSSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM02AAS212D001 |
雙氯芬酸Ⅱ |
01 |
|
2 |
SLFS |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
雙氯芬酸Ⅱ栓劑 |
|
SLFSSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABA196A012 |
氨糖美辛 |
01 |
|
2 |
ATMX |
|
40000 |
0 |
0 |
A012 |
|
|
|
|
|
|
氨糖美辛腸溶片 |
|
ATMXCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABA196E005 |
氨糖美辛 |
01 |
|
2 |
ATMX |
|
40000 |
0 |
0 |
E005 |
|
|
|
|
|
|
氨糖美辛腸溶膠囊 |
|
ATMXCRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABC065A001 |
醋氯芬酸 |
01 |
|
2 |
CLFS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
醋氯芬酸片劑 |
|
CLFSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABC065A006 |
醋氯芬酸 |
01 |
|
2 |
CLFS |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
醋氯芬酸分散片 |
|
CLFSFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABC065A012 |
醋氯芬酸 |
01 |
|
2 |
CLFS |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
醋氯芬酸腸溶片 |
|
CLFSCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABC065E001 |
醋氯芬酸 |
01 |
|
2 |
CLFS |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
醋氯芬酸硬膠囊 |
|
CLFSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABC065E005 |
醋氯芬酸 |
01 |
|
2 |
CLFS |
|
40000 |
0.1 |
0.1 |
E005 |
|
|
|
|
|
|
醋氯芬酸腸溶膠囊 |
|
CLFSCRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABS092A001 |
舒林酸 |
01 |
|
2 |
SLS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
舒林酸片劑 |
|
SLSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABS092E001 |
舒林酸 |
01 |
|
2 |
SLS |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
舒林酸硬膠囊 |
|
SLSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ABT149B002 |
酮咯酸氨丁三醇 |
01 |
|
2 |
TLSADSC |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
酮咯酸氨丁三醇注射液 |
|
TLSADSCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限手術后疼痛或嚴重急性疼痛的短期治療 |
0.2 |
0.2 |
|
| XM01ABY174A001 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
吲哚美辛片劑 |
|
YDMXPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABY174A012 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0 |
0 |
A012 |
|
|
|
|
|
|
吲哚美辛腸溶片 |
|
YDMXCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABY174E001 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
吲哚美辛硬膠囊 |
|
YDMXYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABY174A010 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
吲哚美辛緩釋片 |
|
YDMXHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABY174E003 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
吲哚美辛緩釋膠囊 |
|
YDMXHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ABF643E001 |
復方川芎吲哚美辛 |
01 |
|
2 |
FFCXYDMX |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
復方川芎吲哚美辛硬膠囊 |
|
FFCXYDMXYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ACB098A001 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
吡羅昔康片劑 |
|
BLXKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ACB098A012 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0 |
0 |
A012 |
|
|
|
|
|
|
吡羅昔康腸溶片 |
|
BLXKCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ACB098A017 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
吡羅昔康薄膜衣片 |
|
BLXKBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ACB098A018 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
吡羅昔康糖衣片 |
|
BLXKTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ACB098A025 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
吡羅昔康素片 |
|
BLXKSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ACB098E001 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
吡羅昔康硬膠囊 |
|
BLXKYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01ACL238B001 |
氯諾昔康 |
01 |
|
2 |
LNXK |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
氯諾昔康注射劑 |
|
LNXKZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ACL238B014 |
氯諾昔康 |
01 |
|
2 |
LNXK |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
氯諾昔康凍干粉針 |
|
LNXKDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ACM049A001 |
美洛昔康 |
01 |
|
2 |
MLXK |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
美洛昔康片劑 |
|
MLXKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ACM049A006 |
美洛昔康 |
01 |
|
2 |
MLXK |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
美洛昔康分散片 |
|
MLXKFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01ACM049E001 |
美洛昔康 |
01 |
|
2 |
MLXK |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
美洛昔康硬膠囊 |
|
MLXKYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEB173A001 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
布洛芬片劑 |
|
BLFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173A006 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
布洛芬分散片 |
|
BLFFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173A017 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
布洛芬薄膜衣片 |
|
BLFBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173A018 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
布洛芬糖衣片 |
|
BLFTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173A025 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
布洛芬素片 |
|
BLFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173E001 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
布洛芬硬膠囊 |
|
BLFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173E002 |
布洛芬 |
01 |
|
1 |
BLF |
|
40000 |
0 |
0 |
E002 |
|
|
|
|
|
|
布洛芬軟膠囊 |
|
BLFRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEX094D001 |
小兒布洛芬 |
01 |
|
1 |
XEBLF |
|
40000 |
1 |
1 |
D001 |
|
|
|
|
|
|
小兒布洛芬栓劑 |
|
XEBLFSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173K001 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
K001 |
|
|
|
|
|
|
布洛芬糖漿劑 |
|
BLFTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173X001 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
布洛芬口服溶液劑 |
|
BLFKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173X002 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
X002 |
|
|
|
|
|
|
布洛芬口服混懸劑 |
|
BLFKFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173X004 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
X004 |
|
|
|
|
|
|
布洛芬口服滴劑 |
|
BLFKFDJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173X006 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
X006 |
|
|
|
|
|
|
布洛芬干混懸劑 |
|
BLFGHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173A010 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
布洛芬緩釋片 |
|
BLFHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173E003 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
布洛芬緩釋膠囊 |
|
BLFHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEB173N001 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0 |
0 |
N001 |
|
|
|
|
|
|
布洛芬顆粒劑 |
|
BLFKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM02AAB173F002 |
布洛芬 |
01 |
|
2 |
BLF |
|
40000 |
0.1 |
0.1 |
F002 |
|
|
|
|
|
|
布洛芬乳膏劑 |
|
BLFRGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XM01AEF063V003 |
氟比洛芬 |
01 |
|
2 |
FBLF |
|
40000 |
0.2 |
0.2 |
V003 |
|
|
|
|
|
|
氟比洛芬貼膏劑 |
|
FBLFTGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM01AEF063V005 |
氟比洛芬 |
01 |
|
2 |
FBLF |
|
40000 |
0.1 |
0.1 |
V005 |
|
|
|
|
|
|
氟比洛芬巴布膏劑 |
|
FBLFBBGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEF063V006 |
氟比洛芬 |
01 |
|
2 |
FBLF |
|
40000 |
0.2 |
0.2 |
V006 |
|
|
|
|
|
|
氟比洛芬凝膠貼膏劑 |
|
FBLFNJTGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM01AEF064B002 |
氟比洛芬酯 |
01 |
|
2 |
FBLFZ |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
氟比洛芬酯注射液 |
|
FBLFZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限不能口服藥物或口服藥物效果不理想的術后鎮(zhèn)痛 |
0.1 |
0.1 |
|
| XM01AEJ130N001 |
精氨酸布洛芬 |
01 |
|
2 |
JASBLF |
|
40000 |
0.2 |
0.2 |
N001 |
|
|
|
|
|
|
精氨酸布洛芬顆粒劑 |
|
JASBLFKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM01AEL283A001 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
洛索洛芬片劑 |
|
LSLFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEL283A006 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
洛索洛芬分散片 |
|
LSLFFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEL283A017 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
洛索洛芬薄膜衣片 |
|
LSLFBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEL283E001 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
洛索洛芬硬膠囊 |
|
LSLFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEL283V001 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
V001 |
|
|
|
|
|
|
洛索洛芬貼劑 |
|
LSLFTJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEL283V006 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
V006 |
|
|
|
|
|
|
洛索洛芬凝膠貼膏劑 |
|
LSLFNJTGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEL283V003 |
洛索洛芬 |
01 |
|
2 |
LSLF |
|
40000 |
0.1 |
0.1 |
V003 |
|
|
|
|
|
|
洛索洛芬貼膏劑 |
|
LSLFTGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AEN028A001 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
萘普生片劑 |
|
NPSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEN028A006 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
萘普生分散片 |
|
NPSFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEN028A025 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
萘普生素片 |
|
NPSSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEN028E001 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
萘普生硬膠囊 |
|
NPSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEN028E011 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
E011 |
|
|
|
|
|
|
萘普生腸溶微丸膠囊 |
|
NPSCRWWJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEN028A010 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
萘普生緩釋片 |
|
NPSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEN028E003 |
萘普生 |
01 |
|
2 |
NPS |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
萘普生緩釋膠囊 |
|
NPSHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEY191X002 |
右旋布洛芬 |
01 |
|
2 |
YXBLF |
|
40000 |
1 |
1 |
X002 |
|
|
|
|
|
|
右旋布洛芬口服混懸劑 |
|
YXBLFKFHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XM01AEF026A001 |
芬布芬 |
01 |
|
2 |
FBF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
芬布芬片劑 |
|
FBFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEF026A018 |
芬布芬 |
01 |
|
2 |
FBF |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
芬布芬糖衣片 |
|
FBFTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEF026A025 |
芬布芬 |
01 |
|
2 |
FBF |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
芬布芬素片 |
|
FBFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AEF026E001 |
芬布芬 |
01 |
|
2 |
FBF |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
芬布芬硬膠囊 |
|
FBFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AHA273A001 |
艾瑞昔布 |
01 |
|
2 |
ARXB |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
艾瑞昔布片劑 |
|
ARXBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XM01AHP006B001 |
帕瑞昔布 |
01 |
|
2 |
PRXB |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
帕瑞昔布注射劑 |
|
PRXBZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限不能口服藥物或口服藥物效果不理想的術后鎮(zhèn)痛 |
0.1 |
0.1 |
|
| XM01AHS002E001 |
塞來昔布 |
01 |
|
2 |
SLXB |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
塞來昔布硬膠囊 |
|
SLXBYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XM01AHY094A001 |
依托考昔 |
01 |
|
2 |
YTKX |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
依托考昔片劑 |
|
YTKXPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XM01AXN018A001 |
萘丁美酮 |
01 |
|
1 |
NDMT |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
萘丁美酮片劑 |
|
NDMTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AXN018A006 |
萘丁美酮 |
01 |
|
1 |
NDMT |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
萘丁美酮分散片 |
|
NDMTFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AXN018E001 |
萘丁美酮 |
01 |
|
1 |
NDMT |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
萘丁美酮硬膠囊 |
|
NDMTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AXN042A001 |
尼美舒利 |
01 |
|
1 |
NMSL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
尼美舒利片劑 |
|
NMSLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AXN042A006 |
尼美舒利 |
01 |
|
1 |
NMSL |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
尼美舒利分散片 |
|
NMSLFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AXN042E001 |
尼美舒利 |
01 |
|
1 |
NMSL |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
尼美舒利硬膠囊 |
|
NMSLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM01AXA267A001 |
艾拉莫德 |
01 |
|
2 |
ALMD |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
艾拉莫德片劑 |
|
ALMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限活動性類風濕關節(jié)炎患者的二線治療 |
0.2 |
0.2 |
|
| XM01AXA165A001 |
氨基葡萄糖 |
01 |
|
2 |
AJPTT |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
氨基葡萄糖片劑 |
|
AJPTTPJ |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XM01AXA165E001 |
氨基葡萄糖 |
01 |
|
2 |
AJPTT |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
氨基葡萄糖硬膠囊 |
|
AJPTTYJN |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XM01AXB013E001 |
白芍總苷 |
01 |
|
2 |
BSZG |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
白芍總苷硬膠囊 |
|
BSZGYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AXC009A001 |
草烏甲素 |
01 |
|
2 |
CWJS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
草烏甲素片劑 |
|
CWJSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AXC009E002 |
草烏甲素 |
01 |
|
2 |
CWJS |
|
40000 |
0.1 |
0.1 |
E002 |
|
|
|
|
|
|
草烏甲素軟膠囊 |
|
CWJSRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM01AXS110E001 |
雙醋瑞因 |
01 |
|
2 |
SCRY |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
雙醋瑞因硬膠囊 |
|
SCRYYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM01CCQ053A001 |
青霉胺 |
01 |
|
1 |
QMA |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
青霉胺片劑 |
|
QMAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM02AXH005A001 |
漢防己甲素 |
01 |
|
2 |
HFJJS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
漢防己甲素片劑 |
|
HFJJSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限單純硅肺和煤硅肺 |
0.1 |
0.1 |
|
| XM02AXH005B002 |
漢防己甲素 |
01 |
|
2 |
HFJJS |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
漢防己甲素注射液 |
|
HFJJSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限單純硅肺和煤硅肺 |
0.2 |
0.2 |
|
| XM02AAS197F002 |
雙氯芬酸二乙胺 |
01 |
|
2 |
SLFSEYA |
|
40000 |
0.2 |
0.2 |
F002 |
|
|
|
|
|
|
雙氯芬酸二乙胺乳膏劑 |
|
SLFSEYARGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM02AAS197U001 |
雙氯芬酸二乙胺 |
01 |
|
2 |
SLFSEYA |
|
40000 |
0.2 |
0.2 |
U001 |
|
|
|
|
|
|
雙氯芬酸二乙胺凝膠劑 |
|
SLFSEYANJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM02AAS197U002 |
雙氯芬酸二乙胺 |
01 |
|
2 |
SLFSEYA |
|
40000 |
0.2 |
0.2 |
U002 |
|
|
|
|
|
|
雙氯芬酸二乙胺乳膠劑 |
|
SLFSEYARJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM02AXZ008F001 |
樟腦 |
01 |
|
2 |
ZN |
|
40000 |
0.1 |
0.1 |
F001 |
|
|
|
|
|
|
樟腦軟膏劑 |
|
ZNRGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM02AXZ008T001 |
樟腦 |
01 |
|
2 |
ZN |
|
40000 |
0.1 |
0.1 |
T001 |
|
|
|
|
|
|
樟腦搽劑 |
|
ZNCJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM02AXZ008Z003 |
樟腦 |
01 |
|
2 |
ZN |
|
40000 |
0.1 |
0.1 |
Z003 |
|
|
|
|
|
|
樟腦醑劑 |
|
ZNXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM02AAY174V005 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0.1 |
0.1 |
V005 |
|
|
|
|
|
|
吲哚美辛巴布膏劑 |
|
YDMXBBGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XM02AAB098V001 |
吡羅昔康 |
01 |
|
2 |
BLXK |
|
40000 |
0.1 |
0.1 |
V001 |
|
|
|
|
|
|
吡羅昔康貼劑 |
|
BLXKTJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03ACA052B001 |
阿曲庫銨 |
01 |
|
1 |
AQKA |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
阿曲庫銨注射劑 |
|
AQKAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM03ABL310B002 |
氯化琥珀膽堿 |
01 |
|
1 |
LHHPDJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氯化琥珀膽堿注射液 |
|
LHHPDJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM03ACW026B001 |
維庫溴銨 |
01 |
|
1 |
WKXA |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
維庫溴銨注射劑 |
|
WKXAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM03ACW026B003 |
維庫溴銨 |
01 |
|
1 |
WKXA |
|
40000 |
0 |
0 |
B003 |
|
|
|
|
|
|
維庫溴銨注射用無菌粉末 |
|
WKXAZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM03ACW026B014 |
維庫溴銨 |
01 |
|
1 |
WKXA |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
維庫溴銨凍干粉針 |
|
WKXADGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM03BXB006A001 |
巴氯芬 |
01 |
|
2 |
BLF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
巴氯芬片劑 |
|
BLFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03ACB211B001 |
苯磺順阿曲庫銨 |
01 |
|
2 |
BHSAQKA |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
苯磺順阿曲庫銨注射劑 |
|
BHSAQKAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限阿曲庫銨注射劑不能耐受的患者 |
0.1 |
0.1 |
|
| XM03ACB211B002 |
苯磺順阿曲庫銨 |
01 |
|
2 |
BHSAQKA |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
苯磺順阿曲庫銨注射液 |
|
BHSAQKAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限阿曲庫銨注射劑不能耐受的患者 |
0.1 |
0.1 |
|
| XM03BBF399A001 |
復方氯唑沙宗 |
01 |
|
2 |
FFLZSZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
復方氯唑沙宗片劑 |
|
FFLZSZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03BBF399A006 |
復方氯唑沙宗 |
01 |
|
2 |
FFLZSZ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
復方氯唑沙宗分散片 |
|
FFLZSZFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03BBF399E001 |
復方氯唑沙宗 |
01 |
|
2 |
FFLZSZ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
復方氯唑沙宗硬膠囊 |
|
FFLZSZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03ACL264B002 |
羅庫溴銨 |
01 |
|
2 |
LKXA |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
羅庫溴銨注射液 |
|
LKXAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03ACM101B002 |
米庫氯銨 |
01 |
|
2 |
MKLA |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
米庫氯銨注射液 |
|
MKLAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XM03ACP012B001 |
哌庫溴銨 |
01 |
|
2 |
PKXA |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
哌庫溴銨注射劑 |
|
PKXAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03BXT046A001 |
替扎尼定 |
01 |
|
2 |
TZND |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
替扎尼定片劑 |
|
TZNDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03BXY112A001 |
乙哌立松 |
01 |
|
2 |
YPLS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
乙哌立松片劑 |
|
YPLSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM03BXY112A017 |
乙哌立松 |
01 |
|
2 |
YPLS |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
乙哌立松薄膜衣片 |
|
YPLSBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM04AAB117A001 |
別嘌醇 |
01 |
|
1 |
BPC |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
別嘌醇片劑 |
|
BPCPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM04ACQ079A001 |
秋水仙堿 |
01 |
|
1 |
QSXJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
秋水仙堿片劑 |
|
QSXJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM04ABB077A001 |
苯溴馬隆 |
01 |
|
2 |
BXML |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
苯溴馬隆片劑 |
|
BXMLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM04ABB077E001 |
苯溴馬隆 |
01 |
|
2 |
BXML |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
苯溴馬隆硬膠囊 |
|
BXMLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XM04AAB117A010 |
別嘌醇 |
01 |
|
2 |
BPC |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
別嘌醇緩釋片 |
|
BPCHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM04AAB117E003 |
別嘌醇 |
01 |
|
2 |
BPC |
|
40000 |
0.1 |
0.1 |
E003 |
|
|
|
|
|
|
別嘌醇緩釋膠囊 |
|
BPCHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM04AAF670A001 |
非布司他 |
01 |
|
2 |
FBST |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
非布司他片劑 |
|
FBSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腎功能不全或別嘌醇過敏的痛風患者 |
0.2 |
0.2 |
|
| XM05BAA029A001 |
阿侖膦酸鈉 |
01 |
|
2 |
ALLSN |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
阿侖膦酸鈉片劑 |
|
ALLSNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限中重度骨質疏松 |
0.1 |
0.1 |
|
| XM05BAA029A012 |
阿侖膦酸鈉 |
01 |
|
2 |
ALLSN |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
阿侖膦酸鈉腸溶片 |
|
ALLSNCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
限中重度骨質疏松 |
0.1 |
0.1 |
|
| XM05BXD031X003 |
膽維丁 |
01 |
|
2 |
DWD |
|
40000 |
0.1 |
0.1 |
X003 |
|
|
|
|
|
|
膽維丁口服乳劑 |
|
DWDKFRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM05BXD031A001 |
膽維丁 |
01 |
|
2 |
DWD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
膽維丁片劑 |
|
DWDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM05BXD031A018 |
膽維丁 |
01 |
|
2 |
DWD |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
膽維丁糖衣片 |
|
DWDTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM05BAL072A001 |
利塞膦酸鈉 |
01 |
|
2 |
LSLSN |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
利塞膦酸鈉片劑 |
|
LSLSNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限中重度骨質疏松 |
0.1 |
0.1 |
|
| XM05BAL072E001 |
利塞膦酸鈉 |
01 |
|
2 |
LSLSN |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
利塞膦酸鈉硬膠囊 |
|
LSLSNYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限中重度骨質疏松 |
0.1 |
0.1 |
|
| XM05BAL230A001 |
氯膦酸二鈉 |
01 |
|
2 |
LLSEN |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氯膦酸二鈉片劑 |
|
LLSENPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAL230E001 |
氯膦酸二鈉 |
01 |
|
2 |
LLSEN |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氯膦酸二鈉硬膠囊 |
|
LLSENYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAL230B001 |
氯膦酸二鈉 |
01 |
|
2 |
LLSEN |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
氯膦酸二鈉注射劑 |
|
LLSENZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAL230B002 |
氯膦酸二鈉 |
01 |
|
2 |
LLSEN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
氯膦酸二鈉注射液 |
|
LLSENZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAP004B001 |
帕米膦酸二鈉 |
01 |
|
2 |
PMLSEN |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
帕米膦酸二鈉注射劑 |
|
PMLSENZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAP004B002 |
帕米膦酸二鈉 |
01 |
|
2 |
PMLSEN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
帕米膦酸二鈉注射液 |
|
PMLSENZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAP004B003 |
帕米膦酸二鈉 |
01 |
|
2 |
PMLSEN |
|
40000 |
0.1 |
0.1 |
B003 |
|
|
|
|
|
|
帕米膦酸二鈉注射用無菌粉末 |
|
PMLSENZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAP004B014 |
帕米膦酸二鈉 |
01 |
|
2 |
PMLSEN |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
帕米膦酸二鈉凍干粉針 |
|
PMLSENDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAP107B002 |
帕米膦酸二鈉葡萄糖 |
01 |
|
2 |
PMLSENPTT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
帕米膦酸二鈉葡萄糖注射液 |
|
PMLSENPTTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥骨轉移 |
0.1 |
0.1 |
|
| XM05BAQ049A001 |
羥乙膦酸鈉 |
01 |
|
2 |
QYLSN |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
羥乙膦酸鈉片劑 |
|
QYLSNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限中重度骨質疏松 |
0.1 |
0.1 |
|
| XM05BAY053B002 |
伊班膦酸 |
01 |
|
2 |
YBLS |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
伊班膦酸注射液 |
|
YBLSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松或惡性腫瘤骨轉移并有明顯癌痛的患者 |
0.2 |
0.2 |
|
| XM05BAY163B001 |
因卡膦酸二鈉 |
01 |
|
2 |
YKLSEN |
|
40000 |
0.3 |
0.3 |
B001 |
|
|
|
|
|
|
因卡膦酸二鈉注射劑 |
|
YKLSENZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限惡性腫瘤骨轉移并有明顯癌痛的患者 |
0.3 |
0.3 |
|
| XM05BAZ079B001 |
唑來膦酸 |
01 |
|
2 |
ZLLS |
|
40000 |
0.3 |
0.3 |
B001 |
|
|
|
|
|
|
唑來膦酸注射劑 |
|
ZLLSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松或癌癥骨轉移 |
0.3 |
0.3 |
|
| XM05BAZ079B002 |
唑來膦酸 |
01 |
|
2 |
ZLLS |
|
40000 |
0.3 |
0.3 |
B002 |
|
|
|
|
|
|
唑來膦酸注射液 |
|
ZLLSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松或癌癥骨轉移 |
0.3 |
0.3 |
|
| XM05BAZ079B004 |
唑來膦酸 |
01 |
|
2 |
ZLLS |
|
40000 |
0.3 |
0.3 |
B004 |
|
|
|
|
|
|
唑來膦酸注射用濃溶液 |
|
ZLLSZSYNRY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松或癌癥骨轉移 |
0.3 |
0.3 |
|
| XM05BAZ079B014 |
唑來膦酸 |
01 |
|
2 |
ZLLS |
|
40000 |
0.3 |
0.3 |
B014 |
|
|
|
|
|
|
唑來膦酸凍干粉針 |
|
ZLLSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松或癌癥骨轉移 |
0.3 |
0.3 |
|
| XM09AXB146B002 |
玻璃酸鈉 |
01 |
|
2 |
BLSN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
玻璃酸鈉注射液 |
|
BLSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XM09AXF299B001 |
復方骨肽 |
01 |
|
2 |
FFGT |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
復方骨肽注射劑 |
|
FFGTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松患者確診為骨折延遲愈合后3個月內使用和工傷保險 |
0.2 |
0.2 |
|
| XM09AXF299B002 |
復方骨肽 |
01 |
|
2 |
FFGT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
復方骨肽注射液 |
|
FFGTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重度骨質疏松患者確診為骨折延遲愈合后3個月內使用和工傷保險 |
0.2 |
0.2 |
|
| XN01ABE010W004 |
恩氟烷 |
01 |
|
1 |
EFW |
|
40000 |
0 |
0 |
W004 |
|
|
|
|
|
|
恩氟烷液體劑型 |
|
EFWYTJX |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01ABD071W008 |
地氟烷 |
01 |
|
2 |
DFW |
|
40000 |
0.2 |
0.2 |
W008 |
|
|
|
|
|
|
地氟烷溶液劑 |
|
DFWRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN01ABQ001L019 |
七氟烷 |
01 |
|
2 |
FW |
|
40000 |
0.1 |
0.1 |
L019 |
|
|
|
|
|
|
七氟烷吸入用溶液劑 |
|
FWXRYRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01ABQ001L017 |
七氟烷 |
01 |
|
2 |
FW |
|
40000 |
0.1 |
0.1 |
L017 |
|
|
|
|
|
|
七氟烷吸入劑 |
|
FWXRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01ABQ001L020 |
七氟烷 |
01 |
|
2 |
FW |
|
40000 |
0.1 |
0.1 |
L020 |
|
|
|
|
|
|
七氟烷吸入溶液劑 |
|
FWXRRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AHF027B002 |
芬太尼 |
01 |
|
1 |
FTN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
芬太尼注射液 |
|
FTNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01AHR067B001 |
瑞芬太尼 |
01 |
|
2 |
RFTN |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
瑞芬太尼注射劑 |
|
RFTNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AHR067B014 |
瑞芬太尼 |
01 |
|
2 |
RFTN |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
瑞芬太尼凍干粉針 |
|
RFTNDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AHS091B002 |
舒芬太尼 |
01 |
|
2 |
SFTN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
舒芬太尼注射液 |
|
SFTNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AXB122B002 |
丙泊酚 |
01 |
|
1 |
BBF |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
丙泊酚注射液 |
|
BBFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01AXB122B022 |
丙泊酚 |
01 |
|
1 |
BBF |
|
40000 |
0 |
0 |
B022 |
|
|
|
|
|
|
丙泊酚乳狀注射液 |
|
BBFRZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01AXL185B002 |
氯胺酮 |
01 |
|
1 |
LAT |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氯胺酮注射液 |
|
LATZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01AXB123B002 |
丙泊酚中/長鏈脂肪乳 |
01 |
|
2 |
BBFZCLZFR |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
丙泊酚中/長鏈脂肪乳注射液 |
|
BBFZCLZFRZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限丙泊酚注射劑不能耐受的患者 |
0.1 |
0.1 |
|
| XN01AXQ025B002 |
羥丁酸鈉 |
01 |
|
2 |
QDSN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
羥丁酸鈉注射液 |
|
QDSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AXY045Z013 |
氧化亞氮 |
01 |
|
2 |
YHYD |
|
40000 |
0.1 |
0.1 |
Z013 |
|
|
|
|
|
|
氧化亞氮氣體劑 |
|
YHYDQTJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AXY095B002 |
依托咪酯 |
01 |
|
2 |
YTMZ |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
依托咪酯注射液 |
|
YTMZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01AXY095B022 |
依托咪酯 |
01 |
|
2 |
YTMZ |
|
40000 |
0.1 |
0.1 |
B022 |
|
|
|
|
|
|
依托咪酯乳狀注射液 |
|
YTMZRZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BAD135B001 |
丁卡因 |
01 |
|
1 |
DKY |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
丁卡因注射劑 |
|
DKYZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BAD135B002 |
丁卡因 |
01 |
|
1 |
DKY |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
丁卡因注射液 |
|
DKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BAD135U001 |
丁卡因 |
01 |
|
2 |
DKY |
|
40000 |
0.2 |
0.2 |
U001 |
|
|
|
|
|
|
丁卡因凝膠劑 |
|
DKYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN01BAL241B001 |
氯普魯卡因 |
01 |
|
2 |
LPLKY |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
氯普魯卡因注射劑 |
|
LPLKYZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BAL241B002 |
氯普魯卡因 |
01 |
|
2 |
LPLKY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
氯普魯卡因注射液 |
|
LPLKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BBB164B002 |
布比卡因 |
01 |
|
1 |
BBKY |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
布比卡因注射液 |
|
BBKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BBF120B002 |
復方阿替卡因 |
01 |
|
2 |
FFATKY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
復方阿替卡因注射液 |
|
FFATKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BBL054L001 |
利多卡因 |
01 |
|
2 |
LDKY |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
利多卡因氣霧劑 |
|
LDKYQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BBL054U001 |
利多卡因 |
01 |
|
2 |
LDKY |
|
40000 |
0 |
0 |
U001 |
|
|
|
|
|
|
利多卡因凝膠劑 |
|
LDKYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BBL054X007 |
利多卡因 |
01 |
|
2 |
LDKY |
|
40000 |
0 |
0 |
X007 |
|
|
|
|
|
|
利多卡因膠漿劑 |
|
LDKYJJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BBL284X007 |
利多卡因Ⅰ |
01 |
|
2 |
LDKY |
|
40000 |
0 |
0 |
X007 |
|
|
|
|
|
|
利多卡因Ⅰ膠漿劑 |
|
LDKYJJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BBL265B001 |
羅哌卡因 |
01 |
|
2 |
LPKY |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
羅哌卡因注射劑 |
|
LPKYZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BBL265B002 |
羅哌卡因 |
01 |
|
2 |
LPKY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
羅哌卡因注射液 |
|
LPKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BBL265B003 |
羅哌卡因 |
01 |
|
2 |
LPKY |
|
40000 |
0.1 |
0.1 |
B003 |
|
|
|
|
|
|
羅哌卡因注射用無菌粉末 |
|
LPKYZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BBL265B014 |
羅哌卡因 |
01 |
|
2 |
LPKY |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
羅哌卡因凍干粉針 |
|
LPKYDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN01BBZ055B002 |
左布比卡因 |
01 |
|
2 |
ZBBKY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
左布比卡因注射液 |
|
ZBBKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限布比卡因注射劑不能耐受的患者 |
0.1 |
0.1 |
|
| XN01BBF351F002 |
復方利多卡因 |
01 |
|
2 |
FFLDKY |
|
40000 |
0.2 |
0.2 |
F002 |
|
|
|
|
|
|
復方利多卡因乳膏劑 |
|
FFLDKYRGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN01BBF351B002 |
復方利多卡因 |
01 |
|
2 |
FFLDKY |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
復方利多卡因注射液 |
|
FFLDKYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN01BXD003X007 |
達克羅寧 |
01 |
|
2 |
DKLN |
|
40000 |
0.2 |
0.2 |
X007 |
|
|
|
|
|
|
達克羅寧膠漿劑 |
|
DKLNJJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN01BXL018F002 |
辣椒堿 |
01 |
|
2 |
LJJ |
|
40000 |
0.1 |
0.1 |
F002 |
|
|
|
|
|
|
辣椒堿乳膏劑 |
|
LJJRGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAM022A001 |
嗎啡 |
01 |
|
1 |
MF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
嗎啡片劑 |
|
MFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02AAM022A010 |
嗎啡 |
01 |
|
1 |
MF |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
嗎啡緩釋片 |
|
MFHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02AAM022B002 |
嗎啡 |
01 |
|
1 |
MF |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
嗎啡注射液 |
|
MFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02AAA122A001 |
氨酚待因Ⅰ |
01 |
|
2 |
AFDY |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氨酚待因Ⅰ片劑 |
|
AFDYPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02AAA123A001 |
氨酚待因Ⅱ |
01 |
|
2 |
AFDY |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氨酚待因Ⅱ片劑 |
|
AFDYPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02AJA146A001 |
氨酚雙氫可待因 |
01 |
|
2 |
AFSQKDY |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚雙氫可待因片劑 |
|
AFSQKDYPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAK058B002 |
可待因 |
01 |
|
2 |
KDY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
可待因注射液 |
|
KDYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAL277A001 |
洛芬待因 |
01 |
|
2 |
LFDY |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
洛芬待因片劑 |
|
LFDYPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAL277A010 |
洛芬待因 |
01 |
|
2 |
LFDY |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
洛芬待因緩釋片 |
|
LFDYHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAM022X001 |
嗎啡 |
01 |
|
2 |
MF |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
嗎啡口服溶液劑 |
|
MFKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAM022D001 |
嗎啡 |
01 |
|
2 |
MF |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
嗎啡栓劑 |
|
MFSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAN008B002 |
納美芬 |
01 |
|
2 |
NMF |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
納美芬注射液 |
|
NMFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救搶救 |
0.2 |
0.2 |
|
| XN02AAQ033A001 |
羥考酮 |
01 |
|
2 |
QKT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
羥考酮片劑 |
|
QKTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAQ033E001 |
羥考酮 |
01 |
|
2 |
QKT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
羥考酮硬膠囊 |
|
QKTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAQ033A010 |
羥考酮 |
01 |
|
2 |
QKT |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
羥考酮緩釋片 |
|
QKTHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAQ033B002 |
羥考酮 |
01 |
|
2 |
QKT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
羥考酮注射液 |
|
QKTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AAQ159B002 |
氫嗎啡酮 |
01 |
|
2 |
QMFT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
氫嗎啡酮注射液 |
|
QMFTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN02AAS135A001 |
雙氫可待因 |
01 |
|
2 |
SQKDY |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
雙氫可待因片劑 |
|
SQKDYPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02ABP022B002 |
哌替啶 |
01 |
|
1 |
PTD |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
哌替啶注射液 |
|
PTDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02ABF027V002 |
芬太尼 |
01 |
|
2 |
FTN |
|
40000 |
0.1 |
0.1 |
V002 |
|
|
|
|
|
|
芬太尼透皮貼劑 |
|
FTNTPTJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限癌癥疼痛患者或其他方法難以控制的重度疼痛 |
0.1 |
0.1 |
|
| XN02AFB179B002 |
布托啡諾 |
01 |
|
2 |
BTFN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
布托啡諾注射液 |
|
BTFNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AFN098B002 |
納布啡 |
01 |
|
2 |
NBF |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
納布啡注射液 |
|
NBFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限復合麻醉 |
0.2 |
0.2 |
|
| XN02AXA144A001 |
氨酚曲馬多 |
01 |
|
2 |
AFQMD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚曲馬多片劑 |
|
AFQMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXA144E001 |
氨酚曲馬多 |
01 |
|
2 |
AFQMD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氨酚曲馬多硬膠囊 |
|
AFQMDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXD131V002 |
丁丙諾啡 |
01 |
|
2 |
DBNF |
|
40000 |
0.2 |
0.2 |
V002 |
|
|
|
|
|
|
丁丙諾啡透皮貼劑 |
|
DBNFTPTJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限非阿片類止痛劑不能控制的慢性中重度疼痛的患者 |
0.2 |
0.2 |
|
| XN02AXQ098A001 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
曲馬多片劑 |
|
QMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098A006 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
曲馬多分散片 |
|
QMDFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098E001 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
曲馬多硬膠囊 |
|
QMDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098A010 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
曲馬多緩釋片 |
|
QMDHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098E003 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
E003 |
|
|
|
|
|
|
曲馬多緩釋膠囊 |
|
QMDHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ099A010 |
曲馬多Ⅱ |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
曲馬多Ⅱ緩釋片 |
|
QMDHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098B001 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
曲馬多注射劑 |
|
QMDZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098B002 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
曲馬多注射液 |
|
QMDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098B003 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
B003 |
|
|
|
|
|
|
曲馬多注射用無菌粉末 |
|
QMDZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXQ098B014 |
曲馬多 |
01 |
|
2 |
QMD |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
曲馬多凍干粉針 |
|
QMDDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02AXD092B002 |
地佐辛 |
01 |
|
2 |
DZX |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
地佐辛注射液 |
|
DZXZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BAF118A001 |
復方阿司匹林 |
01 |
|
2 |
FFASPL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
復方阿司匹林片劑 |
|
FFASPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BAF118A025 |
復方阿司匹林 |
01 |
|
2 |
FFASPL |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
復方阿司匹林素片 |
|
FFASPLSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BAX102A001 |
小兒復方阿司匹林 |
01 |
|
2 |
XEFFASPL |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
小兒復方阿司匹林片劑 |
|
XEFFASPLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BAL023B001 |
賴氨匹林 |
01 |
|
2 |
LAPL |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
賴氨匹林注射劑 |
|
LAPLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BAL023B003 |
賴氨匹林 |
01 |
|
2 |
LAPL |
|
40000 |
0 |
0 |
B003 |
|
|
|
|
|
|
賴氨匹林注射用無菌粉末 |
|
LAPLZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BAL023B013 |
賴氨匹林 |
01 |
|
2 |
LAPL |
|
40000 |
0 |
0 |
B013 |
|
|
|
|
|
|
賴氨匹林無菌粉針 |
|
LAPLWJFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BBQ128A001 |
去痛片 |
01 |
|
1 |
QTP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
去痛片片劑 |
|
QTPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BBQ128A025 |
去痛片 |
01 |
|
1 |
QTP |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
去痛片素片 |
|
QTPSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BBA095R010 |
安乃近 |
01 |
|
2 |
ANJ |
|
40000 |
0.1 |
0.1 |
R010 |
|
|
|
|
|
|
安乃近滴鼻液 |
|
ANJDBY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
1 |
1 |
|
| XN02BBA095A001 |
安乃近 |
01 |
|
2 |
ANJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
安乃近片劑 |
|
ANJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BBA095A025 |
安乃近 |
01 |
|
2 |
ANJ |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
安乃近素片 |
|
ANJSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BBM096A001 |
米格來寧 |
01 |
|
2 |
MGLN |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
米格來寧片劑 |
|
MGLNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BBM096A025 |
米格來寧 |
01 |
|
2 |
MGLN |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
米格來寧素片 |
|
MGLNSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BBA095B002 |
安乃近 |
01 |
|
2 |
ANJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
安乃近注射液 |
|
ANJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BBF137B002 |
復方氨基比林 |
01 |
|
2 |
FFAJBL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
復方氨基比林注射液 |
|
FFAJBLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158A001 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
對乙酰氨基酚片劑 |
|
DYXAJFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158A006 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
對乙酰氨基酚分散片 |
|
DYXAJFFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158A017 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
對乙酰氨基酚薄膜衣片 |
|
DYXAJFBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158A025 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
對乙酰氨基酚素片 |
|
DYXAJFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158E001 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
對乙酰氨基酚硬膠囊 |
|
DYXAJFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158E002 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
E002 |
|
|
|
|
|
|
對乙酰氨基酚軟膠囊 |
|
DYXAJFRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BED158N001 |
對乙酰氨基酚 |
01 |
|
1 |
DYXAJF |
|
40000 |
0 |
0 |
N001 |
|
|
|
|
|
|
對乙酰氨基酚顆粒劑 |
|
DYXAJFKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BEX097A001 |
小兒對乙酰氨基酚 |
01 |
|
1 |
XEDYXAJF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
小兒對乙酰氨基酚片劑 |
|
XEDYXAJFPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BEA141A001 |
氨酚羥考酮 |
01 |
|
2 |
AFQKT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚羥考酮片劑 |
|
AFQKTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BEA141E001 |
氨酚羥考酮 |
01 |
|
2 |
AFQKT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氨酚羥考酮硬膠囊 |
|
AFQKTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158A010 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
對乙酰氨基酚緩釋片 |
|
DYXAJFHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158K001 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
對乙酰氨基酚糖漿劑 |
|
DYXAJFTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158X001 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
對乙酰氨基酚口服溶液劑 |
|
DYXAJFKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158X002 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
對乙酰氨基酚口服混懸劑 |
|
DYXAJFKFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158X004 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
X004 |
|
|
|
|
|
|
對乙酰氨基酚口服滴劑 |
|
DYXAJFKFDJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158X006 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
X006 |
|
|
|
|
|
|
對乙酰氨基酚干混懸劑 |
|
DYXAJFGHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158X008 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
X008 |
|
|
|
|
|
|
對乙酰氨基酚口服液 |
|
DYXAJFKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158X012 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
X012 |
|
|
|
|
|
|
對乙酰氨基酚混懸滴劑 |
|
DYXAJFHXDJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BED158D001 |
對乙酰氨基酚 |
01 |
|
2 |
DYXAJF |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
對乙酰氨基酚栓劑 |
|
DYXAJFSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BEF250A001 |
復方對乙酰氨基酚 |
01 |
|
2 |
FFDYXAJF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
復方對乙酰氨基酚片劑 |
|
FFDYXAJFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BEF250A025 |
復方對乙酰氨基酚 |
01 |
|
2 |
FFDYXAJF |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
復方對乙酰氨基酚素片 |
|
FFDYXAJFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BEB133B001 |
丙帕他莫 |
01 |
|
2 |
BPTM |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
丙帕他莫注射劑 |
|
BPTMZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN02BGL266A001 |
羅通定 |
01 |
|
2 |
LTD |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
羅通定片劑 |
|
LTDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BGL266A017 |
羅通定 |
01 |
|
2 |
LTD |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
羅通定薄膜衣片 |
|
LTDBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BGL266A025 |
羅通定 |
01 |
|
2 |
LTD |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
羅通定素片 |
|
LTDSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BGL266B002 |
羅通定 |
01 |
|
2 |
LTD |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
羅通定注射液 |
|
LTDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN02BGP112E001 |
普瑞巴林 |
01 |
|
2 |
PRBL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
普瑞巴林硬膠囊 |
|
PRBLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BGG057B001 |
高烏甲素 |
01 |
|
2 |
GWJS |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
高烏甲素注射劑 |
|
GWJSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BGG057B002 |
高烏甲素 |
01 |
|
2 |
GWJS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
高烏甲素注射液 |
|
GWJSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BGG057B014 |
高烏甲素 |
01 |
|
2 |
GWJS |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
高烏甲素凍干粉針 |
|
GWJSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BGN064A001 |
牛痘疫苗接種家兔炎癥皮膚提取物 |
01 |
|
2 |
NDYMJZJTYZPFTQW |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
牛痘疫苗接種家兔炎癥皮膚提取物片劑 |
|
NDYMJZJTYZPFTQWPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02BGN064B002 |
牛痘疫苗接種家兔炎癥皮膚提取物 |
01 |
|
2 |
NDYMJZJTYZPFTQW |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
牛痘疫苗接種家兔炎癥皮膚提取物注射液 |
|
NDYMJZJTYZPFTQWZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN02CCL077A001 |
利扎曲普坦 |
01 |
|
2 |
LZQPT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
利扎曲普坦片劑 |
|
LZQPTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN02CCL077E001 |
利扎曲普坦 |
01 |
|
2 |
LZQPT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
利扎曲普坦硬膠囊 |
|
LZQPTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN02CCS094A001 |
舒馬普坦 |
01 |
|
2 |
SMPT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
舒馬普坦片劑 |
|
SMPTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN02CCS094E001 |
舒馬普坦 |
01 |
|
2 |
SMPT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
舒馬普坦硬膠囊 |
|
SMPTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN02CCZ076A001 |
佐米曲普坦 |
01 |
|
2 |
ZMQPT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
佐米曲普坦片劑 |
|
ZMQPTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN02CCZ076A006 |
佐米曲普坦 |
01 |
|
2 |
ZMQPT |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
佐米曲普坦分散片 |
|
ZMQPTFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN02CCZ076E001 |
佐米曲普坦 |
01 |
|
2 |
ZMQPT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
佐米曲普坦硬膠囊 |
|
ZMQPTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限偏頭痛急性發(fā)作患者的二線用藥 |
0.1 |
0.1 |
|
| XN03AAB049A001 |
苯巴比妥 |
01 |
|
1 |
BBBT |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
苯巴比妥片劑 |
|
BBBTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AAB049A025 |
苯巴比妥 |
01 |
|
1 |
BBBT |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
苯巴比妥素片 |
|
BBBTSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AAB049B001 |
苯巴比妥 |
01 |
|
1 |
BBBT |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
苯巴比妥注射劑 |
|
BBBTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AAB049B002 |
苯巴比妥 |
01 |
|
1 |
BBBT |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
苯巴比妥注射液 |
|
BBBTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AAP067A001 |
撲米酮 |
01 |
|
2 |
PMT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
撲米酮片劑 |
|
PMTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AAP067A025 |
撲米酮 |
01 |
|
2 |
PMT |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
撲米酮素片 |
|
PMTSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03ABB074A001 |
苯妥英鈉 |
01 |
|
1 |
BTYN |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
苯妥英鈉片劑 |
|
BTYNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03ABB074A017 |
苯妥英鈉 |
01 |
|
1 |
BTYN |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
苯妥英鈉薄膜衣片 |
|
BTYNBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03ABB074A018 |
苯妥英鈉 |
01 |
|
1 |
BTYN |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
苯妥英鈉糖衣片 |
|
BTYNTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03ABB074A025 |
苯妥英鈉 |
01 |
|
1 |
BTYN |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
苯妥英鈉素片 |
|
BTYNSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AEL250A001 |
氯硝西泮 |
01 |
|
1 |
LXXP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯硝西泮片劑 |
|
LXXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AEL250B002 |
氯硝西泮 |
01 |
|
2 |
LXXP |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
氯硝西泮注射液 |
|
LXXPZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AFK019A001 |
卡馬西平 |
01 |
|
1 |
KMXP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
卡馬西平片劑 |
|
KMXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AFK019A025 |
卡馬西平 |
01 |
|
1 |
KMXP |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
卡馬西平素片 |
|
KMXPSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AFK019E001 |
卡馬西平 |
01 |
|
1 |
KMXP |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
卡馬西平硬膠囊 |
|
KMXPYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AFA206A001 |
奧卡西平 |
01 |
|
1 |
AKXP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
奧卡西平片劑 |
|
AKXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AFK019A010 |
卡馬西平 |
01 |
|
2 |
KMXP |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
卡馬西平緩釋片 |
|
KMXPHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AFK019E003 |
卡馬西平 |
01 |
|
2 |
KMXP |
|
40000 |
0.1 |
0.1 |
E003 |
|
|
|
|
|
|
卡馬西平緩釋膠囊 |
|
KMXPHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AFA206X002 |
奧卡西平 |
01 |
|
2 |
AKXP |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
奧卡西平口服混懸劑 |
|
AKXPKFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB140A001 |
丙戊酸鈉 |
01 |
|
1 |
BWSN |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
丙戊酸鈉片劑 |
|
BWSNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AGB140A018 |
丙戊酸鈉 |
01 |
|
1 |
BWSN |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
丙戊酸鈉糖衣片 |
|
BWSNTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN03AGB140K001 |
丙戊酸鈉 |
01 |
|
2 |
BWSN |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
丙戊酸鈉糖漿劑 |
|
BWSNTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB140X001 |
丙戊酸鈉 |
01 |
|
2 |
BWSN |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
丙戊酸鈉口服溶液劑 |
|
BWSNKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB140A010 |
丙戊酸鈉 |
01 |
|
2 |
BWSN |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
丙戊酸鈉緩釋片 |
|
BWSNHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB231A010 |
丙戊酸鈉Ⅰ |
01 |
|
2 |
BWSN |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
丙戊酸鈉Ⅰ緩釋片 |
|
BWSNHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB140B001 |
丙戊酸鈉 |
01 |
|
2 |
BWSN |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
丙戊酸鈉注射劑 |
|
BWSNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB139A001 |
丙戊酸鎂 |
01 |
|
2 |
BWSM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
丙戊酸鎂片劑 |
|
BWSMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGB139A010 |
丙戊酸鎂 |
01 |
|
2 |
BWSM |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
丙戊酸鎂緩釋片 |
|
BWSMHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGA181A001 |
氨酪酸 |
01 |
|
2 |
ALS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酪酸片劑 |
|
ALSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGA181A017 |
氨酪酸 |
01 |
|
2 |
ALS |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
氨酪酸薄膜衣片 |
|
ALSBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AGA181A018 |
氨酪酸 |
01 |
|
2 |
ALS |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
氨酪酸糖衣片 |
|
ALSTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXJ019A001 |
加巴噴丁 |
01 |
|
2 |
JBPD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
加巴噴丁片劑 |
|
JBPDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXJ019E001 |
加巴噴丁 |
01 |
|
2 |
JBPD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
加巴噴丁硬膠囊 |
|
JBPDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXL009A001 |
拉莫三嗪 |
01 |
|
2 |
LMSQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
拉莫三嗪片劑 |
|
LMSQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXL009A006 |
拉莫三嗪 |
01 |
|
2 |
LMSQ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
拉莫三嗪分散片 |
|
LMSQFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXT110A001 |
托吡酯 |
01 |
|
2 |
TBZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
托吡酯片劑 |
|
TBZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXT110E001 |
托吡酯 |
01 |
|
2 |
TBZ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
托吡酯硬膠囊 |
|
TBZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXZ075A001 |
左乙拉西坦 |
01 |
|
2 |
ZYLXT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
左乙拉西坦片劑 |
|
ZYLXTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXZ075X001 |
左乙拉西坦 |
01 |
|
2 |
ZYLXT |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
左乙拉西坦口服溶液劑 |
|
ZYLXTKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XN03AXL371A001 |
拉考沙胺 |
01 |
|
2 |
LKSA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
拉考沙胺片劑 |
|
LKSAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN03AXZ080A001 |
唑尼沙胺 |
01 |
|
2 |
ZNSA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
唑尼沙胺片劑 |
|
ZNSAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04AAB061A001 |
苯海索 |
01 |
|
1 |
BHS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
苯海索片劑 |
|
BHSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BAD164A001 |
多巴絲肼 |
01 |
|
1 |
DBSJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
多巴絲肼片劑 |
|
DBSJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BAD164E001 |
多巴絲肼 |
01 |
|
1 |
DBSJ |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
多巴絲肼硬膠囊 |
|
DBSJYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BAZ068A001 |
左旋多巴 |
01 |
|
1 |
ZXDB |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
左旋多巴片劑 |
|
ZXDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BAZ068E001 |
左旋多巴 |
01 |
|
1 |
ZXDB |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
左旋多巴硬膠囊 |
|
ZXDBYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BAK008A001 |
卡比多巴 |
01 |
|
2 |
KBDB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
卡比多巴片劑 |
|
KBDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BAQ156E001 |
屈昔多巴 |
01 |
|
2 |
QXDB |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
屈昔多巴硬膠囊 |
|
QXDBYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XN04BAZ099A010 |
卡左雙多巴（左旋多巴/卡比多巴） |
01 |
|
2 |
KZSDB(ZXDBKBDB) |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
卡左雙多巴（左旋多巴/卡比多巴）緩釋片 |
|
KZSDB(ZXDBKBDB)HSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BAZ099A011 |
卡左雙多巴（左旋多巴/卡比多巴） |
01 |
|
2 |
KZSDB(ZXDBKBDB) |
|
40000 |
0.1 |
0.1 |
A011 |
|
|
|
|
|
|
卡左雙多巴（左旋多巴/卡比多巴）控釋片 |
|
KZSDB(ZXDBKBDB)KSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BAF338A001 |
復方卡比多巴 |
01 |
|
2 |
FFKBDB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
復方卡比多巴片劑 |
|
FFKBDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BBJ119A001 |
金剛烷胺 |
01 |
|
1 |
JGWA |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
金剛烷胺片劑 |
|
JGWAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BBJ119A025 |
金剛烷胺 |
01 |
|
1 |
JGWA |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
金剛烷胺素片 |
|
JGWASP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BBJ119E001 |
金剛烷胺 |
01 |
|
1 |
JGWA |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
金剛烷胺硬膠囊 |
|
JGWAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BCA048B002 |
阿撲嗎啡 |
01 |
|
1 |
APMF |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
阿撲嗎啡注射液 |
|
APMFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN04BCB089A010 |
吡貝地爾 |
01 |
|
2 |
BBDE |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
吡貝地爾緩釋片 |
|
BBDEHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BCL337A001 |
羅匹尼羅 |
01 |
|
2 |
LPNL |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
羅匹尼羅片劑 |
|
LPNLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XN04BCL337A010 |
羅匹尼羅 |
01 |
|
2 |
LPNL |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
羅匹尼羅緩釋片 |
|
LPNLHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BCP088A010 |
普拉克索 |
01 |
|
2 |
PLKS |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
普拉克索緩釋片 |
|
PLKSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BCP088A001 |
普拉克索 |
01 |
|
2 |
PLKS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
普拉克索片劑 |
|
PLKSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BDS170A001 |
司來吉蘭 |
01 |
|
2 |
SLJL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
司來吉蘭片劑 |
|
SLJLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BDS170E001 |
司來吉蘭 |
01 |
|
2 |
SLJL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
司來吉蘭硬膠囊 |
|
SLJLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN04BDL360A001 |
雷沙吉蘭 |
01 |
|
2 |
LSJL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
雷沙吉蘭片劑 |
|
LSJLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BXE012A001 |
恩他卡朋 |
01 |
|
2 |
ETKP |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩他卡朋片劑 |
|
ETKPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BXE067A001 |
恩他卡朋雙多巴 |
01 |
|
2 |
ETKPSDB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩他卡朋雙多巴片劑 |
|
ETKPSDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BXE068A001 |
恩他卡朋雙多巴Ⅱ |
01 |
|
2 |
ETKPSDB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩他卡朋雙多巴Ⅱ片劑 |
|
ETKPSDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BXE069A001 |
恩他卡朋雙多巴Ⅲ |
01 |
|
2 |
ETKPSDB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩他卡朋雙多巴Ⅲ片劑 |
|
ETKPSDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN04BXE073A001 |
恩他卡朋雙多巴Ⅳ |
01 |
|
2 |
ETKPSDB |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
恩他卡朋雙多巴Ⅳ片劑 |
|
ETKPSDBPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XN05AAL192A001 |
氯丙嗪 |
01 |
|
1 |
LBQ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯丙嗪片劑 |
|
LBQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AAL192A017 |
氯丙嗪 |
01 |
|
1 |
LBQ |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
氯丙嗪薄膜衣片 |
|
LBQBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AAL192A018 |
氯丙嗪 |
01 |
|
1 |
LBQ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
氯丙嗪糖衣片 |
|
LBQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AAL192B002 |
氯丙嗪 |
01 |
|
1 |
LBQ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氯丙嗪注射液 |
|
LBQZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AAF562B001 |
復方鹽酸氯丙嗪 |
01 |
|
2 |
FFYSLBQ |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
復方鹽酸氯丙嗪注射劑 |
|
FFYSLBQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ABF041A001 |
奮乃靜 |
01 |
|
1 |
FNJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
奮乃靜片劑 |
|
FNJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ABF041A017 |
奮乃靜 |
01 |
|
1 |
FNJ |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
奮乃靜薄膜衣片 |
|
FNJBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ABF041A018 |
奮乃靜 |
01 |
|
1 |
FNJ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
奮乃靜糖衣片 |
|
FNJTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ABF041B002 |
奮乃靜 |
01 |
|
1 |
FNJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
奮乃靜注射液 |
|
FNJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ABS017A001 |
三氟拉嗪 |
01 |
|
1 |
SFLQ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
三氟拉嗪片劑 |
|
SFLQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ABS017A018 |
三氟拉嗪 |
01 |
|
1 |
SFLQ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
三氟拉嗪糖衣片 |
|
SFLQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ABF070A001 |
氟奮乃靜 |
01 |
|
2 |
FFNJ |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
氟奮乃靜片劑 |
|
FFNJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ABF070A018 |
氟奮乃靜 |
01 |
|
2 |
FFNJ |
|
40000 |
0.2 |
0.2 |
A018 |
|
|
|
|
|
|
氟奮乃靜糖衣片 |
|
FFNJTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ABF070B002 |
氟奮乃靜 |
01 |
|
2 |
FFNJ |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
氟奮乃靜注射液 |
|
FFNJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ABG122B002 |
癸氟奮乃靜 |
01 |
|
2 |
GFFNJ |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
癸氟奮乃靜注射液 |
|
GFFNJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ACP009B002 |
哌泊塞嗪 |
01 |
|
2 |
PBSQ |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
哌泊塞嗪注射液 |
|
PBSQZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ADF085A001 |
氟哌啶醇 |
01 |
|
1 |
FPDC |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氟哌啶醇片劑 |
|
FPDCPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ADF085A018 |
氟哌啶醇 |
01 |
|
1 |
FPDC |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
氟哌啶醇糖衣片 |
|
FPDCTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ADF085B002 |
氟哌啶醇 |
01 |
|
1 |
FPDC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氟哌啶醇注射液 |
|
FPDCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ADF086B002 |
氟哌利多 |
01 |
|
2 |
FPLD |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
氟哌利多注射液 |
|
FPLDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05AEQ010A001 |
齊拉西酮 |
01 |
|
2 |
QLXT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
齊拉西酮片劑 |
|
QLXTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AEQ010E001 |
齊拉西酮 |
01 |
|
2 |
QLXT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
齊拉西酮硬膠囊 |
|
QLXTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AEQ010B001 |
齊拉西酮 |
01 |
|
2 |
QLXT |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
齊拉西酮注射劑 |
|
QLXTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限不配合口服給藥患者 |
0.2 |
0.2 |
|
| XN05AEQ010B002 |
齊拉西酮 |
01 |
|
2 |
QLXT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
齊拉西酮注射液 |
|
QLXTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限不配合口服給藥患者 |
0.2 |
0.2 |
|
| XN05AFL242A001 |
氯普噻噸 |
01 |
|
2 |
LPSD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氯普噻噸片劑 |
|
LPSDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AFL242A018 |
氯普噻噸 |
01 |
|
2 |
LPSD |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
氯普噻噸糖衣片 |
|
LPSDTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AFL242B002 |
氯普噻噸 |
01 |
|
2 |
LPSD |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
氯普噻噸注射液 |
|
LPSDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AGW076A001 |
五氟利多 |
01 |
|
1 |
WFLD |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
五氟利多片劑 |
|
WFLDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AGW076A017 |
五氟利多 |
01 |
|
1 |
WFLD |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
五氟利多薄膜衣片 |
|
WFLDBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AGW076A018 |
五氟利多 |
01 |
|
1 |
WFLD |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
五氟利多糖衣片 |
|
WFLDTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AHK094A001 |
喹硫平 |
01 |
|
1 |
KLP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
喹硫平片劑 |
|
KLPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AHL195A001 |
氯氮平 |
01 |
|
1 |
LDP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯氮平片劑 |
|
LDPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AHL195A006 |
氯氮平 |
01 |
|
1 |
LDP |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
氯氮平分散片 |
|
LDPFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AHA204A001 |
奧氮平 |
01 |
|
2 |
ADP |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
奧氮平片劑 |
|
ADPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AHL195A022 |
氯氮平 |
01 |
|
2 |
LDP |
|
40000 |
0.1 |
0.1 |
A022 |
|
|
|
|
|
|
氯氮平口腔崩解片 |
|
LDPKQBJP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AHA204A022 |
奧氮平 |
01 |
|
2 |
ADP |
|
40000 |
0.2 |
0.2 |
A022 |
|
|
|
|
|
|
奧氮平口腔崩解片 |
|
ADPKQBJP |
|
0 |
0 |
0 |
2020-1-1 |
|
限吞咽困難的患者 |
0.2 |
0.2 |
|
| XN05ALS090A001 |
舒必利 |
01 |
|
1 |
SBL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
舒必利片劑 |
|
SBLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ALS090A025 |
舒必利 |
01 |
|
1 |
SBL |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
舒必利素片 |
|
SBLSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ALS090B002 |
舒必利 |
01 |
|
1 |
SBL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
舒必利注射液 |
|
SBLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ALA161A001 |
氨磺必利 |
01 |
|
2 |
AHBL |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
氨磺必利片劑 |
|
AHBLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05ALL130A001 |
硫必利 |
01 |
|
2 |
LBL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
硫必利片劑 |
|
LBLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05ALL130B001 |
硫必利 |
01 |
|
2 |
LBL |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
硫必利注射劑 |
|
LBLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05ALL130B002 |
硫必利 |
01 |
|
2 |
LBL |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
硫必利注射液 |
|
LBLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05ALL130B014 |
硫必利 |
01 |
|
2 |
LBL |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
硫必利凍干粉針 |
|
LBLDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05ANT017A001 |
碳酸鋰 |
01 |
|
1 |
TSL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
碳酸鋰片劑 |
|
TSLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05ANT017A010 |
碳酸鋰 |
01 |
|
2 |
TSL |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
碳酸鋰緩釋片 |
|
TSLHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXA028A001 |
阿立哌唑 |
01 |
|
1 |
ALPZ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
阿立哌唑片劑 |
|
ALPZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AXA028E001 |
阿立哌唑 |
01 |
|
1 |
ALPZ |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
阿立哌唑硬膠囊 |
|
ALPZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AXA028A022 |
阿立哌唑 |
01 |
|
1 |
ALPZ |
|
40000 |
0 |
0 |
A022 |
|
|
|
|
|
|
阿立哌唑口腔崩解片 |
|
ALPZKQBJP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05AXL071A001 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
利培酮片劑 |
|
LPTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXL071A006 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
利培酮分散片 |
|
LPTFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXL071E001 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
利培酮硬膠囊 |
|
LPTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXL071X001 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
利培酮口服溶液劑 |
|
LPTKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXL071X008 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.1 |
0.1 |
X008 |
|
|
|
|
|
|
利培酮口服液 |
|
LPTKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXL071A022 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.1 |
0.1 |
A022 |
|
|
|
|
|
|
利培酮口腔崩解片 |
|
LPTKQBJP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05AXL071B015 |
利培酮 |
01 |
|
2 |
LPT |
|
40000 |
0.2 |
0.2 |
B015 |
|
|
|
|
|
|
利培酮微球注射劑 |
|
LPTWQZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限不配合口服給藥患者 |
0.2 |
0.2 |
|
| XN05AXP001A010 |
帕利哌酮 |
01 |
|
2 |
PLPT |
|
40000 |
0.2 |
0.2 |
A010 |
|
|
|
|
|
|
帕利哌酮緩釋片 |
|
PLPTHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05AXP001B002 |
帕利哌酮 |
01 |
|
2 |
PLPT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
帕利哌酮注射液 |
|
PLPTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限不配合口服給藥患者 |
0.2 |
0.2 |
|
| XN05AXP020A001 |
哌羅匹隆 |
01 |
|
2 |
PLPL |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
哌羅匹隆片劑 |
|
PLPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05BAA050A001 |
阿普唑侖 |
01 |
|
1 |
APZL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
阿普唑侖片劑 |
|
APZLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAA050A025 |
阿普唑侖 |
01 |
|
1 |
APZL |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
阿普唑侖素片 |
|
APZLSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAA050E001 |
阿普唑侖 |
01 |
|
1 |
APZL |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
阿普唑侖硬膠囊 |
|
APZLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAD088A001 |
地西泮 |
01 |
|
1 |
DXP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
地西泮片劑 |
|
DXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAD088A025 |
地西泮 |
01 |
|
1 |
DXP |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
地西泮素片 |
|
DXPSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAD088B002 |
地西泮 |
01 |
|
1 |
DXP |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
地西泮注射液 |
|
DXPZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAL037A001 |
勞拉西泮 |
01 |
|
1 |
LLXP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
勞拉西泮片劑 |
|
LLXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BAA217A001 |
奧沙西泮 |
01 |
|
2 |
ASXP |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
奧沙西泮片劑 |
|
ASXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05BAD088M001 |
地西泮 |
01 |
|
2 |
DXP |
|
40000 |
0.2 |
0.2 |
M001 |
|
|
|
|
|
|
地西泮膜劑 |
|
DXPMJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05BAF233A001 |
復方地西泮 |
01 |
|
2 |
FFDXP |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
復方地西泮片劑 |
|
FFDXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05BBQ036A018 |
羥嗪 |
01 |
|
1 |
QQ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
羥嗪糖衣片 |
|
QQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BED136A001 |
丁螺環(huán)酮 |
01 |
|
1 |
DLHT |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
丁螺環(huán)酮片劑 |
|
DLHTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05BET010A001 |
坦度螺酮 |
01 |
|
2 |
TDLT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
坦度螺酮片劑 |
|
TDLTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05BET010E001 |
坦度螺酮 |
01 |
|
2 |
TDLT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
坦度螺酮硬膠囊 |
|
TDLTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CAS169E001 |
司可巴比妥 |
01 |
|
2 |
SKBBT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
司可巴比妥硬膠囊 |
|
SKBBTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CAY154B001 |
異戊巴比妥 |
01 |
|
2 |
YWBBT |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
異戊巴比妥注射劑 |
|
YWBBTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CDA087A001 |
艾司唑侖 |
01 |
|
1 |
ASZL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
艾司唑侖片劑 |
|
ASZLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05CDA087A025 |
艾司唑侖 |
01 |
|
1 |
ASZL |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
艾司唑侖素片 |
|
ASZLSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05CDM084B002 |
咪達唑侖 |
01 |
|
1 |
MDZL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
咪達唑侖注射液 |
|
MDZLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN05CDM084A001 |
咪達唑侖 |
01 |
|
2 |
MDZL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
咪達唑侖片劑 |
|
MDZLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CDX080A001 |
硝西泮 |
01 |
|
2 |
XXP |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
硝西泮片劑 |
|
XXPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CDA087B002 |
艾司唑侖 |
01 |
|
2 |
ASZL |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
艾司唑侖注射液 |
|
ASZLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFY202A001 |
右佐匹克隆 |
01 |
|
2 |
YZPKL |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
右佐匹克隆片劑 |
|
YZPKLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05CFZ003A001 |
扎來普隆 |
01 |
|
2 |
ZLPL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
扎來普隆片劑 |
|
ZLPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ003A006 |
扎來普隆 |
01 |
|
2 |
ZLPL |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
扎來普隆分散片 |
|
ZLPLFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ003E001 |
扎來普隆 |
01 |
|
2 |
ZLPL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
扎來普隆硬膠囊 |
|
ZLPLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ077A001 |
佐匹克隆 |
01 |
|
2 |
ZPKL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
佐匹克隆片劑 |
|
ZPKLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ077E001 |
佐匹克隆 |
01 |
|
2 |
ZPKL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
佐匹克隆硬膠囊 |
|
ZPKLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ078A001 |
唑吡坦 |
01 |
|
2 |
ZBT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
唑吡坦片劑 |
|
ZBTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ078A006 |
唑吡坦 |
01 |
|
2 |
ZBT |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
唑吡坦分散片 |
|
ZBTFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ078A017 |
唑吡坦 |
01 |
|
2 |
ZBT |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
唑吡坦薄膜衣片 |
|
ZBTBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CFZ078E001 |
唑吡坦 |
01 |
|
2 |
ZBT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
唑吡坦硬膠囊 |
|
ZBTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN05CMY189B002 |
右美托咪定 |
01 |
|
2 |
YMTMD |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
右美托咪定注射液 |
|
YMTMDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN05CMY123A001 |
乙酰天麻素 |
01 |
|
2 |
YXTMS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
乙酰天麻素片劑 |
|
YXTMSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AAA037A001 |
阿米替林 |
01 |
|
1 |
AMTL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
阿米替林片劑 |
|
AMTLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAA037A017 |
阿米替林 |
01 |
|
1 |
AMTL |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
阿米替林薄膜衣片 |
|
AMTLBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAA037A018 |
阿米替林 |
01 |
|
1 |
AMTL |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
阿米替林糖衣片 |
|
AMTLTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAB132A001 |
丙米嗪 |
01 |
|
1 |
BMQ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
丙米嗪片劑 |
|
BMQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAB132A018 |
丙米嗪 |
01 |
|
1 |
BMQ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
丙米嗪糖衣片 |
|
BMQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAD175A001 |
多塞平 |
01 |
|
1 |
DSP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
多塞平片劑 |
|
DSPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAD175A018 |
多塞平 |
01 |
|
1 |
DSP |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
多塞平糖衣片 |
|
DSPTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAL237A001 |
氯米帕明 |
01 |
|
1 |
LMPM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯米帕明片劑 |
|
LMPMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAL237A017 |
氯米帕明 |
01 |
|
1 |
LMPM |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
氯米帕明薄膜衣片 |
|
LMPMBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAL237A018 |
氯米帕明 |
01 |
|
1 |
LMPM |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
氯米帕明糖衣片 |
|
LMPMTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAL237B002 |
氯米帕明 |
01 |
|
1 |
LMPM |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氯米帕明注射液 |
|
LMPMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AAM018A001 |
馬普替林 |
01 |
|
2 |
MPTL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
馬普替林片劑 |
|
MPTLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABP002A001 |
帕羅西汀 |
01 |
|
1 |
PLXT |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
帕羅西汀片劑 |
|
PLXTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06ABA225A001 |
艾司西酞普蘭 |
01 |
|
1 |
ASXTPL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
艾司西酞普蘭片劑 |
|
ASXTPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06ABF098A001 |
氟西汀 |
01 |
|
1 |
FXT |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氟西汀片劑 |
|
FXTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06ABF098A006 |
氟西汀 |
01 |
|
1 |
FXT |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
氟西汀分散片 |
|
FXTFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06ABF098A012 |
氟西汀 |
01 |
|
1 |
FXT |
|
40000 |
0 |
0 |
A012 |
|
|
|
|
|
|
氟西汀腸溶片 |
|
FXTCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06ABF098E001 |
氟西汀 |
01 |
|
1 |
FXT |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
氟西汀硬膠囊 |
|
FXTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06ABF071A001 |
氟伏沙明 |
01 |
|
2 |
FFSM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氟伏沙明片劑 |
|
FFSMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABS066A001 |
舍曲林 |
01 |
|
2 |
SQL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
舍曲林片劑 |
|
SQLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABS066A006 |
舍曲林 |
01 |
|
2 |
SQL |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
舍曲林分散片 |
|
SQLFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABS066E001 |
舍曲林 |
01 |
|
2 |
SQL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
舍曲林硬膠囊 |
|
SQLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABX016A001 |
西酞普蘭 |
01 |
|
2 |
XTPL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
西酞普蘭片劑 |
|
XTPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABX016A017 |
西酞普蘭 |
01 |
|
2 |
XTPL |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
西酞普蘭薄膜衣片 |
|
XTPLBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06ABX016E001 |
西酞普蘭 |
01 |
|
2 |
XTPL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
西酞普蘭硬膠囊 |
|
XTPLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXM093A001 |
米氮平 |
01 |
|
1 |
MDP |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
米氮平片劑 |
|
MDPPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AXW067A001 |
文拉法辛 |
01 |
|
1 |
WLFX |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
文拉法辛片劑 |
|
WLFXPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AXW067E001 |
文拉法辛 |
01 |
|
1 |
WLFX |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
文拉法辛硬膠囊 |
|
WLFXYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AXW067A010 |
文拉法辛 |
01 |
|
1 |
WLFX |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
文拉法辛緩釋片 |
|
WLFXHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AXW067E003 |
文拉法辛 |
01 |
|
1 |
WLFX |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
文拉法辛緩釋膠囊 |
|
WLFXHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06AXA268A001 |
阿戈美拉汀 |
01 |
|
2 |
AGMLT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
阿戈美拉汀片劑 |
|
AGMLTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXD151A012 |
度洛西汀 |
01 |
|
2 |
DLXT |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
度洛西汀腸溶片 |
|
DLXTCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXD151E005 |
度洛西汀 |
01 |
|
2 |
DLXT |
|
40000 |
0.1 |
0.1 |
E005 |
|
|
|
|
|
|
度洛西汀腸溶膠囊 |
|
DLXTCRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXM025A001 |
嗎氯貝胺 |
01 |
|
2 |
MLBA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
嗎氯貝胺片劑 |
|
MLBAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXM025A017 |
嗎氯貝胺 |
01 |
|
2 |
MLBA |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
嗎氯貝胺薄膜衣片 |
|
MLBABMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXM025E001 |
嗎氯貝胺 |
01 |
|
2 |
MLBA |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
嗎氯貝胺硬膠囊 |
|
MLBAYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXM092A001 |
米安色林 |
01 |
|
2 |
MASL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
米安色林片劑 |
|
MASLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXM103A001 |
米那普侖 |
01 |
|
2 |
MNPL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
米那普侖片劑 |
|
MNPLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXQ113A001 |
曲唑酮 |
01 |
|
2 |
QZT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
曲唑酮片劑 |
|
QZTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXR066A001 |
瑞波西汀 |
01 |
|
2 |
RBXT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
瑞波西汀片劑 |
|
RBXTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXR066E001 |
瑞波西汀 |
01 |
|
2 |
RBXT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
瑞波西汀硬膠囊 |
|
RBXTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXS009A001 |
噻奈普汀 |
01 |
|
2 |
SNPT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
噻奈普汀片劑 |
|
SNPTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06AXA090A001 |
安非他酮 |
01 |
|
2 |
AFTT |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
安非他酮片劑 |
|
AFTTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN06BXS086A001 |
石杉堿甲 |
01 |
|
1 |
SSJJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
石杉堿甲片劑 |
|
SSJJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06BXS086E001 |
石杉堿甲 |
01 |
|
1 |
SSJJ |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
石杉堿甲硬膠囊 |
|
SSJJYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN06BXJ053A006 |
甲氯芬酯 |
01 |
|
2 |
JLFZ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
甲氯芬酯分散片 |
|
JLFZFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06BXJ053E001 |
甲氯芬酯 |
01 |
|
2 |
JLFZ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
甲氯芬酯硬膠囊 |
|
JLFZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06BCK115B002 |
咖啡因 |
01 |
|
2 |
KFY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
咖啡因注射液 |
|
KFYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06BAP010A001 |
哌甲酯 |
01 |
|
2 |
PJZ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
哌甲酯片劑 |
|
PJZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06BAP010A010 |
哌甲酯 |
01 |
|
2 |
PJZ |
|
40000 |
1 |
1 |
A010 |
|
|
|
|
|
|
哌甲酯緩釋片 |
|
PJZHSP |
|
0 |
1 |
1 |
2020-1-1 |
|
限由專科醫(yī)生采用DSM-IV診斷標準作出明確診斷的兒童患者 |
0.1 |
0.1 |
|
| XN06BAP010B001 |
哌甲酯 |
01 |
|
2 |
PJZ |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
哌甲酯注射劑 |
|
PJZZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN06BAT117E001 |
托莫西汀 |
01 |
|
2 |
TMXT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
托莫西汀硬膠囊 |
|
TMXTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06BXA083A001 |
艾地苯醌 |
01 |
|
2 |
ADBK |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
艾地苯醌片劑 |
|
ADBKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN06BXG106B002 |
谷紅 |
01 |
|
2 |
GH |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
谷紅注射液 |
|
GHZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXJ001B001 |
肌氨肽苷 |
01 |
|
2 |
JATG |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
肌氨肽苷注射劑 |
|
JATGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXJ001B002 |
肌氨肽苷 |
01 |
|
2 |
JATG |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
肌氨肽苷注射液 |
|
JATGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXJ001B014 |
肌氨肽苷 |
01 |
|
2 |
JATG |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
肌氨肽苷凍干粉針 |
|
JATGDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXY117B001 |
乙酰谷酰胺 |
01 |
|
2 |
YXGXA |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
乙酰谷酰胺注射劑 |
|
YXGXAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXY117B002 |
乙酰谷酰胺 |
01 |
|
2 |
YXGXA |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
乙酰谷酰胺注射液 |
|
YXGXAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXY117B003 |
乙酰谷酰胺 |
01 |
|
2 |
YXGXA |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
乙酰谷酰胺注射用無菌粉末 |
|
YXGXAZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06BXY117B014 |
乙酰谷酰胺 |
01 |
|
2 |
YXGXA |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
乙酰谷酰胺凍干粉針 |
|
YXGXADGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服同類藥品口服制劑患者 |
0.2 |
0.2 |
|
| XN06CAF088A001 |
氟哌噻噸美利曲辛 |
01 |
|
2 |
FPSDMLQX |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氟哌噻噸美利曲辛片劑 |
|
FPSDMLQXPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06CAF088E001 |
氟哌噻噸美利曲辛 |
01 |
|
2 |
FPSDMLQX |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氟哌噻噸美利曲辛硬膠囊 |
|
FPSDMLQXYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06DAD171A001 |
多奈哌齊 |
01 |
|
2 |
DNPQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
多奈哌齊片劑 |
|
DNPQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAD171A006 |
多奈哌齊 |
01 |
|
2 |
DNPQ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
多奈哌齊分散片 |
|
DNPQFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAD171E001 |
多奈哌齊 |
01 |
|
2 |
DNPQ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
多奈哌齊硬膠囊 |
|
DNPQYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAD171A022 |
多奈哌齊 |
01 |
|
2 |
DNPQ |
|
40000 |
0.1 |
0.1 |
A022 |
|
|
|
|
|
|
多奈哌齊口腔崩解片 |
|
DNPQKQBJP |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAJ021A001 |
加蘭他敏 |
01 |
|
2 |
JLTM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
加蘭他敏片劑 |
|
JLTMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAJ021A006 |
加蘭他敏 |
01 |
|
2 |
JLTM |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
加蘭他敏分散片 |
|
JLTMFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAJ021E001 |
加蘭他敏 |
01 |
|
2 |
JLTM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
加蘭他敏硬膠囊 |
|
JLTMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DAK005E001 |
卡巴拉汀 |
01 |
|
2 |
KBLT |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
卡巴拉汀硬膠囊 |
|
KBLTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.1 |
0.1 |
|
| XN06DXM045A001 |
美金剛 |
01 |
|
2 |
MJG |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
美金剛片劑 |
|
MJGPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的中重度至重度阿爾茨海默型癡呆 |
0.1 |
0.1 |
|
| XN06DXM045X001 |
美金剛 |
01 |
|
2 |
MJG |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
美金剛口服溶液劑 |
|
MJGKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限吞咽困難且明確診斷的中重度至重度阿爾茨海默型癡呆 |
0.1 |
0.1 |
|
| XN06DAL359V002 |
利斯的明 |
01 |
|
2 |
LSDM |
|
40000 |
0.2 |
0.2 |
V002 |
|
|
|
|
|
|
利斯的明透皮貼劑 |
|
LSDMTPTJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限明確診斷的阿爾茨海默病 |
0.2 |
0.2 |
|
| XN06DAJ021B002 |
加蘭他敏 |
01 |
|
2 |
JLTM |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
加蘭他敏注射液 |
|
JLTMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN06DXF415B002 |
復方腦肽節(jié)苷脂 |
01 |
|
2 |
FFNTJGZ |
|
40000 |
0.3 |
0.3 |
B002 |
|
|
|
|
|
|
復方腦肽節(jié)苷脂注射液 |
|
FFNTJGZZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥腦血管病急性期、重度顱腦損傷急性期，使用不超過14天 |
0.3 |
0.3 |
|
| XN07AAX155B001 |
新斯的明 |
01 |
|
1 |
XSDM |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
新斯的明注射劑 |
|
XSDMZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07AAX155B002 |
新斯的明 |
01 |
|
1 |
XSDM |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
新斯的明注射液 |
|
XSDMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07AAX164A001 |
溴吡斯的明 |
01 |
|
1 |
XBSDM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
溴吡斯的明片劑 |
|
XBSDMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07AAX164A018 |
溴吡斯的明 |
01 |
|
1 |
XBSDM |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
溴吡斯的明糖衣片 |
|
XBSDMTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07AAX175A001 |
溴新斯的明 |
01 |
|
1 |
XXSDM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
溴新斯的明片劑 |
|
XXSDMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07BCM054A001 |
美沙酮 |
01 |
|
2 |
MST |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
美沙酮片劑 |
|
MSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07BCM054X001 |
美沙酮 |
01 |
|
2 |
MST |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
美沙酮口服溶液劑 |
|
MSTKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07BBN010A001 |
納曲酮 |
01 |
|
2 |
NQT |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
納曲酮片劑 |
|
NQTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07CAB046A001 |
倍他司汀 |
01 |
|
1 |
BTST |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
倍他司汀片劑 |
|
BTSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAB046A017 |
倍他司汀 |
01 |
|
1 |
BTST |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
倍他司汀薄膜衣片 |
|
BTSTBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAB046A018 |
倍他司汀 |
01 |
|
1 |
BTST |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
倍他司汀糖衣片 |
|
BTSTTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAD070A001 |
地芬尼多 |
01 |
|
1 |
DFND |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
地芬尼多片劑 |
|
DFNDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAD070A017 |
地芬尼多 |
01 |
|
1 |
DFND |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
地芬尼多薄膜衣片 |
|
DFNDBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAD070A018 |
地芬尼多 |
01 |
|
1 |
DFND |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
地芬尼多糖衣片 |
|
DFNDTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAF072A001 |
氟桂利嗪 |
01 |
|
1 |
FGLQ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氟桂利嗪片劑 |
|
FGLQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAF072A006 |
氟桂利嗪 |
01 |
|
1 |
FGLQ |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
氟桂利嗪分散片 |
|
FGLQFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAF072E001 |
氟桂利嗪 |
01 |
|
1 |
FGLQ |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
氟桂利嗪硬膠囊 |
|
FGLQYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07CAB046B002 |
倍他司汀 |
01 |
|
2 |
BTST |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
倍他司汀注射液 |
|
BTSTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07CAB046B014 |
倍他司汀 |
01 |
|
2 |
BTST |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
倍他司汀凍干粉針 |
|
BTSTDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07CAF072H002 |
氟桂利嗪 |
01 |
|
2 |
FGLQ |
|
40000 |
0.2 |
0.2 |
H002 |
|
|
|
|
|
|
氟桂利嗪滴丸 |
|
FGLQDW |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07CAF072X001 |
氟桂利嗪 |
01 |
|
2 |
FGLQ |
|
40000 |
0.2 |
0.2 |
X001 |
|
|
|
|
|
|
氟桂利嗪口服溶液劑 |
|
FGLQKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07CAE045E001 |
二維三七桂利嗪 |
01 |
|
2 |
EWSGLQ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
二維三七桂利嗪硬膠囊 |
|
EWSGLQYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXB025A001 |
胞磷膽堿 |
01 |
|
2 |
BLDJ |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
胞磷膽堿片劑 |
|
BLDJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07XXB025E001 |
胞磷膽堿 |
01 |
|
2 |
BLDJ |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
胞磷膽堿硬膠囊 |
|
BLDJYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07XXB220B001 |
胞磷膽堿（胞二磷膽堿） |
01 |
|
2 |
BLDJ(BELDJ) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
胞磷膽堿（胞二磷膽堿）注射劑 |
|
BLDJ(BELDJ)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限出現意識障礙的急性顱腦外傷和腦手術后患者，支付不超過14天 |
0.2 |
0.2 |
|
| XN07XXB220B002 |
胞磷膽堿（胞二磷膽堿） |
01 |
|
2 |
BLDJ(BELDJ) |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
胞磷膽堿（胞二磷膽堿）注射液 |
|
BLDJ(BELDJ)ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限出現意識障礙的急性顱腦外傷和腦手術后患者，支付不超過14天 |
0.2 |
0.2 |
|
| XN07XXB220B014 |
胞磷膽堿（胞二磷膽堿） |
01 |
|
2 |
BLDJ(BELDJ) |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
胞磷膽堿（胞二磷膽堿）凍干粉針 |
|
BLDJ(BELDJ)DGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限出現意識障礙的急性顱腦外傷和腦手術后患者，支付不超過14天 |
0.2 |
0.2 |
|
| XN07XXB093B001 |
吡拉西坦 |
01 |
|
2 |
BLXT |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
吡拉西坦注射劑 |
|
BLXTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腦外傷所致的腦功能障礙患者，支付不超過14天 |
0.1 |
0.1 |
|
| XN07XXB093B002 |
吡拉西坦 |
01 |
|
2 |
BLXT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
吡拉西坦注射液 |
|
BLXTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限腦外傷所致的腦功能障礙患者，支付不超過14天 |
0.1 |
0.1 |
|
| XN07XXB093B014 |
吡拉西坦 |
01 |
|
2 |
BLXT |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
吡拉西坦凍干粉針 |
|
BLXTDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腦外傷所致的腦功能障礙患者，支付不超過14天 |
0.1 |
0.1 |
|
| XN07XXB221A001 |
吡拉西坦（乙酰胺吡咯烷酮） |
01 |
|
2 |
BLXT(YXABLWT) |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
吡拉西坦（乙酰胺吡咯烷酮）片劑 |
|
BLXT(YXABLWT)PJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXB221A006 |
吡拉西坦（乙酰胺吡咯烷酮） |
01 |
|
2 |
BLXT(YXABLWT) |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
吡拉西坦（乙酰胺吡咯烷酮）分散片 |
|
BLXT(YXABLWT)FSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXB221A025 |
吡拉西坦（乙酰胺吡咯烷酮） |
01 |
|
2 |
BLXT(YXABLWT) |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
吡拉西坦（乙酰胺吡咯烷酮）素片 |
|
BLXT(YXABLWT)SP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXB221E001 |
吡拉西坦（乙酰胺吡咯烷酮） |
01 |
|
2 |
BLXT(YXABLWT) |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
吡拉西坦（乙酰胺吡咯烷酮）硬膠囊 |
|
BLXT(YXABLWT)YJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXD130E002 |
丁苯酞 |
01 |
|
2 |
DBT |
|
40000 |
0.2 |
0.2 |
E002 |
|
|
|
|
|
|
丁苯酞軟膠囊 |
|
DBTRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限新發(fā)的中度急性缺血性腦卒中患者發(fā)作72小時以內開始使用，支付不超過20天 |
0.2 |
0.2 |
|
| XN07XXD221B002 |
丁苯酞氯化鈉 |
01 |
|
2 |
DBTLHN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
丁苯酞氯化鈉注射液 |
|
DBTLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限新發(fā)的急性中度缺血性腦卒中患者在發(fā)作48小時內開始使用，支付不超過14天 |
0.2 |
0.2 |
|
| XN07XXG107A001 |
谷維素 |
01 |
|
2 |
GWS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
谷維素片劑 |
|
GWSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07XXG107A017 |
谷維素 |
01 |
|
2 |
GWS |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
谷維素薄膜衣片 |
|
GWSBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07XXG107A025 |
谷維素 |
01 |
|
2 |
GWS |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
谷維素素片 |
|
GWSSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XN07XXH044B002 |
環(huán)輪寧 |
01 |
|
2 |
HLN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
環(huán)輪寧注射液 |
|
HLNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07XXL068A001 |
利魯唑 |
01 |
|
2 |
LLZ |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
利魯唑片劑 |
|
LLZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07XXL068E001 |
利魯唑 |
01 |
|
2 |
LLZ |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
利魯唑硬膠囊 |
|
LLZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XN07XXT050A001 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
天麻素片劑 |
|
TMSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXT050A017 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
天麻素薄膜衣片 |
|
TMSBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXT050A018 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
天麻素糖衣片 |
|
TMSTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXT050A025 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
天麻素素片 |
|
TMSSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXT050E001 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
天麻素硬膠囊 |
|
TMSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XN07XXT050B001 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
天麻素注射劑 |
|
TMSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服的血管神經性頭痛或眩暈癥患者，支付不超過14天 |
0.1 |
0.1 |
|
| XN07XXT050B002 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
天麻素注射液 |
|
TMSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服的血管神經性頭痛或眩暈癥患者，支付不超過14天 |
0.1 |
0.1 |
|
| XN07XXT050B014 |
天麻素 |
01 |
|
2 |
TMS |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
天麻素凍干粉針 |
|
TMSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服的血管神經性頭痛或眩暈癥患者，支付不超過14天 |
0.1 |
0.1 |
|
| XP01AAS111W001 |
雙碘喹啉 |
01 |
|
2 |
SDKL |
|
40000 |
0.1 |
0.1 |
W001 |
|
|
|
|
|
|
雙碘喹啉口服常釋劑型 |
|
SDKLKFCSJX |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP01BAB148A001 |
伯氨喹 |
01 |
|
1 |
BAK |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
伯氨喹片劑 |
|
BAKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BAB148A018 |
伯氨喹 |
01 |
|
1 |
BAK |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
伯氨喹糖衣片 |
|
BAKTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BEH006A001 |
蒿甲醚 |
01 |
|
1 |
HJM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
蒿甲醚片劑 |
|
HJMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BEH006E001 |
蒿甲醚 |
01 |
|
1 |
HJM |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
蒿甲醚硬膠囊 |
|
HJMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BEH006E002 |
蒿甲醚 |
01 |
|
1 |
HJM |
|
40000 |
0 |
0 |
E002 |
|
|
|
|
|
|
蒿甲醚軟膠囊 |
|
HJMRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BCK093A001 |
奎寧 |
01 |
|
1 |
KN |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
奎寧片劑 |
|
KNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BCK093A018 |
奎寧 |
01 |
|
1 |
KN |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
奎寧糖衣片 |
|
KNTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BAL223A001 |
氯喹 |
01 |
|
1 |
LK |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯喹片劑 |
|
LKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BAL223A018 |
氯喹 |
01 |
|
1 |
LK |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
氯喹糖衣片 |
|
LKTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BAL223B002 |
氯喹 |
01 |
|
1 |
LK |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氯喹注射液 |
|
LKZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BDY108A001 |
乙胺嘧啶 |
01 |
|
1 |
YAMD |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
乙胺嘧啶片劑 |
|
YAMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP01BXG138A012 |
咯萘啶 |
01 |
|
2 |
LND |
|
40000 |
0.1 |
0.1 |
A012 |
|
|
|
|
|
|
咯萘啶腸溶片 |
|
LNDCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP01BXG138B002 |
咯萘啶 |
01 |
|
2 |
LND |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
咯萘啶注射液 |
|
LNDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP01BDH108A001 |
磺胺多辛乙胺嘧啶 |
01 |
|
2 |
HADXYAMD |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
磺胺多辛乙胺嘧啶片劑 |
|
HADXYAMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XP01BCK093B002 |
奎寧 |
01 |
|
2 |
KN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
奎寧注射液 |
|
KNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XP01BAP013A001 |
哌喹 |
01 |
|
2 |
PK |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
哌喹片劑 |
|
PKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP01BAQ034A001 |
羥氯喹 |
01 |
|
2 |
QLK |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
羥氯喹片劑 |
|
QLKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP01BEQ051D001 |
青蒿素 |
01 |
|
2 |
QHS |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
青蒿素栓劑 |
|
QHSSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP01CBP083B002 |
葡萄糖酸銻鈉 |
01 |
|
1 |
PTTSTN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
葡萄糖酸銻鈉注射液 |
|
PTTSTNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02BAB092A001 |
吡喹酮 |
01 |
|
1 |
BKT |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
吡喹酮片劑 |
|
BKTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02BAB092A017 |
吡喹酮 |
01 |
|
1 |
BKT |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
吡喹酮薄膜衣片 |
|
BKTBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02BAB092A025 |
吡喹酮 |
01 |
|
1 |
BKT |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
吡喹酮素片 |
|
BKTSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CAA010A001 |
阿苯達唑 |
01 |
|
1 |
ABDZ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
阿苯達唑片劑 |
|
ABDZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CAA010A017 |
阿苯達唑 |
01 |
|
1 |
ABDZ |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
阿苯達唑薄膜衣片 |
|
ABDZBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CAA010E001 |
阿苯達唑 |
01 |
|
1 |
ABDZ |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
阿苯達唑硬膠囊 |
|
ABDZYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CAJ028A001 |
甲苯咪唑 |
01 |
|
1 |
JBMZ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
甲苯咪唑片劑 |
|
JBMZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CBP021A001 |
哌嗪 |
01 |
|
2 |
PQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
哌嗪片劑 |
|
PQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP02CBP021A025 |
哌嗪 |
01 |
|
2 |
PQ |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
哌嗪素片 |
|
PQSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP02CBP021A015 |
哌嗪 |
01 |
|
2 |
PQ |
|
40000 |
0.1 |
0.1 |
A015 |
|
|
|
|
|
|
哌嗪錠劑 |
|
PQDJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP02CCS134A001 |
雙羥萘酸噻嘧啶 |
01 |
|
2 |
SQNSSMD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
雙羥萘酸噻嘧啶片劑 |
|
SQNSSMDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP02CCS134N001 |
雙羥萘酸噻嘧啶 |
01 |
|
2 |
SQNSSMD |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
雙羥萘酸噻嘧啶顆粒劑 |
|
SQNSSMDKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP02CCS134D001 |
雙羥萘酸噻嘧啶 |
01 |
|
2 |
SQNSSMD |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
雙羥萘酸噻嘧啶栓劑 |
|
SQNSSMDSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP02CEZ072A001 |
左旋咪唑 |
01 |
|
2 |
ZXMZ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
左旋咪唑片劑 |
|
ZXMZPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CEZ072A012 |
左旋咪唑 |
01 |
|
2 |
ZXMZ |
|
40000 |
0 |
0 |
A012 |
|
|
|
|
|
|
左旋咪唑腸溶片 |
|
ZXMZCRP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CEZ072A018 |
左旋咪唑 |
01 |
|
2 |
ZXMZ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
左旋咪唑糖衣片 |
|
ZXMZTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP02CEZ072A025 |
左旋咪唑 |
01 |
|
2 |
ZXMZ |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
左旋咪唑素片 |
|
ZXMZSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XP03AXK076F002 |
克羅米通 |
01 |
|
2 |
KLMT |
|
40000 |
0.1 |
0.1 |
F002 |
|
|
|
|
|
|
克羅米通乳膏劑 |
|
KLMTRGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XP03ABL091F002 |
林旦 |
01 |
|
2 |
LD |
|
40000 |
0.1 |
0.1 |
F002 |
|
|
|
|
|
|
林旦乳膏劑 |
|
LDRGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01AAM001R001 |
麻黃堿 |
01 |
|
1 |
MHJ |
|
40000 |
0 |
0 |
R001 |
|
|
|
|
|
|
麻黃堿滴鼻劑 |
|
MHJDBJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01AAM001R010 |
麻黃堿 |
01 |
|
1 |
MHJ |
|
40000 |
0 |
0 |
R010 |
|
|
|
|
|
|
麻黃堿滴鼻液 |
|
MHJDBY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01AAQ032L002 |
羥甲唑啉 |
01 |
|
2 |
QJZL |
|
40000 |
0 |
0 |
L002 |
|
|
|
|
|
|
羥甲唑啉噴霧劑 |
|
QJZLPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01AAQ032R010 |
羥甲唑啉 |
01 |
|
2 |
QJZL |
|
40000 |
0 |
0 |
R010 |
|
|
|
|
|
|
羥甲唑啉滴鼻液 |
|
QJZLDBY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01AAS013R010 |
賽洛唑啉 |
01 |
|
2 |
SLZL |
|
40000 |
0.1 |
0.1 |
R010 |
|
|
|
|
|
|
賽洛唑啉滴鼻液 |
|
SLZLDBY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ABF048R010 |
呋麻 |
01 |
|
2 |
FM |
|
40000 |
0 |
0 |
R010 |
|
|
|
|
|
|
呋麻滴鼻液 |
|
FMDBY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXA210A001 |
奧洛他定 |
01 |
|
2 |
ALTD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
奧洛他定片劑 |
|
ALTDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AXA210E001 |
奧洛他定 |
01 |
|
2 |
ALTD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
奧洛他定硬膠囊 |
|
ALTDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR01ACD041R003 |
氮?斯汀 |
01 |
|
2 |
DST |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
氮?斯汀鼻用噴霧劑 |
|
DSTBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ACS207R010 |
色甘酸鈉 |
01 |
|
2 |
SGSN |
|
40000 |
0.2 |
0.2 |
R010 |
|
|
|
|
|
|
色甘酸鈉滴鼻液 |
|
SGSNDBY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR01ACZ058R003 |
左卡巴斯汀 |
01 |
|
2 |
ZKBST |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
左卡巴斯汀鼻用噴霧劑 |
|
ZKBSTBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ACS242R003 |
色甘萘甲那敏 |
01 |
|
2 |
SGNJNM |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
色甘萘甲那敏鼻用噴霧劑 |
|
SGNJNMBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ADB041L001 |
倍氯米松 |
01 |
|
1 |
BLMS |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
倍氯米松氣霧劑 |
|
BLMSQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01ADB041L016 |
倍氯米松 |
01 |
|
1 |
BLMS |
|
40000 |
0 |
0 |
L016 |
|
|
|
|
|
|
倍氯米松吸入性混懸液 |
|
BLMSXRXHXY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01ADB041R003 |
倍氯米松 |
01 |
|
1 |
BLMS |
|
40000 |
0 |
0 |
R003 |
|
|
|
|
|
|
倍氯米松鼻用噴霧劑 |
|
BLMSBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01ADB041R012 |
倍氯米松 |
01 |
|
1 |
BLMS |
|
40000 |
0 |
0 |
R012 |
|
|
|
|
|
|
倍氯米松鼻用氣霧劑 |
|
BLMSBYQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01ADB205L001 |
倍氯米松福莫特羅 |
01 |
|
2 |
BLMSFMTL |
|
40000 |
0.1 |
0.1 |
L001 |
|
|
|
|
|
|
倍氯米松福莫特羅氣霧劑 |
|
BLMSFMTLQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ADB165R003 |
布地奈德 |
01 |
|
2 |
BDND |
|
40000 |
0 |
0 |
R003 |
|
|
|
|
|
|
布地奈德鼻用噴霧劑 |
|
BDNDBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03BAB165L001 |
布地奈德 |
01 |
|
2 |
BDND |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
布地奈德氣霧劑 |
|
BDNDQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03BAB165L013 |
布地奈德 |
01 |
|
2 |
BDND |
|
40000 |
0 |
0 |
L013 |
|
|
|
|
|
|
布地奈德粉末吸入劑 |
|
BDNDFMXRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03BAB165L016 |
布地奈德 |
01 |
|
2 |
BDND |
|
40000 |
0 |
0 |
L016 |
|
|
|
|
|
|
布地奈德吸入性混懸液 |
|
BDNDXRXHXY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR01ADF095L001 |
氟替卡松 |
01 |
|
2 |
FTKS |
|
40000 |
0.1 |
0.1 |
L001 |
|
|
|
|
|
|
氟替卡松氣霧劑 |
|
FTKSQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ADF095L016 |
氟替卡松 |
01 |
|
2 |
FTKS |
|
40000 |
0.1 |
0.1 |
L016 |
|
|
|
|
|
|
氟替卡松吸入性混懸液 |
|
FTKSXRXHXY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ADF095R003 |
氟替卡松 |
01 |
|
2 |
FTKS |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
氟替卡松鼻用噴霧劑 |
|
FTKSBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ADK037R003 |
糠酸莫米松 |
01 |
|
2 |
KSMMS |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
糠酸莫米松鼻用噴霧劑 |
|
KSMMSBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR01ADQ082R003 |
曲安奈德 |
01 |
|
2 |
QAND |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
曲安奈德鼻用噴霧劑 |
|
QANDBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03ACS048L001 |
沙丁胺醇 |
01 |
|
1 |
SDAC |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
沙丁胺醇氣霧劑 |
|
SDACQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03ACS048L009 |
沙丁胺醇 |
01 |
|
1 |
SDAC |
|
40000 |
0 |
0 |
L009 |
|
|
|
|
|
|
沙丁胺醇霧化吸入液 |
|
SDACWHXRY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03ACS048L019 |
沙丁胺醇 |
01 |
|
1 |
SDAC |
|
40000 |
0 |
0 |
L019 |
|
|
|
|
|
|
沙丁胺醇吸入用溶液劑 |
|
SDACXRYRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03AKB166L013 |
布地奈德福莫特羅（Ⅰ、Ⅱ） |
01 |
|
2 |
BDNDFMTL() |
|
40000 |
0.1 |
0.1 |
L013 |
|
|
|
|
|
|
布地奈德福莫特羅（Ⅰ、Ⅱ）粉末吸入劑 |
|
BDNDFMTL()FMXRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03ACF104L003 |
福莫特羅 |
01 |
|
2 |
FMTL |
|
40000 |
0.1 |
0.1 |
L003 |
|
|
|
|
|
|
福莫特羅粉霧劑 |
|
FMTLFWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03ACF104L013 |
福莫特羅 |
01 |
|
2 |
FMTL |
|
40000 |
0.1 |
0.1 |
L013 |
|
|
|
|
|
|
福莫特羅粉末吸入劑 |
|
FMTLFMXRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03ACS053L001 |
沙美特羅 |
01 |
|
2 |
SMTL |
|
40000 |
0.1 |
0.1 |
L001 |
|
|
|
|
|
|
沙美特羅氣霧劑 |
|
SMTLQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03ACS053L003 |
沙美特羅 |
01 |
|
2 |
SMTL |
|
40000 |
0.1 |
0.1 |
L003 |
|
|
|
|
|
|
沙美特羅粉霧劑 |
|
SMTLFWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03AKS054L001 |
沙美特羅替卡松 |
01 |
|
2 |
SMTLTKS |
|
40000 |
0.1 |
0.1 |
L001 |
|
|
|
|
|
|
沙美特羅替卡松氣霧劑 |
|
SMTLTKSQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03AKS054L013 |
沙美特羅替卡松 |
01 |
|
2 |
SMTLTKS |
|
40000 |
0.1 |
0.1 |
L013 |
|
|
|
|
|
|
沙美特羅替卡松粉末吸入劑 |
|
SMTLTKSFMXRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03ACT022L001 |
特布他林 |
01 |
|
2 |
TBTL |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
特布他林氣霧劑 |
|
TBTLQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03ACT022L008 |
特布他林 |
01 |
|
2 |
TBTL |
|
40000 |
0 |
0 |
L008 |
|
|
|
|
|
|
特布他林霧化溶液劑 |
|
TBTLWHRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03BBY139L001 |
異丙托溴銨 |
01 |
|
1 |
YBTXA |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
異丙托溴銨氣霧劑 |
|
YBTXAQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03BBY139L019 |
異丙托溴銨 |
01 |
|
1 |
YBTXA |
|
40000 |
0 |
0 |
L019 |
|
|
|
|
|
|
異丙托溴銨吸入用溶液劑 |
|
YBTXAXRYRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03BBF576L019 |
復方異丙托溴銨 |
01 |
|
2 |
FFYBTXA |
|
40000 |
0.1 |
0.1 |
L019 |
|
|
|
|
|
|
復方異丙托溴銨吸入用溶液劑 |
|
FFYBTXAXRYRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03BBS010L002 |
噻托溴銨 |
01 |
|
2 |
STXA |
|
40000 |
0.1 |
0.1 |
L002 |
|
|
|
|
|
|
噻托溴銨噴霧劑 |
|
STXAPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03BBS010L013 |
噻托溴銨 |
01 |
|
2 |
STXA |
|
40000 |
0.1 |
0.1 |
L013 |
|
|
|
|
|
|
噻托溴銨粉末吸入劑 |
|
STXAFMXRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03BCS207L001 |
色甘酸鈉 |
01 |
|
2 |
SGSN |
|
40000 |
0.1 |
0.1 |
L001 |
|
|
|
|
|
|
色甘酸鈉氣霧劑 |
|
SGSNQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CCB016A001 |
班布特羅 |
01 |
|
1 |
BBTL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
班布特羅片劑 |
|
BBTLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCB016A025 |
班布特羅 |
01 |
|
1 |
BBTL |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
班布特羅素片 |
|
BBTLSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCB016E001 |
班布特羅 |
01 |
|
1 |
BBTL |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
班布特羅硬膠囊 |
|
BBTLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCS048A001 |
沙丁胺醇 |
01 |
|
1 |
SDAC |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
沙丁胺醇片劑 |
|
SDACPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCS048E001 |
沙丁胺醇 |
01 |
|
1 |
SDAC |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
沙丁胺醇硬膠囊 |
|
SDACYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCT022A001 |
特布他林 |
01 |
|
1 |
TBTL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
特布他林片劑 |
|
TBTLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCT022E001 |
特布他林 |
01 |
|
1 |
TBTL |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
特布他林硬膠囊 |
|
TBTLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCB016X001 |
班布特羅 |
01 |
|
2 |
BBTL |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
班布特羅口服溶液劑 |
|
BBTLKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CCB016N001 |
班布特羅 |
01 |
|
2 |
BBTL |
|
40000 |
0.2 |
0.2 |
N001 |
|
|
|
|
|
|
班布特羅顆粒劑 |
|
BBTLKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR03CCB127A001 |
丙卡特羅 |
01 |
|
2 |
BKTL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
丙卡特羅片劑 |
|
BKTLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CCB127E001 |
丙卡特羅 |
01 |
|
2 |
BKTL |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
丙卡特羅硬膠囊 |
|
BKTLYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CCB127X001 |
丙卡特羅 |
01 |
|
2 |
BKTL |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
丙卡特羅口服溶液劑 |
|
BKTLKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CCB127N001 |
丙卡特羅 |
01 |
|
2 |
BKTL |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
丙卡特羅顆粒劑 |
|
BKTLKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CKF323E001 |
復方甲氧那明 |
01 |
|
2 |
FFJYNM |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
復方甲氧那明硬膠囊 |
|
FFJYNMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCK075D001 |
克侖特羅 |
01 |
|
2 |
KLTL |
|
40000 |
0.1 |
0.1 |
D001 |
|
|
|
|
|
|
克侖特羅栓劑 |
|
KLTLSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03CCS048A010 |
沙丁胺醇 |
01 |
|
2 |
SDAC |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
沙丁胺醇緩釋片 |
|
SDACHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCS048A011 |
沙丁胺醇 |
01 |
|
2 |
SDAC |
|
40000 |
0 |
0 |
A011 |
|
|
|
|
|
|
沙丁胺醇控釋片 |
|
SDACKSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCS048E003 |
沙丁胺醇 |
01 |
|
2 |
SDAC |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
沙丁胺醇緩釋膠囊 |
|
SDACHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCS248A010 |
沙丁胺醇Ⅱ |
01 |
|
2 |
SDAC |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
沙丁胺醇Ⅱ緩釋片 |
|
SDACHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCS048B002 |
沙丁胺醇 |
01 |
|
2 |
SDAC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
沙丁胺醇注射液 |
|
SDACZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCT022B002 |
特布他林 |
01 |
|
2 |
TBTL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
特布他林注射液 |
|
TBTLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03CCT022B014 |
特布他林 |
01 |
|
2 |
TBTL |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
特布他林凍干粉針 |
|
TBTLDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03ACY268L003 |
茚達特羅 |
01 |
|
2 |
YDTL |
|
40000 |
0.1 |
0.1 |
L003 |
|
|
|
|
|
|
茚達特羅粉霧劑 |
|
YDTLFWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR03CCA199X001 |
氨溴特羅 |
01 |
|
2 |
AXTL |
|
40000 |
0.2 |
0.2 |
X001 |
|
|
|
|
|
|
氨溴特羅口服溶液劑 |
|
AXTLKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR03DAA113A001 |
氨茶堿 |
01 |
|
1 |
ACJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氨茶堿片劑 |
|
ACJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAA113A025 |
氨茶堿 |
01 |
|
1 |
ACJ |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
氨茶堿素片 |
|
ACJSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAA113A010 |
氨茶堿 |
01 |
|
1 |
ACJ |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
氨茶堿緩釋片 |
|
ACJHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAA113B001 |
氨茶堿 |
01 |
|
1 |
ACJ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
氨茶堿注射劑 |
|
ACJZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAA113B002 |
氨茶堿 |
01 |
|
1 |
ACJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氨茶堿注射液 |
|
ACJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAA113B014 |
氨茶堿 |
01 |
|
1 |
ACJ |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
氨茶堿凍干粉針 |
|
ACJDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAC011A001 |
茶堿 |
01 |
|
1 |
CJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
茶堿片劑 |
|
CJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAC011A010 |
茶堿 |
01 |
|
1 |
CJ |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
茶堿緩釋片 |
|
CJHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAC011E003 |
茶堿 |
01 |
|
1 |
CJ |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
茶堿緩釋膠囊 |
|
CJHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAC131E003 |
茶堿Ⅱ |
01 |
|
1 |
CJ |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
茶堿Ⅱ緩釋膠囊 |
|
CJHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAD179A001 |
多索茶堿 |
01 |
|
2 |
DSCJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
多索茶堿片劑 |
|
DSCJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAD179E001 |
多索茶堿 |
01 |
|
2 |
DSCJ |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
多索茶堿硬膠囊 |
|
DSCJYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAD179B001 |
多索茶堿 |
01 |
|
2 |
DSCJ |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
多索茶堿注射劑 |
|
DSCJZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服且氨茶堿不能耐受的患者 |
0 |
0 |
|
| XR03DAD179B002 |
多索茶堿 |
01 |
|
2 |
DSCJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
多索茶堿注射液 |
|
DSCJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服且氨茶堿不能耐受的患者 |
0 |
0 |
|
| XR03DAD179B014 |
多索茶堿 |
01 |
|
2 |
DSCJ |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
多索茶堿凍干粉針 |
|
DSCJDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法口服且氨茶堿不能耐受的患者 |
0 |
0 |
|
| XR03DAE030A001 |
二羥丙茶堿 |
01 |
|
2 |
EQBCJ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
二羥丙茶堿片劑 |
|
EQBCJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAE030B002 |
二羥丙茶堿 |
01 |
|
2 |
EQBCJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
二羥丙茶堿注射液 |
|
EQBCJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DAE030B014 |
二羥丙茶堿 |
01 |
|
2 |
EQBCJ |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
二羥丙茶堿凍干粉針 |
|
EQBCJDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR03DCM082A001 |
孟魯司特 |
01 |
|
2 |
MLST |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
孟魯司特片劑 |
|
MLSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR03DCM082A005 |
孟魯司特 |
01 |
|
2 |
MLST |
|
40000 |
1 |
1 |
A005 |
|
|
|
|
|
|
孟魯司特咀嚼片 |
|
MLSTJJP |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR03DCM082N001 |
孟魯司特 |
01 |
|
2 |
MLST |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
孟魯司特顆粒劑 |
|
MLSTKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR03DXX047B001 |
細辛腦 |
01 |
|
2 |
XXN |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
細辛腦注射劑 |
|
XXNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR03DXX047B002 |
細辛腦 |
01 |
|
2 |
XXN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
細辛腦注射液 |
|
XXNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR03DXX047B014 |
細辛腦 |
01 |
|
2 |
XXN |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
細辛腦凍干粉針 |
|
XXNDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR05CBA198A001 |
氨溴索 |
01 |
|
1 |
AXS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氨溴索片劑 |
|
AXSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBA198A006 |
氨溴索 |
01 |
|
1 |
AXS |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
氨溴索分散片 |
|
AXSFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBA198E001 |
氨溴索 |
01 |
|
1 |
AXS |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
氨溴索硬膠囊 |
|
AXSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBB020B001 |
半胱氨酸 |
01 |
|
1 |
BGAS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
半胱氨酸注射劑 |
|
BGASZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBX169A001 |
溴己新 |
01 |
|
1 |
XJX |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
溴己新片劑 |
|
XJXPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBS192A001 |
羧甲司坦 |
01 |
|
1 |
SJST |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
羧甲司坦片劑 |
|
SJSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBS192A017 |
羧甲司坦 |
01 |
|
1 |
SJST |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
羧甲司坦薄膜衣片 |
|
SJSTBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBS192A025 |
羧甲司坦 |
01 |
|
1 |
SJST |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
羧甲司坦素片 |
|
SJSTSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBA198K001 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
氨溴索糖漿劑 |
|
AXSTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR05CBA198X001 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
氨溴索口服溶液劑 |
|
AXSKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR05CBA198X008 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0.1 |
0.1 |
X008 |
|
|
|
|
|
|
氨溴索口服液 |
|
AXSKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR05CBA101E012 |
桉檸蒎 |
01 |
|
2 |
ANP |
|
40000 |
0.1 |
0.1 |
E012 |
|
|
|
|
|
|
桉檸蒎腸溶軟膠囊 |
|
ANPCRRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05CBA198N001 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0 |
0 |
N001 |
|
|
|
|
|
|
氨溴索顆粒劑 |
|
AXSKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBA198B001 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
氨溴索注射劑 |
|
AXSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法使用氨溴索口服制劑的排痰困難患者 |
0 |
0 |
|
| XR05CBA198B002 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氨溴索注射液 |
|
AXSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法使用氨溴索口服制劑的排痰困難患者 |
0 |
0 |
|
| XR05CBA198B014 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
氨溴索凍干粉針 |
|
AXSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法使用氨溴索口服制劑的排痰困難患者 |
0 |
0 |
|
| XR05CBF100A001 |
福多司坦 |
01 |
|
2 |
FDST |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
福多司坦片劑 |
|
FDSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XR05CBF100E001 |
福多司坦 |
01 |
|
2 |
FDST |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
福多司坦硬膠囊 |
|
FDSTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XR05CBS192X001 |
羧甲司坦 |
01 |
|
2 |
SJST |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
羧甲司坦口服溶液劑 |
|
SJSTKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBX169B001 |
溴己新 |
01 |
|
2 |
XJX |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
溴己新注射劑 |
|
XJXZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法使用溴己新口服制劑的排痰困難患者 |
0 |
0 |
|
| XR05CBX169B002 |
溴己新 |
01 |
|
2 |
XJX |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
溴己新注射液 |
|
XJXZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法使用溴己新口服制劑的排痰困難患者 |
0 |
0 |
|
| XR05CBX169B014 |
溴己新 |
01 |
|
2 |
XJX |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
溴己新凍干粉針 |
|
XJXDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限無法使用溴己新口服制劑的排痰困難患者 |
0 |
0 |
|
| XR05CBY116A001 |
乙酰半胱氨酸 |
01 |
|
2 |
YXBGAS |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
乙酰半胱氨酸片劑 |
|
YXBGASPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBY116E001 |
乙酰半胱氨酸 |
01 |
|
2 |
YXBGAS |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
乙酰半胱氨酸硬膠囊 |
|
YXBGASYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBY116N001 |
乙酰半胱氨酸 |
01 |
|
2 |
YXBGAS |
|
40000 |
0.2 |
0.2 |
N001 |
|
|
|
|
|
|
乙酰半胱氨酸顆粒劑 |
|
YXBGASKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR05CBY116L019 |
乙酰半胱氨酸 |
01 |
|
2 |
YXBGAS |
|
40000 |
0 |
0 |
L019 |
|
|
|
|
|
|
乙酰半胱氨酸吸入用溶液劑 |
|
YXBGASXRYRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBA198A010 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0 |
0 |
A010 |
|
|
|
|
|
|
氨溴索緩釋片 |
|
AXSHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05CBA198E003 |
氨溴索 |
01 |
|
2 |
AXS |
|
40000 |
0 |
0 |
E003 |
|
|
|
|
|
|
氨溴索緩釋膠囊 |
|
AXSHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05DAK058A001 |
可待因 |
01 |
|
1 |
KDY |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
可待因片劑 |
|
KDYPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05DBP035A001 |
噴托維林 |
01 |
|
1 |
PTWL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
噴托維林片劑 |
|
PTWLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05DBP035A017 |
噴托維林 |
01 |
|
1 |
PTWL |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
噴托維林薄膜衣片 |
|
PTWLBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05DBP035A018 |
噴托維林 |
01 |
|
1 |
PTWL |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
噴托維林糖衣片 |
|
PTWLTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05DBE051A001 |
二氧丙嗪 |
01 |
|
2 |
EYBQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
二氧丙嗪片劑 |
|
EYBQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR05DBE051A018 |
二氧丙嗪 |
01 |
|
2 |
EYBQ |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
二氧丙嗪糖衣片 |
|
EYBQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR05DAY187A001 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
右美沙芬片劑 |
|
YMSFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187A006 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
右美沙芬分散片 |
|
YMSFFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187A018 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
右美沙芬糖衣片 |
|
YMSFTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187E001 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
右美沙芬硬膠囊 |
|
YMSFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187E002 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
E002 |
|
|
|
|
|
|
右美沙芬軟膠囊 |
|
YMSFRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187K001 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
右美沙芬糖漿劑 |
|
YMSFTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187X001 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
右美沙芬口服溶液劑 |
|
YMSFKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187X008 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
X008 |
|
|
|
|
|
|
右美沙芬口服液 |
|
YMSFKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187N001 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
右美沙芬顆粒劑 |
|
YMSFKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05DAY187X013 |
右美沙芬 |
01 |
|
2 |
YMSF |
|
40000 |
0.1 |
0.1 |
X013 |
|
|
|
|
|
|
右美沙芬緩釋混懸劑 |
|
YMSFHSHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XR05FBF273A001 |
復方甘草 |
01 |
|
1 |
FFGC |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
復方甘草片劑 |
|
FFGCPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05FBF273A017 |
復方甘草 |
01 |
|
1 |
FFGC |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
復方甘草薄膜衣片 |
|
FFGCBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05FBF273A025 |
復方甘草 |
01 |
|
1 |
FFGC |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
復方甘草素片 |
|
FFGCSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05FBF273X001 |
復方甘草 |
01 |
|
1 |
FFGC |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
復方甘草口服溶液劑 |
|
FFGCKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05FAK065K001 |
可愈 |
01 |
|
2 |
KY |
|
40000 |
0.2 |
0.2 |
K001 |
|
|
|
|
|
|
可愈糖漿劑 |
|
KYTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲；限二線用藥 |
0.2 |
0.2 |
|
| XR05FAY220X001 |
愈酚偽麻待因 |
01 |
|
2 |
YFWMDY |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
愈酚偽麻待因口服溶液劑 |
|
YFWMDYKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR05XXA150E001 |
氨酚偽麻 |
01 |
|
2 |
AFWM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氨酚偽麻硬膠囊 |
|
AFWMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA150N001 |
氨酚偽麻 |
01 |
|
2 |
AFWM |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
氨酚偽麻顆粒劑 |
|
AFWMKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA153E001 |
氨酚偽麻美芬 |
01 |
|
2 |
AFWMMF |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氨酚偽麻美芬硬膠囊 |
|
AFWMMFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA153A017 |
氨酚偽麻美芬 |
01 |
|
2 |
AFWMMF |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
氨酚偽麻美芬薄膜衣片 |
|
AFWMMFBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA155A001 |
氨酚偽麻美芬Ⅱ |
01 |
|
2 |
AFWMMF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚偽麻美芬Ⅱ片劑 |
|
AFWMMFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA295A001 |
氨酚偽麻美芬Ⅱ/苯酚偽麻 |
01 |
|
2 |
AFWMMFBFWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚偽麻美芬Ⅱ/苯酚偽麻片劑 |
|
AFWMMFBFWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA154A001 |
氨酚偽麻美芬Ⅲ |
01 |
|
2 |
AFWMMF |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚偽麻美芬Ⅲ片劑 |
|
AFWMMFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA157E001 |
氨酚偽麻那敏 |
01 |
|
2 |
AFWMNM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氨酚偽麻那敏硬膠囊 |
|
AFWMNMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA157A001 |
氨酚偽麻那敏 |
01 |
|
2 |
AFWMNM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨酚偽麻那敏片劑 |
|
AFWMNMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA157X001 |
氨酚偽麻那敏 |
01 |
|
2 |
AFWMNM |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
氨酚偽麻那敏口服溶液劑 |
|
AFWMNMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA177E001 |
氨咖麻敏 |
01 |
|
2 |
AKMM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
氨咖麻敏硬膠囊 |
|
AKMMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA179X001 |
氨咖愈敏 |
01 |
|
2 |
AKYM |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
氨咖愈敏口服溶液劑 |
|
AKYMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA190A001 |
氨麻苯美 |
01 |
|
2 |
AMBM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨麻苯美片劑 |
|
AMBMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA191X001 |
氨麻美敏 |
01 |
|
2 |
AMMM |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
氨麻美敏口服溶液劑 |
|
AMMMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA191A017 |
氨麻美敏 |
01 |
|
2 |
AMMM |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
氨麻美敏薄膜衣片 |
|
AMMMBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA191A025 |
氨麻美敏 |
01 |
|
2 |
AMMM |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
氨麻美敏素片 |
|
AMMMSP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA193A001 |
氨麻美敏Ⅱ |
01 |
|
2 |
AMMM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨麻美敏Ⅱ片劑 |
|
AMMMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA193A017 |
氨麻美敏Ⅱ |
01 |
|
2 |
AMMM |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
氨麻美敏Ⅱ薄膜衣片 |
|
AMMMBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXA192A001 |
氨麻美敏Ⅲ |
01 |
|
2 |
AMMM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
氨麻美敏Ⅲ片劑 |
|
AMMMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB033A001 |
貝敏偽麻 |
01 |
|
2 |
BMWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
貝敏偽麻片劑 |
|
BMWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB174A006 |
布洛偽麻 |
01 |
|
2 |
BLWM |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
布洛偽麻分散片 |
|
BLWMFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB174E001 |
布洛偽麻 |
01 |
|
2 |
BLWM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
布洛偽麻硬膠囊 |
|
BLWMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB174N001 |
布洛偽麻 |
01 |
|
2 |
BLWM |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
布洛偽麻顆粒劑 |
|
BLWMKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB174A001 |
布洛偽麻 |
01 |
|
2 |
BLWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
布洛偽麻片劑 |
|
BLWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB174A017 |
布洛偽麻 |
01 |
|
2 |
BLWM |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
布洛偽麻薄膜衣片 |
|
BLWMBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXB174A025 |
布洛偽麻 |
01 |
|
2 |
BLWM |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
布洛偽麻素片 |
|
BLWMSP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF033E001 |
酚咖麻敏 |
01 |
|
2 |
FKMM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
酚咖麻敏硬膠囊 |
|
FKMMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF032A001 |
酚咖 |
01 |
|
2 |
FK |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
酚咖片劑 |
|
FKPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF032A017 |
酚咖 |
01 |
|
2 |
FK |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
酚咖薄膜衣片 |
|
FKBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF032A025 |
酚咖 |
01 |
|
2 |
FK |
|
40000 |
0.1 |
0.1 |
A025 |
|
|
|
|
|
|
酚咖素片 |
|
FKSP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF035E001 |
酚麻美敏 |
01 |
|
2 |
FMMM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
酚麻美敏硬膠囊 |
|
FMMMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF035A001 |
酚麻美敏 |
01 |
|
2 |
FMMM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
酚麻美敏片劑 |
|
FMMMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF036X001 |
酚美愈偽麻 |
01 |
|
2 |
FMYWM |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
酚美愈偽麻口服溶液劑 |
|
FMYWMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF130K001 |
復方氨酚美沙 |
01 |
|
2 |
FFAFMS |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
復方氨酚美沙糖漿劑 |
|
FFAFMSTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF131N001 |
復方氨酚那敏 |
01 |
|
2 |
FFAFNM |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
復方氨酚那敏顆粒劑 |
|
FFAFNMKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF132A001 |
復方氨酚葡鋅 |
01 |
|
2 |
FFAFPX |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
復方氨酚葡鋅片劑 |
|
FFAFPXPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF263E001 |
復方酚咖偽麻 |
01 |
|
2 |
FFFKWM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
復方酚咖偽麻硬膠囊 |
|
FFFKWMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF437K001 |
復方氫溴酸右美沙芬 |
01 |
|
2 |
FFQXSYMSF |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
復方氫溴酸右美沙芬糖漿劑 |
|
FFQXSYMSFTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF542N001 |
復方鋅布 |
01 |
|
2 |
FFXB |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
復方鋅布顆粒劑 |
|
FFXBKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF568E003 |
復方鹽酸偽麻黃堿 |
01 |
|
2 |
FFYSWMHJ |
|
40000 |
0.1 |
0.1 |
E003 |
|
|
|
|
|
|
復方鹽酸偽麻黃堿緩釋膠囊 |
|
FFYSWMHJHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF656X001 |
復方愈創(chuàng)木酚磺酸鉀 |
01 |
|
2 |
FFYCMFHSJ |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
復方愈創(chuàng)木酚磺酸鉀口服溶液劑 |
|
FFYCMFHSJKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXF592K001 |
復方愈酚噴托那敏 |
01 |
|
2 |
FFYFPTNM |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
復方愈酚噴托那敏糖漿劑 |
|
FFYFPTNMTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXK002A001 |
咖酚偽麻 |
01 |
|
2 |
KFWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
咖酚偽麻片劑 |
|
KFWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXM044A001 |
美酚偽麻 |
01 |
|
2 |
MFWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
美酚偽麻片劑 |
|
MFWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXM050X001 |
美敏偽麻 |
01 |
|
2 |
MMWM |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
美敏偽麻口服溶液劑 |
|
MMWMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXM069E001 |
美愈偽麻 |
01 |
|
2 |
MYWM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
美愈偽麻硬膠囊 |
|
MYWMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXM069X001 |
美愈偽麻 |
01 |
|
2 |
MYWM |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
美愈偽麻口服溶液劑 |
|
MYWMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXM069X008 |
美愈偽麻 |
01 |
|
2 |
MYWM |
|
40000 |
0.1 |
0.1 |
X008 |
|
|
|
|
|
|
美愈偽麻口服液 |
|
MYWMKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXP036A001 |
噴托維林氯化銨 |
01 |
|
2 |
PTWLLHA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
噴托維林氯化銨片劑 |
|
PTWLLHAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXP036K001 |
噴托維林氯化銨 |
01 |
|
2 |
PTWLLHA |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
噴托維林氯化銨糖漿劑 |
|
PTWLLHATJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXP065A001 |
撲爾偽麻 |
01 |
|
2 |
PEWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
撲爾偽麻片劑 |
|
PEWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXS127N001 |
雙撲偽麻 |
01 |
|
2 |
SPWM |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
雙撲偽麻顆粒劑 |
|
SPWMKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXW063E001 |
偽麻那敏 |
01 |
|
2 |
WMNM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
偽麻那敏硬膠囊 |
|
WMNMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY188K001 |
右美沙芬愈創(chuàng)甘油醚 |
01 |
|
2 |
YMSFYCGYM |
|
40000 |
0.1 |
0.1 |
K001 |
|
|
|
|
|
|
右美沙芬愈創(chuàng)甘油醚糖漿劑 |
|
YMSFYCGYMTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY213A001 |
愈創(chuàng)維林那敏 |
01 |
|
2 |
YCWLNM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
愈創(chuàng)維林那敏片劑 |
|
YCWLNMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY217N001 |
愈酚噴托異丙嗪 |
01 |
|
2 |
YFPTYBQ |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
愈酚噴托異丙嗪顆粒劑 |
|
YFPTYBQKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY218A001 |
愈酚維林 |
01 |
|
2 |
YFWL |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
愈酚維林片劑 |
|
YFWLPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY218A018 |
愈酚維林 |
01 |
|
2 |
YFWL |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
愈酚維林糖衣片 |
|
YFWLTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY219A001 |
愈酚偽麻 |
01 |
|
2 |
YFWM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
愈酚偽麻片劑 |
|
YFWMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY222E001 |
愈美 |
01 |
|
2 |
YM |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
愈美硬膠囊 |
|
YMYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY222N001 |
愈美 |
01 |
|
2 |
YM |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
愈美顆粒劑 |
|
YMKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XR05XXY222A001 |
愈美 |
01 |
|
2 |
YM |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
愈美片劑 |
|
YMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.2 |
0.2 |
|
| XR05XXM069N001 |
美愈偽麻 |
01 |
|
2 |
MYWM |
|
40000 |
0.1 |
0.1 |
N001 |
|
|
|
|
|
|
美愈偽麻顆粒劑 |
|
MYWMKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XN02BEF129X008 |
復方氨酚甲麻 |
01 |
|
2 |
FFAFJM |
|
40000 |
0.1 |
0.1 |
X008 |
|
|
|
|
|
|
復方氨酚甲麻口服液 |
|
FFAFJMKFY |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0.1 |
0.1 |
|
| XN02BEF136X001 |
復方氨酚愈敏 |
01 |
|
2 |
FFAFYM |
|
40000 |
0 |
0 |
X001 |
|
|
|
|
|
|
復方氨酚愈敏口服溶液劑 |
|
FFAFYMKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
◇；▲ |
0 |
0 |
|
| XR06AAB058A001 |
苯海拉明 |
01 |
|
1 |
BHLM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
苯海拉明片劑 |
|
BHLMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AAB058A017 |
苯海拉明 |
01 |
|
1 |
BHLM |
|
40000 |
0 |
0 |
A017 |
|
|
|
|
|
|
苯海拉明薄膜衣片 |
|
BHLMBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AAB058A018 |
苯海拉明 |
01 |
|
1 |
BHLM |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
苯海拉明糖衣片 |
|
BHLMTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AAB058E002 |
苯海拉明 |
01 |
|
1 |
BHLM |
|
40000 |
0 |
0 |
E002 |
|
|
|
|
|
|
苯海拉明軟膠囊 |
|
BHLMRJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AAB058B002 |
苯海拉明 |
01 |
|
1 |
BHLM |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
苯海拉明注射液 |
|
BHLMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06ABL189A001 |
氯苯那敏 |
01 |
|
1 |
LBNM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯苯那敏片劑 |
|
LBNMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06ABL189A025 |
氯苯那敏 |
01 |
|
1 |
LBNM |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
氯苯那敏素片 |
|
LBNMSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXL226A001 |
氯雷他定 |
01 |
|
1 |
LLTD |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
氯雷他定片劑 |
|
LLTDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXL226A006 |
氯雷他定 |
01 |
|
1 |
LLTD |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
氯雷他定分散片 |
|
LLTDFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXL226E001 |
氯雷他定 |
01 |
|
1 |
LLTD |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
氯雷他定硬膠囊 |
|
LLTDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXS011A001 |
賽庚啶 |
01 |
|
1 |
SGD |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
賽庚啶片劑 |
|
SGDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06ADY136B002 |
異丙嗪 |
01 |
|
1 |
YBQ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
異丙嗪注射液 |
|
YBQZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06ADY136A001 |
異丙嗪 |
01 |
|
1 |
YBQ |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
異丙嗪片劑 |
|
YBQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06ADY136A018 |
異丙嗪 |
01 |
|
1 |
YBQ |
|
40000 |
0 |
0 |
A018 |
|
|
|
|
|
|
異丙嗪糖衣片 |
|
YBQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06ADX134A001 |
小兒異丙嗪 |
01 |
|
1 |
XEYBQ |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
小兒異丙嗪片劑 |
|
XEYBQPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXA016E001 |
阿伐斯汀 |
01 |
|
2 |
AFST |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
阿伐斯汀硬膠囊 |
|
AFSTYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXB217A001 |
貝他斯汀 |
01 |
|
2 |
BTST |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
貝他斯汀片劑 |
|
BTSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AAC010A001 |
茶苯海明 |
01 |
|
2 |
CBHM |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
茶苯海明片劑 |
|
CBHMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXD078A001 |
地氯雷他定 |
01 |
|
2 |
DLLTD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
地氯雷他定片劑 |
|
DLLTDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AXD078A006 |
地氯雷他定 |
01 |
|
2 |
DLLTD |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
地氯雷他定分散片 |
|
DLLTDFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AXD078E001 |
地氯雷他定 |
01 |
|
2 |
DLLTD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
地氯雷他定硬膠囊 |
|
DLLTDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AXD078K001 |
地氯雷他定 |
01 |
|
2 |
DLLTD |
|
40000 |
1 |
1 |
K001 |
|
|
|
|
|
|
地氯雷他定糖漿劑 |
|
DLLTDTJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06AXD078X006 |
地氯雷他定 |
01 |
|
2 |
DLLTD |
|
40000 |
1 |
1 |
X006 |
|
|
|
|
|
|
地氯雷他定干混懸劑 |
|
DLLTDGHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06ABL189B002 |
氯苯那敏 |
01 |
|
2 |
LBNM |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
氯苯那敏注射液 |
|
LBNMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXL226K001 |
氯雷他定 |
01 |
|
2 |
LLTD |
|
40000 |
0 |
0 |
K001 |
|
|
|
|
|
|
氯雷他定糖漿劑 |
|
LLTDTJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXM089A010 |
咪唑斯汀 |
01 |
|
2 |
MZST |
|
40000 |
0.1 |
0.1 |
A010 |
|
|
|
|
|
|
咪唑斯汀緩釋片 |
|
MZSTHSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXQ107A001 |
曲普利啶 |
01 |
|
2 |
QPLD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
曲普利啶片劑 |
|
QPLDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXQ107E001 |
曲普利啶 |
01 |
|
2 |
QPLD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
曲普利啶硬膠囊 |
|
QPLDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXQ122A001 |
去氯羥嗪 |
01 |
|
2 |
QLQQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
去氯羥嗪片劑 |
|
QLQQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXQ122A018 |
去氯羥嗪 |
01 |
|
2 |
QLQQ |
|
40000 |
0.1 |
0.1 |
A018 |
|
|
|
|
|
|
去氯羥嗪糖衣片 |
|
QLQQTYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXT061A001 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
酮替芬片劑 |
|
TTFPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXT061A006 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0 |
0 |
A006 |
|
|
|
|
|
|
酮替芬分散片 |
|
TTFFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXT061A025 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0 |
0 |
A025 |
|
|
|
|
|
|
酮替芬素片 |
|
TTFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXT061E001 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
酮替芬硬膠囊 |
|
TTFYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR06AXT061L001 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0.1 |
0.1 |
L001 |
|
|
|
|
|
|
酮替芬氣霧劑 |
|
TTFQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXT061R003 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0.1 |
0.1 |
R003 |
|
|
|
|
|
|
酮替芬鼻用噴霧劑 |
|
TTFBYPWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AEX017A001 |
西替利嗪 |
01 |
|
2 |
XTLQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
西替利嗪片劑 |
|
XTLQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AEX017A006 |
西替利嗪 |
01 |
|
2 |
XTLQ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
西替利嗪分散片 |
|
XTLQFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AEX017E001 |
西替利嗪 |
01 |
|
2 |
XTLQ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
西替利嗪硬膠囊 |
|
XTLQYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AEX017K001 |
西替利嗪 |
01 |
|
2 |
XTLQ |
|
40000 |
1 |
1 |
K001 |
|
|
|
|
|
|
西替利嗪糖漿劑 |
|
XTLQTJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06AEX017X001 |
西替利嗪 |
01 |
|
2 |
XTLQ |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
西替利嗪口服溶液劑 |
|
XTLQKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06AEX017X004 |
西替利嗪 |
01 |
|
2 |
XTLQ |
|
40000 |
1 |
1 |
X004 |
|
|
|
|
|
|
西替利嗪口服滴劑 |
|
XTLQKFDJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06AXY065A001 |
依巴斯汀 |
01 |
|
2 |
YBST |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
依巴斯汀片劑 |
|
YBSTPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR06AXY072E003 |
依美斯汀 |
01 |
|
2 |
YMST |
|
40000 |
0.1 |
0.1 |
E003 |
|
|
|
|
|
|
依美斯汀緩釋膠囊 |
|
YMSTHSJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AEZ066A001 |
左西替利嗪 |
01 |
|
2 |
ZXTLQ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
左西替利嗪片劑 |
|
ZXTLQPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AEZ066A006 |
左西替利嗪 |
01 |
|
2 |
ZXTLQ |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
左西替利嗪分散片 |
|
ZXTLQFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AEZ066E001 |
左西替利嗪 |
01 |
|
2 |
ZXTLQ |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
左西替利嗪硬膠囊 |
|
ZXTLQYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XR06AEZ066X001 |
左西替利嗪 |
01 |
|
2 |
ZXTLQ |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
左西替利嗪口服溶液劑 |
|
ZXTLQKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06AEZ066X004 |
左西替利嗪 |
01 |
|
2 |
ZXTLQ |
|
40000 |
1 |
1 |
X004 |
|
|
|
|
|
|
左西替利嗪口服滴劑 |
|
ZXTLQKFDJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限兒童 |
0.1 |
0.1 |
|
| XR06AXG080A001 |
枸地氯雷他定 |
01 |
|
2 |
GDLLTD |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
枸地氯雷他定片劑 |
|
GDLLTDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR06AXG080E001 |
枸地氯雷他定 |
01 |
|
2 |
GDLLTD |
|
40000 |
0.2 |
0.2 |
E001 |
|
|
|
|
|
|
枸地氯雷他定硬膠囊 |
|
GDLLTDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR07ABB031B002 |
貝美格 |
01 |
|
1 |
BMG |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
貝美格注射液 |
|
BMGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR07ABL271B002 |
洛貝林 |
01 |
|
1 |
LBL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
洛貝林注射液 |
|
LBLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR07ABN040B002 |
尼可剎米 |
01 |
|
1 |
NKSM |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
尼可剎米注射液 |
|
NKSMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR07ABD176B001 |
多沙普侖 |
01 |
|
2 |
DSPL |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
多沙普侖注射劑 |
|
DSPLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR07ABD176B002 |
多沙普侖 |
01 |
|
2 |
DSPL |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
多沙普侖注射液 |
|
DSPLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XR07ABE019B001 |
二甲弗林 |
01 |
|
2 |
EJFL |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
二甲弗林注射劑 |
|
EJFLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR07ABE019B002 |
二甲弗林 |
01 |
|
2 |
EJFL |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
二甲弗林注射液 |
|
EJFLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XR07AAN066B014 |
牛肺表面活性劑 |
01 |
|
2 |
NFBMHXJ |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
牛肺表面活性劑凍干粉針 |
|
NFBMHXJDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
限新生兒 |
0.1 |
0.1 |
|
| XR07AAZ038B002 |
豬肺磷脂 |
01 |
|
2 |
ZFLZ |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
豬肺磷脂注射液 |
|
ZFLZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
限新生兒 |
0.1 |
0.1 |
|
| XR07AXH011B002 |
核酪 |
01 |
|
2 |
HL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
核酪注射液 |
|
HLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XR07AXY034B001 |
炎琥寧 |
01 |
|
2 |
YHN |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
炎琥寧注射劑 |
|
YHNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XR07AXY034B002 |
炎琥寧 |
01 |
|
2 |
YHN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
炎琥寧注射液 |
|
YHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XR07AXY034B003 |
炎琥寧 |
01 |
|
2 |
YHN |
|
40000 |
0 |
0 |
B003 |
|
|
|
|
|
|
炎琥寧注射用無菌粉末 |
|
YHNZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XR07AXY034B014 |
炎琥寧 |
01 |
|
2 |
YHN |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
炎琥寧凍干粉針 |
|
YHNDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限病毒性肺炎 |
0 |
0 |
|
| XS01ADA075G010 |
阿昔洛韋 |
01 |
|
1 |
AXLW |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
阿昔洛韋滴眼液 |
|
AXLWDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAH016G004 |
紅霉素 |
01 |
|
1 |
HMS |
|
40000 |
0 |
0 |
G004 |
|
|
|
|
|
|
紅霉素眼膏劑 |
|
HMSYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAJ123G004 |
金霉素 |
01 |
|
1 |
JMS |
|
40000 |
0 |
0 |
G004 |
|
|
|
|
|
|
金霉素眼膏劑 |
|
JMSYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01ADL052G010 |
利巴韋林 |
01 |
|
1 |
LBWL |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
利巴韋林滴眼液 |
|
LBWLDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAL062G001 |
利福平 |
01 |
|
1 |
LFP |
|
40000 |
0 |
0 |
G001 |
|
|
|
|
|
|
利福平滴眼劑 |
|
LFPDYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAL062G010 |
利福平 |
01 |
|
1 |
LFP |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
利福平滴眼液 |
|
LFPDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAL232G010 |
氯霉素 |
01 |
|
1 |
LMS |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
氯霉素滴眼液 |
|
LMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AXQ022G010 |
羥芐唑 |
01 |
|
1 |
QBZ |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
羥芐唑滴眼液 |
|
QBZDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAQ072G010 |
慶大霉素 |
01 |
|
1 |
QDMS |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
慶大霉素滴眼液 |
|
QDMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AEZ074G010 |
左氧氟沙星 |
01 |
|
1 |
ZYFSX |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
左氧氟沙星滴眼液 |
|
ZYFSXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAF075G010 |
氟康唑 |
01 |
|
2 |
FKZ |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
氟康唑滴眼液 |
|
FKZDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01ADG075G006 |
更昔洛韋 |
01 |
|
2 |
GXLW |
|
40000 |
0.1 |
0.1 |
G006 |
|
|
|
|
|
|
更昔洛韋眼用凝膠劑 |
|
GXLWYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01AEH038G004 |
環(huán)丙沙星 |
01 |
|
2 |
HBSX |
|
40000 |
0.1 |
0.1 |
G004 |
|
|
|
|
|
|
環(huán)丙沙星眼膏劑 |
|
HBSXYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01AEH038G010 |
環(huán)丙沙星 |
01 |
|
2 |
HBSX |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
環(huán)丙沙星滴眼液 |
|
HBSXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01ABH060G010 |
磺胺醋酰鈉 |
01 |
|
2 |
HACXN |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
磺胺醋酰鈉滴眼液 |
|
HACXNDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AAL092G010 |
林可霉素 |
01 |
|
2 |
LKMS |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
林可霉素滴眼液 |
|
LKMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01AAN006G010 |
那他霉素 |
01 |
|
2 |
NTMS |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
那他霉素滴眼液 |
|
NTMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01AEN076G010 |
諾氟沙星 |
01 |
|
2 |
NFSX |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
諾氟沙星滴眼液 |
|
NFSXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01AAT125G004 |
妥布霉素 |
01 |
|
2 |
TBMS |
|
40000 |
0.2 |
0.2 |
G004 |
|
|
|
|
|
|
妥布霉素眼膏劑 |
|
TBMSYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01AAT125G010 |
妥布霉素 |
01 |
|
2 |
TBMS |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
妥布霉素滴眼液 |
|
TBMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01AEY040G004 |
氧氟沙星 |
01 |
|
2 |
YFSX |
|
40000 |
0 |
0 |
G004 |
|
|
|
|
|
|
氧氟沙星眼膏劑 |
|
YFSXYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AEY040G010 |
氧氟沙星 |
01 |
|
2 |
YFSX |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
氧氟沙星滴眼液 |
|
YFSXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AEZ074G006 |
左氧氟沙星 |
01 |
|
2 |
ZYFSX |
|
40000 |
0 |
0 |
G006 |
|
|
|
|
|
|
左氧氟沙星眼用凝膠劑 |
|
ZYFSXYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01AEJ022G010 |
加替沙星 |
01 |
|
2 |
JTSX |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
加替沙星滴眼液 |
|
JTSXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01AEJ022G006 |
加替沙星 |
01 |
|
2 |
JTSX |
|
40000 |
0.2 |
0.2 |
G006 |
|
|
|
|
|
|
加替沙星眼用凝膠劑 |
|
JTSXYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XS01AEM122G010 |
莫西沙星 |
01 |
|
2 |
MXSX |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
莫西沙星滴眼液 |
|
MXSXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.2 |
0.2 |
|
| XS01AXL256A001 |
卵磷脂絡合碘 |
01 |
|
2 |
LLZLHD |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
卵磷脂絡合碘片劑 |
|
LLZLHDPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01AXL256E001 |
卵磷脂絡合碘 |
01 |
|
2 |
LLZLHD |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
卵磷脂絡合碘硬膠囊 |
|
LLZLHDYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01BAD085G010 |
地塞米松 |
01 |
|
1 |
DSMS |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
地塞米松滴眼液 |
|
DSMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01BAK060G004 |
可的松 |
01 |
|
1 |
KDS |
|
40000 |
0 |
0 |
G004 |
|
|
|
|
|
|
可的松眼膏劑 |
|
KDSYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01BAK060G010 |
可的松 |
01 |
|
1 |
KDS |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
可的松滴眼液 |
|
KDSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01BAD085J001 |
地塞米松 |
01 |
|
2 |
DSMS |
|
40000 |
0.2 |
0.2 |
J001 |
|
|
|
|
|
|
地塞米松植入劑 |
|
DSMSZRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01BAF080G010 |
氟米龍 |
01 |
|
2 |
FML |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
氟米龍滴眼液 |
|
FMLDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01BAP060G010 |
潑尼松龍 |
01 |
|
2 |
PNSL |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
潑尼松龍滴眼液 |
|
PNSLDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01BCP089G010 |
普拉洛芬 |
01 |
|
2 |
PLLF |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
普拉洛芬滴眼液 |
|
PLLFDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01BBQ074G010 |
慶大霉素氟米龍 |
01 |
|
2 |
QDMSFML |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
慶大霉素氟米龍滴眼液 |
|
QDMSFMLDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01BCS227G010 |
雙氯芬酸鈉 |
01 |
|
2 |
SLFSN |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
雙氯芬酸鈉滴眼液 |
|
SLFSNDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01BCX230G010 |
溴芬酸鈉 |
01 |
|
2 |
XFSN |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
溴芬酸鈉滴眼液 |
|
XFSNDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限眼部手術后炎癥 |
0.1 |
0.1 |
|
| XS01BCY174G010 |
吲哚美辛 |
01 |
|
2 |
YDMX |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
吲哚美辛滴眼液 |
|
YDMXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01CAT126G004 |
妥布霉素地塞米松 |
01 |
|
2 |
TBMSDSMS |
|
40000 |
0.1 |
0.1 |
G004 |
|
|
|
|
|
|
妥布霉素地塞米松眼膏劑 |
|
TBMSDSMSYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01CAT126G010 |
妥布霉素地塞米松 |
01 |
|
2 |
TBMSDSMS |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
妥布霉素地塞米松滴眼液 |
|
TBMSDSMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EBM035G010 |
毛果蕓香堿 |
01 |
|
1 |
MGYXJ |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
毛果蕓香堿滴眼液 |
|
MGYXJDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01EBM035B002 |
毛果蕓香堿 |
01 |
|
1 |
MGYXJ |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
毛果蕓香堿注射液 |
|
MGYXJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01EDS008G010 |
噻嗎洛爾 |
01 |
|
1 |
SMLE |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
噻嗎洛爾滴眼液 |
|
SMLEDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01ECY125A001 |
乙酰唑胺 |
01 |
|
1 |
YXZA |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
乙酰唑胺片劑 |
|
YXZAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01EEB032G010 |
貝美前列素 |
01 |
|
2 |
BMQLS |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
貝美前列素滴眼液 |
|
BMQLSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XS01EDB043G010 |
倍他洛爾 |
01 |
|
2 |
BTLE |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
倍他洛爾滴眼液 |
|
BTLEDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01ECB172G010 |
布林佐胺 |
01 |
|
2 |
BLZA |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
布林佐胺滴眼液 |
|
BLZADYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01ECC063A001 |
醋甲唑胺 |
01 |
|
2 |
CJZA |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
醋甲唑胺片劑 |
|
CJZAPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EDK027G010 |
卡替洛爾 |
01 |
|
2 |
KTLE |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
卡替洛爾滴眼液 |
|
KTLEDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EEL010G010 |
拉坦前列素 |
01 |
|
2 |
LTQLS |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
拉坦前列素滴眼液 |
|
LTQLSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XS01EBM035A001 |
毛果蕓香堿 |
01 |
|
2 |
MGYXJ |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
毛果蕓香堿片劑 |
|
MGYXJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EBM035G006 |
毛果蕓香堿 |
01 |
|
2 |
MGYXJ |
|
40000 |
0.1 |
0.1 |
G006 |
|
|
|
|
|
|
毛果蕓香堿眼用凝膠劑 |
|
MGYXJYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EEQ092G010 |
曲伏前列素 |
01 |
|
2 |
QFQLS |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
曲伏前列素滴眼液 |
|
QFQLSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限二線用藥 |
0.1 |
0.1 |
|
| XS01EAX174G010 |
溴莫尼定 |
01 |
|
2 |
XMND |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
溴莫尼定滴眼液 |
|
XMNDDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EDZ056G010 |
左布諾洛爾 |
01 |
|
2 |
ZBNLE |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
左布諾洛爾滴眼液 |
|
ZBNLEDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01EDB212G010 |
布林佐胺噻嗎洛爾 |
01 |
|
2 |
BLZASMLE |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
布林佐胺噻嗎洛爾滴眼液 |
|
BLZASMLEDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01FAA068G004 |
阿托品 |
01 |
|
1 |
ATP |
|
40000 |
0 |
0 |
G004 |
|
|
|
|
|
|
阿托品眼膏劑 |
|
ATPYGJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01FAT109G010 |
托吡卡胺 |
01 |
|
1 |
TBKA |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
托吡卡胺滴眼液 |
|
TBKADYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01FAA068G006 |
阿托品 |
01 |
|
2 |
ATP |
|
40000 |
0 |
0 |
G006 |
|
|
|
|
|
|
阿托品眼用凝膠劑 |
|
ATPYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01FAF508G010 |
復方托吡卡胺 |
01 |
|
2 |
FFTBKA |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
復方托吡卡胺滴眼液 |
|
FFTBKADYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01FAZ007A001 |
樟柳堿 |
01 |
|
2 |
ZLJ |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
樟柳堿片劑 |
|
ZLJPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01FAZ007B002 |
樟柳堿 |
01 |
|
2 |
ZLJ |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
樟柳堿注射液 |
|
ZLJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01FAF594B002 |
復方樟柳堿 |
01 |
|
2 |
FFZLJ |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
復方樟柳堿注射液 |
|
FFZLJZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01GXA210G010 |
奧洛他定 |
01 |
|
2 |
ALTD |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
奧洛他定滴眼液 |
|
ALTDDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01GXD041G010 |
氮?斯汀 |
01 |
|
2 |
DST |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
氮?斯汀滴眼液 |
|
DSTDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01GXS207G010 |
色甘酸鈉 |
01 |
|
2 |
SGSN |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
色甘酸鈉滴眼液 |
|
SGSNDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01GXT061G010 |
酮替芬 |
01 |
|
2 |
TTF |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
酮替芬滴眼液 |
|
TTFDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01GXY072G010 |
依美斯汀 |
01 |
|
2 |
YMST |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
依美斯汀滴眼液 |
|
YMSTDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01GAN024G010 |
萘敏維 |
01 |
|
2 |
NMW |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
萘敏維滴眼液 |
|
NMWDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01GXB100G010 |
吡嘧司特 |
01 |
|
2 |
BMST |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
吡嘧司特滴眼液 |
|
BMSTDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01HAA203G010 |
奧布卡因 |
01 |
|
2 |
ABKY |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
奧布卡因滴眼液 |
|
ABKYDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01JAY171B001 |
吲哚菁綠 |
01 |
|
2 |
YDJL |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
吲哚菁綠注射劑 |
|
YDJLZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01JAY171B014 |
吲哚菁綠 |
01 |
|
2 |
YDJL |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
吲哚菁綠凍干粉針 |
|
YDJLDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01JAY182B002 |
熒光素鈉 |
01 |
|
2 |
YGSN |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
熒光素鈉注射液 |
|
YGSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01KAB146G010 |
玻璃酸鈉 |
01 |
|
2 |
BLSN |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
玻璃酸鈉滴眼液 |
|
BLSNDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01KAQ023G010 |
羥丙甲纖維素 |
01 |
|
2 |
QBJXWS |
|
40000 |
0 |
0 |
G010 |
|
|
|
|
|
|
羥丙甲纖維素滴眼液 |
|
QBJXWSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01XAP098B001 |
普羅碘銨 |
01 |
|
1 |
PLDA |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
普羅碘銨注射劑 |
|
PLDAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01XAP098B002 |
普羅碘銨 |
01 |
|
1 |
PLDA |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
普羅碘銨注射液 |
|
PLDAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS01XAH033G010 |
環(huán)孢素 |
01 |
|
2 |
HBS |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
環(huán)孢素滴眼液 |
|
HBSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01XAQ020A001 |
羥苯磺酸 |
01 |
|
2 |
QBHS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
羥苯磺酸片劑 |
|
QBHSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01XAQ020A006 |
羥苯磺酸 |
01 |
|
2 |
QBHS |
|
40000 |
0.1 |
0.1 |
A006 |
|
|
|
|
|
|
羥苯磺酸分散片 |
|
QBHSFSP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01XAQ020E001 |
羥苯磺酸 |
01 |
|
2 |
QBHS |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
羥苯磺酸硬膠囊 |
|
QBHSYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01XAT002G010 |
他克莫司 |
01 |
|
2 |
TKMS |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
他克莫司滴眼液 |
|
TKMSDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限有眼瞼結膜巨大乳頭增殖的患者 |
0.2 |
0.2 |
|
| XS01XAW035G006 |
維生素A棕櫚酸酯 |
01 |
|
2 |
WSSAZLSZ |
|
40000 |
0.2 |
0.2 |
G006 |
|
|
|
|
|
|
維生素A棕櫚酸酯眼用凝膠劑 |
|
WSSAZLSZYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有Sjogren's綜合征、神經麻痹性角膜炎、暴露性角膜炎的患者 |
0.2 |
0.2 |
|
| XS01XAC078G010 |
重組牛堿性成纖維細胞生長因子 |
01 |
|
2 |
CZNJXCXWXBSCYZ |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
重組牛堿性成纖維細胞生長因子滴眼液 |
|
CZNJXCXWXBSCYZDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS01XAC078G006 |
重組牛堿性成纖維細胞生長因子 |
01 |
|
2 |
CZNJXCXWXBSCYZ |
|
40000 |
0.2 |
0.2 |
G006 |
|
|
|
|
|
|
重組牛堿性成纖維細胞生長因子眼用凝膠劑 |
|
CZNJXCXWXBSCYZYYNJJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS01XAC089G001 |
重組人表皮生長因子 |
01 |
|
2 |
CZRBPSCYZ |
|
40000 |
0.1 |
0.1 |
G001 |
|
|
|
|
|
|
重組人表皮生長因子滴眼劑 |
|
CZRBPSCYZDYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限有明確角膜潰瘍或角膜損傷的患者 |
0.1 |
0.1 |
|
| XS01XAC156G010 |
重組人表皮生長因子（酵母） |
01 |
|
2 |
CZRBPSCYZ(JM) |
|
40000 |
0.1 |
0.1 |
G010 |
|
|
|
|
|
|
重組人表皮生長因子（酵母）滴眼液 |
|
CZRBPSCYZ(JM)DYY |
|
0 |
0 |
0 |
2020-1-1 |
|
限有明確角膜潰瘍或角膜損傷的患者 |
0.1 |
0.1 |
|
| XS01XAB101G010 |
吡諾克辛 |
01 |
|
2 |
BNKX |
|
40000 |
0.2 |
0.2 |
G010 |
|
|
|
|
|
|
吡諾克辛滴眼液 |
|
BNKXDYY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XS02AAL092Q010 |
林可霉素 |
01 |
|
1 |
LKMS |
|
40000 |
0 |
0 |
Q010 |
|
|
|
|
|
|
林可霉素滴耳液 |
|
LKMSDEY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS02AAY040Q010 |
氧氟沙星 |
01 |
|
1 |
YFSX |
|
40000 |
0 |
0 |
Q010 |
|
|
|
|
|
|
氧氟沙星滴耳液 |
|
YFSXDEY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XS02AAL279Q010 |
洛美沙星 |
01 |
|
2 |
LMSX |
|
40000 |
0.1 |
0.1 |
Q010 |
|
|
|
|
|
|
洛美沙星滴耳液 |
|
LMSXDEY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS02AAZ074Q010 |
左氧氟沙星 |
01 |
|
2 |
ZYFSX |
|
40000 |
0.1 |
0.1 |
Q010 |
|
|
|
|
|
|
左氧氟沙星滴耳液 |
|
ZYFSXDEY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XS03AAH038Q010 |
環(huán)丙沙星 |
01 |
|
2 |
HBSX |
|
40000 |
0.1 |
0.1 |
Q010 |
|
|
|
|
|
|
環(huán)丙沙星滴耳液 |
|
HBSXDEY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DBC025X002 |
腸內營養(yǎng)劑（SP） |
01 |
|
2 |
CNYYJ(SP) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（SP）口服混懸劑 |
|
CNYYJ(SP)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC026P004 |
腸內營養(yǎng)劑（TP） |
01 |
|
2 |
CNYYJ(TP) |
|
40000 |
0.1 |
0.1 |
P004 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TP）口服粉劑 |
|
CNYYJ(TP)KFFJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC026X002 |
腸內營養(yǎng)劑（TP） |
01 |
|
2 |
CNYYJ(TP) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TP）口服混懸劑 |
|
CNYYJ(TP)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC026X003 |
腸內營養(yǎng)劑（TP） |
01 |
|
2 |
CNYYJ(TP) |
|
40000 |
0.1 |
0.1 |
X003 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TP）口服乳劑 |
|
CNYYJ(TP)KFRJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC027X002 |
腸內營養(yǎng)劑（TPF） |
01 |
|
2 |
CNYYJ(TPF) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF）口服混懸劑 |
|
CNYYJ(TPF)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC027X010 |
腸內營養(yǎng)劑（TPF） |
01 |
|
2 |
CNYYJ(TPF) |
|
40000 |
0.1 |
0.1 |
X010 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF）乳劑 |
|
CNYYJ(TPF)RJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC028X002 |
腸內營養(yǎng)劑（TPF-D） |
01 |
|
2 |
CNYYJ(TPF-D) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF-D）口服混懸劑 |
|
CNYYJ(TPF-D)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限糖尿病患者 |
0.1 |
0.1 |
|
| XV06DBC028X010 |
腸內營養(yǎng)劑（TPF-D） |
01 |
|
2 |
CNYYJ(TPF-D) |
|
40000 |
0.1 |
0.1 |
X010 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF-D）乳劑 |
|
CNYYJ(TPF-D)RJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限糖尿病患者 |
0.1 |
0.1 |
|
| XV06DBC029X002 |
腸內營養(yǎng)劑（TPF-DM） |
01 |
|
2 |
CNYYJ(TPF-DM) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF-DM）口服混懸劑 |
|
CNYYJ(TPF-DM)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限糖尿病患者 |
0.1 |
0.1 |
|
| XV06DBC030X002 |
腸內營養(yǎng)劑（TPF-FOS） |
01 |
|
2 |
CNYYJ(TPF-FOS) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF-FOS）口服混懸劑 |
|
CNYYJ(TPF-FOS)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC031X010 |
腸內營養(yǎng)劑（TPF-T） |
01 |
|
2 |
CNYYJ(TPF-T) |
|
40000 |
0.1 |
0.1 |
X010 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPF-T）乳劑 |
|
CNYYJ(TPF-T)RJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限腫瘤患者 |
0.1 |
0.1 |
|
| XV06DBC032X010 |
腸內營養(yǎng)劑（TP-HE） |
01 |
|
2 |
CNYYJ(TP-HE) |
|
40000 |
0.1 |
0.1 |
X010 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TP-HE）乳劑 |
|
CNYYJ(TP-HE)RJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC033X002 |
腸內營養(yǎng)劑（TP-MCT） |
01 |
|
2 |
CNYYJ(TP-MCT) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TP-MCT）口服混懸劑 |
|
CNYYJ(TP-MCT)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC034X002 |
腸內營養(yǎng)劑（TPSPA） |
01 |
|
2 |
CNYYJ(TPSPA) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑（TPSPA）口服混懸劑 |
|
CNYYJ(TPSPA)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC036X002 |
腸內營養(yǎng)劑Ⅱ（TP） |
01 |
|
2 |
CNYYJ(TP) |
|
40000 |
0.1 |
0.1 |
X002 |
|
|
|
|
|
|
腸內營養(yǎng)劑Ⅱ（TP）口服混懸劑 |
|
CNYYJ(TP)KFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限呼吸系統(tǒng)疾病患者 |
0.1 |
0.1 |
|
| XV06DBC037P004 |
腸內營養(yǎng)粉（AA） |
01 |
|
2 |
CNYYF(AA) |
|
40000 |
0.1 |
0.1 |
P004 |
|
|
|
|
|
|
腸內營養(yǎng)粉（AA）口服粉劑 |
|
CNYYF(AA)KFFJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBD154P004 |
短肽型腸內營養(yǎng)劑 |
01 |
|
2 |
DTXCNYYJ |
|
40000 |
0.1 |
0.1 |
P004 |
|
|
|
|
|
|
短肽型腸內營養(yǎng)劑口服粉劑 |
|
DTXCNYYJKFFJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBZ013P004 |
整蛋白型腸內營養(yǎng)劑 |
01 |
|
2 |
ZDBXCNYYJ |
|
40000 |
0.1 |
0.1 |
P004 |
|
|
|
|
|
|
整蛋白型腸內營養(yǎng)劑口服粉劑 |
|
ZDBXCNYYJKFFJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥患者 |
0.1 |
0.1 |
|
| XV06DBC154P004 |
腸內營養(yǎng)粉（AA-PA） |
01 |
|
2 |
CNYYF(AA-PA) |
|
40000 |
1 |
1 |
P004 |
|
|
|
|
|
|
腸內營養(yǎng)粉（AA-PA）口服粉劑 |
|
CNYYF(AA-PA)KFFJ |
|
0 |
1 |
1 |
2020-1-1 |
|
限經營養(yǎng)風險篩查，明確具有營養(yǎng)風險的1歲以下住院患兒。 |
0.1 |
0.1 |
|
| XV06DXD249B002 |
多種微量元素 |
01 |
|
2 |
DZWLYS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
多種微量元素注射液 |
|
DZWLYSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限配合腸外營養(yǎng)用 |
0.1 |
0.1 |
|
| XV06DXD201B002 |
多種微量元素Ⅰ |
01 |
|
2 |
DZWLYS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
多種微量元素Ⅰ注射液 |
|
DZWLYSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限配合腸外營養(yǎng)用 |
0.1 |
0.1 |
|
| XV06DXD202B002 |
多種微量元素Ⅱ |
01 |
|
2 |
DZWLYS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
多種微量元素Ⅱ注射液 |
|
DZWLYSZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限配合腸外營養(yǎng)用 |
0.1 |
0.1 |
|
| XV06DXF108B001 |
輔酶A |
01 |
|
2 |
FMA |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
輔酶A注射劑 |
|
FMAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.1 |
0.1 |
|
| XV06DXF108B003 |
輔酶A |
01 |
|
2 |
FMA |
|
40000 |
0.1 |
0.1 |
B003 |
|
|
|
|
|
|
輔酶A注射用無菌粉末 |
|
FMAZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.1 |
0.1 |
|
| XV06DXF108B014 |
輔酶A |
01 |
|
2 |
FMA |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
輔酶A凍干粉針 |
|
FMADGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.1 |
0.1 |
|
| XV06DXF109B002 |
輔酶Q10 |
01 |
|
2 |
FMQ10 |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
輔酶Q10注射液 |
|
FMQ10ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.1 |
0.1 |
|
| XV06DEF113A001 |
復方α-酮酸 |
01 |
|
2 |
FF-TS |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
復方α-酮酸片劑 |
|
FF-TSPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DXH041B001 |
環(huán)磷腺苷 |
01 |
|
2 |
HLXG |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
環(huán)磷腺苷注射劑 |
|
HLXGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXH041B002 |
環(huán)磷腺苷 |
01 |
|
2 |
HLXG |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
環(huán)磷腺苷注射液 |
|
HLXGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXH041B003 |
環(huán)磷腺苷 |
01 |
|
2 |
HLXG |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
環(huán)磷腺苷注射用無菌粉末 |
|
HLXGZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXH041B014 |
環(huán)磷腺苷 |
01 |
|
2 |
HLXG |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
環(huán)磷腺苷凍干粉針 |
|
HLXGDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DCP072P001 |
葡萄糖 |
01 |
|
2 |
PTT |
|
40000 |
0.1 |
0.1 |
P001 |
|
|
|
|
|
|
葡萄糖口服散劑 |
|
PTTKFSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DCP072P004 |
葡萄糖 |
01 |
|
2 |
PTT |
|
40000 |
0.1 |
0.1 |
P004 |
|
|
|
|
|
|
葡萄糖口服粉劑 |
|
PTTKFFJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DXS025B001 |
三磷酸腺苷 |
01 |
|
2 |
SLSXG |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
三磷酸腺苷注射劑 |
|
SLSXGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.2 |
0.2 |
|
| XV06DXS025B002 |
三磷酸腺苷 |
01 |
|
2 |
SLSXG |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
三磷酸腺苷注射液 |
|
SLSXGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.2 |
0.2 |
|
| XV06DXS025B003 |
三磷酸腺苷 |
01 |
|
2 |
SLSXG |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
三磷酸腺苷注射用無菌粉末 |
|
SLSXGZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.2 |
0.2 |
|
| XV06DXS025B014 |
三磷酸腺苷 |
01 |
|
2 |
SLSXG |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
三磷酸腺苷凍干粉針 |
|
SLSXGDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限急救、搶救 |
0.2 |
0.2 |
|
| XV03ABD111B002 |
碘解磷定 |
01 |
|
1 |
DJLD |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘解磷定注射液 |
|
DJLDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABE036B002 |
二巰丙醇 |
01 |
|
1 |
EQBC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
二巰丙醇注射液 |
|
EQBCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABE037B002 |
二巰丙磺鈉 |
01 |
|
1 |
EQBHN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
二巰丙磺鈉注射液 |
|
EQBHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABE038B001 |
二巰丁二鈉 |
01 |
|
1 |
EQDEN |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
二巰丁二鈉注射劑 |
|
EQDENZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABE039E001 |
二巰丁二酸 |
01 |
|
1 |
EQDES |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
二巰丁二酸硬膠囊 |
|
EQDESYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABF079B002 |
氟馬西尼 |
01 |
|
1 |
FMXN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氟馬西尼注射液 |
|
FMXNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABL131B001 |
硫代硫酸鈉 |
01 |
|
1 |
LDLSN |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
硫代硫酸鈉注射劑 |
|
LDLSNZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABL131B002 |
硫代硫酸鈉 |
01 |
|
1 |
LDLSN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
硫代硫酸鈉注射液 |
|
LDLSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABL221B002 |
氯解磷定 |
01 |
|
1 |
LJLD |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
氯解磷定注射液 |
|
LJLDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABN007B001 |
納洛酮 |
01 |
|
1 |
NLT |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
納洛酮注射劑 |
|
NLTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABN007B002 |
納洛酮 |
01 |
|
1 |
NLT |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
納洛酮注射液 |
|
NLTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABN007B003 |
納洛酮 |
01 |
|
1 |
NLT |
|
40000 |
0 |
0 |
B003 |
|
|
|
|
|
|
納洛酮注射用無菌粉末 |
|
NLTZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABN007B014 |
納洛酮 |
01 |
|
1 |
NLT |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
納洛酮凍干粉針 |
|
NLTDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABX036B002 |
烯丙嗎啡 |
01 |
|
1 |
XBMF |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
烯丙嗎啡注射液 |
|
XBMFZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABY003B002 |
亞甲藍 |
01 |
|
1 |
YJL |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
亞甲藍注射液 |
|
YJLZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABY021B002 |
亞硝酸鈉 |
01 |
|
1 |
YXSN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
亞硝酸鈉注射液 |
|
YXSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABY022L001 |
亞硝酸異戊酯 |
01 |
|
1 |
YXSYWZ |
|
40000 |
0 |
0 |
L001 |
|
|
|
|
|
|
亞硝酸異戊酯氣霧劑 |
|
YXSYWZQWJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABY067B002 |
依地酸鈣鈉 |
01 |
|
1 |
YDSGN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
依地酸鈣鈉注射液 |
|
YDSGNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABY114B002 |
乙酰胺 |
01 |
|
1 |
YXA |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
乙酰胺注射液 |
|
YXAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABY205B002 |
魚精蛋白 |
01 |
|
1 |
YJDB |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
魚精蛋白注射液 |
|
YJDBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABF395B002 |
復方氯解磷定 |
01 |
|
2 |
FFLJLD |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
復方氯解磷定注射液 |
|
FFLJLDZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABW091B002 |
戊乙奎醚 |
01 |
|
2 |
WYKM |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
戊乙奎醚注射液 |
|
WYKMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV03ABY067A001 |
依地酸鈣鈉 |
01 |
|
2 |
YDSGN |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
依地酸鈣鈉片劑 |
|
YDSGNPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03ABN007A003 |
納洛酮 |
01 |
|
2 |
NLT |
|
40000 |
1 |
1 |
A003 |
|
|
|
|
|
|
納洛酮舌下片 |
|
NLTSXP |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XV03ABG105A002 |
谷胱甘肽 |
01 |
|
2 |
GGGT |
|
40000 |
1 |
1 |
A002 |
|
|
|
|
|
|
谷胱甘肽含片 |
|
GGGTHP |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XV03ACQ126B001 |
去鐵胺 |
01 |
|
1 |
QTA |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
去鐵胺注射劑 |
|
QTAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY023A001 |
亞葉酸鈣 |
01 |
|
1 |
YYSG |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
亞葉酸鈣片劑 |
|
YYSGPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY023E001 |
亞葉酸鈣 |
01 |
|
1 |
YYSG |
|
40000 |
0 |
0 |
E001 |
|
|
|
|
|
|
亞葉酸鈣硬膠囊 |
|
YYSGYJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY023B001 |
亞葉酸鈣 |
01 |
|
1 |
YYSG |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
亞葉酸鈣注射劑 |
|
YYSGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY023B002 |
亞葉酸鈣 |
01 |
|
1 |
YYSG |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
亞葉酸鈣注射液 |
|
YYSGZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY023B014 |
亞葉酸鈣 |
01 |
|
1 |
YYSG |
|
40000 |
0 |
0 |
B014 |
|
|
|
|
|
|
亞葉酸鈣凍干粉針 |
|
YYSGDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY236B002 |
亞葉酸鈣氯化鈉 |
01 |
|
1 |
YYSGLHN |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
亞葉酸鈣氯化鈉注射液 |
|
YYSGLHNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFM056B002 |
美司鈉（美司那） |
01 |
|
2 |
MSN(MSN) |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
美司鈉（美司那）注射液 |
|
MSN(MSN)ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV03AFY185B001 |
右丙亞胺（右雷佐生） |
01 |
|
2 |
YBYA(YLZS) |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
右丙亞胺（右雷佐生）注射劑 |
|
YBYA(YLZS)ZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限在使用阿霉素（多柔比星）后并有心臟損害臨床證據 |
0.2 |
0.2 |
|
| XV03AFZ073B001 |
左亞葉酸鈣 |
01 |
|
2 |
ZYYSG |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
左亞葉酸鈣注射劑 |
|
ZYYSGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV03AFZ073B014 |
左亞葉酸鈣 |
01 |
|
2 |
ZYYSG |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
左亞葉酸鈣凍干粉針 |
|
ZYYSGDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV03AXT006B002 |
胎盤多肽 |
01 |
|
2 |
TPDT |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
胎盤多肽注射液 |
|
TPDTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限惡性腫瘤放化療引起的白細胞減少 |
0.2 |
0.2 |
|
| XV03AXW024E001 |
維參鋅 |
01 |
|
2 |
WCX |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
維參鋅硬膠囊 |
|
WCXYJN |
|
0 |
1 |
0 |
2020-1-1 |
|
限工傷保險 |
1 |
1 |
|
| XV04CXB177B001 |
布氏菌素 |
01 |
|
1 |
BSJS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
布氏菌素注射劑 |
|
BSJSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV04CFJ116B001 |
結核菌素純蛋白衍生物 |
01 |
|
1 |
JHJSCDBYSW |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
結核菌素純蛋白衍生物注射劑 |
|
JHJSCDBYSWZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV04CFJ151B001 |
舊結核菌素 |
01 |
|
1 |
JJHJS |
|
40000 |
0 |
0 |
B001 |
|
|
|
|
|
|
舊結核菌素注射劑 |
|
JJHJSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV06DXF109A001 |
輔酶Q10 |
01 |
|
2 |
FMQ10 |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
輔酶Q10片劑 |
|
FMQ10PJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DXF109E001 |
輔酶Q10 |
01 |
|
2 |
FMQ10 |
|
40000 |
0.1 |
0.1 |
E001 |
|
|
|
|
|
|
輔酶Q10硬膠囊 |
|
FMQ10YJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DXF109E002 |
輔酶Q10 |
01 |
|
2 |
FMQ10 |
|
40000 |
0.1 |
0.1 |
E002 |
|
|
|
|
|
|
輔酶Q10軟膠囊 |
|
FMQ10RJN |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV06DDG046B001 |
肝水解肽 |
01 |
|
2 |
GSJT |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
肝水解肽注射劑 |
|
GSJTZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥肝炎 |
0.1 |
0.1 |
|
| XV06DDG046B002 |
肝水解肽 |
01 |
|
2 |
GSJT |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
肝水解肽注射液 |
|
GSJTZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限重癥肝炎 |
0.1 |
0.1 |
|
| XV06DXE017B001 |
二丁酰環(huán)磷腺苷鈣 |
01 |
|
2 |
EDXHLXGG |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
二丁酰環(huán)磷腺苷鈣注射劑 |
|
EDXHLXGGZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限心絞痛急性發(fā)作、急性心肌梗死 |
0.1 |
0.1 |
|
| XV06DXF107B001 |
輔酶Ⅰ |
01 |
|
2 |
FM |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
輔酶Ⅰ注射劑 |
|
FMZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限冠心病急性發(fā)作 |
0.2 |
0.2 |
|
| XV06DXH042B001 |
環(huán)磷腺苷葡胺 |
01 |
|
2 |
HLXGPA |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
環(huán)磷腺苷葡胺注射劑 |
|
HLXGPAZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXH042B002 |
環(huán)磷腺苷葡胺 |
01 |
|
2 |
HLXGPA |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
環(huán)磷腺苷葡胺注射液 |
|
HLXGPAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXH042B014 |
環(huán)磷腺苷葡胺 |
01 |
|
2 |
HLXGPA |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
環(huán)磷腺苷葡胺凍干粉針 |
|
HLXGPADGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXS027B001 |
三磷酸腺苷輔酶胰島素 |
01 |
|
2 |
SLSXGFMYDS |
|
40000 |
0.1 |
0.1 |
B001 |
|
|
|
|
|
|
三磷酸腺苷輔酶胰島素注射劑 |
|
SLSXGFMYDSZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
限缺血性心腦血管疾病 |
0.1 |
0.1 |
|
| XV06DXS027B014 |
三磷酸腺苷輔酶胰島素 |
01 |
|
2 |
SLSXGFMYDS |
|
40000 |
0.1 |
0.1 |
B014 |
|
|
|
|
|
|
三磷酸腺苷輔酶胰島素凍干粉針 |
|
SLSXGFMYDSDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
限缺血性心腦血管疾病 |
0.1 |
0.1 |
|
| XV06DCL022X001 |
賴氨肌醇維B12 |
01 |
|
2 |
LAJCWB12 |
|
40000 |
0.2 |
0.2 |
X001 |
|
|
|
|
|
|
賴氨肌醇維B12口服溶液劑 |
|
LAJCWB12KFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXS024B001 |
三磷酸胞苷二鈉 |
01 |
|
2 |
SLSBGEN |
|
40000 |
0.2 |
0.2 |
B001 |
|
|
|
|
|
|
三磷酸胞苷二鈉注射劑 |
|
SLSBGENZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXS024B002 |
三磷酸胞苷二鈉 |
01 |
|
2 |
SLSBGEN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
三磷酸胞苷二鈉注射液 |
|
SLSBGENZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXS024B003 |
三磷酸胞苷二鈉 |
01 |
|
2 |
SLSBGEN |
|
40000 |
0.2 |
0.2 |
B003 |
|
|
|
|
|
|
三磷酸胞苷二鈉注射用無菌粉末 |
|
SLSBGENZSYWJFM |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV06DXS024B014 |
三磷酸胞苷二鈉 |
01 |
|
2 |
SLSBGEN |
|
40000 |
0.2 |
0.2 |
B014 |
|
|
|
|
|
|
三磷酸胞苷二鈉凍干粉針 |
|
SLSBGENDGFZ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV08ABD101B002 |
碘比醇 |
01 |
|
1 |
DBC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘比醇注射液 |
|
DBCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08ABD104B002 |
碘佛醇 |
01 |
|
1 |
DFC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘佛醇注射液 |
|
DFCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08ABD107B002 |
碘海醇 |
01 |
|
1 |
DHC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘海醇注射液 |
|
DHCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08ADD110B002 |
碘化油 |
01 |
|
1 |
DHY |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘化油注射液 |
|
DHYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08ABD115B002 |
碘帕醇 |
01 |
|
1 |
DPC |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘帕醇注射液 |
|
DPCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08ABD117B002 |
碘普羅胺 |
01 |
|
1 |
DPLA |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
碘普羅胺注射液 |
|
DPLAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08AAF011B002 |
泛影葡胺 |
01 |
|
1 |
FYPA |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
泛影葡胺注射液 |
|
FYPAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XH03CAY281B002 |
罌粟乙碘油 |
01 |
|
2 |
YSYDY |
|
40000 |
0.3 |
0.3 |
B002 |
|
|
|
|
|
|
罌粟乙碘油注射液 |
|
YSYDYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.3 |
0.3 |
|
| XV08ABD113B002 |
碘克沙醇 |
01 |
|
2 |
DKSC |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
碘克沙醇注射液 |
|
DKSCZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV08ABD114B002 |
碘美普爾 |
01 |
|
2 |
DMPE |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
碘美普爾注射液 |
|
DMPEZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV08AAF012B002 |
泛影酸鈉 |
01 |
|
2 |
FYSN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
泛影酸鈉注射液 |
|
FYSNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV08AAF261B002 |
復方泛影葡胺 |
01 |
|
2 |
FFFYPA |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
復方泛影葡胺注射液 |
|
FFFYPAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08BAL142X002 |
硫酸鋇 |
01 |
|
1 |
LSB |
|
40000 |
0 |
0 |
X002 |
|
|
|
|
|
|
硫酸鋇口服混懸劑 |
|
LSBKFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08BAL143X002 |
硫酸鋇Ⅰ型 |
01 |
|
1 |
LSBX |
|
40000 |
0 |
0 |
X002 |
|
|
|
|
|
|
硫酸鋇Ⅰ型口服混懸劑 |
|
LSBXKFHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08BAL144X006 |
硫酸鋇Ⅱ型 |
01 |
|
1 |
LSBX |
|
40000 |
0 |
0 |
X006 |
|
|
|
|
|
|
硫酸鋇Ⅱ型干混懸劑 |
|
LSBXGHXJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08BAL143S003 |
硫酸鋇Ⅰ型 |
01 |
|
2 |
LSBX |
|
40000 |
0 |
0 |
S003 |
|
|
|
|
|
|
硫酸鋇Ⅰ型灌腸劑 |
|
LSBXGCJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08CAG003B002 |
釓雙胺 |
01 |
|
1 |
GSA |
|
40000 |
0 |
0 |
B002 |
|
|
|
|
|
|
釓雙胺注射液 |
|
GSAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| XV08CAG001B002 |
釓貝葡胺 |
01 |
|
2 |
GBPA |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
釓貝葡胺注射液 |
|
GBPAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV08CAG002B002 |
釓噴酸葡胺 |
01 |
|
2 |
GPSPA |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
釓噴酸葡胺注射液 |
|
GPSPAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV08CAG004B002 |
釓特酸葡胺 |
01 |
|
2 |
GTSPA |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
釓特酸葡胺注射液 |
|
GTSPAZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV08CAG153B002 |
釓塞酸二鈉 |
01 |
|
2 |
GSSEN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
釓塞酸二鈉注射液 |
|
GSSENZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV08DAL161B001 |
六氟化硫微泡 |
01 |
|
2 |
LFHLWP |
|
40000 |
0.3 |
0.3 |
B001 |
|
|
|
|
|
|
六氟化硫微泡注射劑 |
|
LFHLWPZSJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.3 |
0.3 |
|
| XV08DAS145N001 |
雙重造影產氣 |
01 |
|
2 |
SCZYCQ |
|
40000 |
0.2 |
0.2 |
N001 |
|
|
|
|
|
|
雙重造影產氣顆粒劑 |
|
SCZYCQKLJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV09CAD043B002 |
锝[99mTc]二巰丁二酸鹽 |
01 |
|
2 |
D[99MTC]EQDESY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
锝[99mTc]二巰丁二酸鹽注射液 |
|
D[99MTC]EQDESYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV09EAD046B002 |
锝[99mTc]聚合白蛋白 |
01 |
|
2 |
D[99MTC]JHBDB |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
锝[99mTc]聚合白蛋白注射液 |
|
D[99MTC]JHBDBZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV09CAD047B002 |
锝[99mTc]噴替酸鹽 |
01 |
|
2 |
D[99MTC]PTSY |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
锝[99mTc]噴替酸鹽注射液 |
|
D[99MTC]PTSYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV09CAD048B002 |
锝[99mTc]雙半胱氨酸 |
01 |
|
2 |
D[99MTC]SBGAS |
|
40000 |
0.1 |
0.1 |
B002 |
|
|
|
|
|
|
锝[99mTc]雙半胱氨酸注射液 |
|
D[99MTC]SBGASZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XV09BAD055B002 |
锝[99mTc]亞甲基二膦酸鹽 |
01 |
|
2 |
D[99MTC]YJJELSY |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
锝[99mTc]亞甲基二膦酸鹽注射液 |
|
D[99MTC]YJJELSYZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV09DAD053B002 |
锝[99mTc]依替菲寧 |
01 |
|
2 |
D[99MTC]YTFN |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
锝[99mTc]依替菲寧注射液 |
|
D[99MTC]YTFNZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV09GBD095Z005 |
碘[125I]密封籽源 |
01 |
|
2 |
D[125]MFZY |
|
40000 |
0.2 |
0.2 |
Z005 |
|
|
|
|
|
|
碘[125I]密封籽源放射性密封籽源 |
|
D[125]MFZYFSXMFZY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV09FXD096X001 |
碘[131I]化鈉 |
01 |
|
2 |
D[131]HN |
|
40000 |
0.2 |
0.2 |
X001 |
|
|
|
|
|
|
碘[131I]化鈉口服溶液劑 |
|
D[131]HNKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XV10BXL213B002 |
氯化鍶[89Sr] |
01 |
|
2 |
LHS[89SR] |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
氯化鍶[89Sr]注射液 |
|
LHS[89SR]ZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| XC01DXY165B002 |
銀杏達莫 |
01 |
|
2 |
YXDM |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
銀杏達莫注射液 |
|
YXDMZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限缺血性心腦血管疾病急性期住院患者，支付不超過14天 |
0.2 |
0.2 |
|
| XC01DXY168A001 |
銀杏葉提取物 |
01 |
|
2 |
YXYTQW |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
銀杏葉提取物片劑 |
|
YXYTQWPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XC01DXY168B002 |
銀杏葉提取物 |
01 |
|
2 |
YXYTQW |
|
40000 |
0.2 |
0.2 |
B002 |
|
|
|
|
|
|
銀杏葉提取物注射液 |
|
YXYTQWZSY |
|
0 |
0 |
0 |
2020-1-1 |
|
限缺血性心腦血管疾病急性期住院患者；限耳部血流及神經障礙患者。支付不超過14天 |
0.2 |
0.2 |
|
| XC01DXY168W006 |
銀杏葉提取物 |
01 |
|
2 |
YXYTQW |
|
40000 |
0.3 |
0.3 |
W006 |
|
|
|
|
|
|
銀杏葉提取物滴劑 |
|
YXYTQWDJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.3 |
0.3 |
|
| XC01DXY166X001 |
銀杏蜜環(huán) |
01 |
|
2 |
YXMH |
|
40000 |
0.1 |
0.1 |
X001 |
|
|
|
|
|
|
銀杏蜜環(huán)口服溶液劑 |
|
YXMHKFRYJ |
|
0 |
0 |
0 |
2020-1-1 |
|
▲ |
0.1 |
0.1 |
|
| XC08EXS107A001 |
薯蕷皂苷 |
01 |
|
2 |
SYZG |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
薯蕷皂苷片劑 |
|
SYZGPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XC08EXS107A017 |
薯蕷皂苷 |
01 |
|
2 |
SYZG |
|
40000 |
0.1 |
0.1 |
A017 |
|
|
|
|
|
|
薯蕷皂苷薄膜衣片 |
|
SYZGBMYP |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XC02AAF383A001 |
復方羅布麻 |
01 |
|
2 |
FFLBM |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
復方羅布麻片劑 |
|
FFLBMPJ |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| XF000000000 |
西藥非基本醫(yī)療保險支付 |
01 |
|
3 |
XYFJBYLBXZF |
|
40000 |
1 |
1 |
|
|
|
|
|
|
|
西藥非基本醫(yī)療保險支付 |
8000 |
XYFJBYLBXZF |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| 100001 |
藥品甲類 |
01 |
|
1 |
YPJL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
藥品甲類 |
8000 |
YPJL |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0 |
0 |
|
| 100002 |
藥品乙類10% |
01 |
|
2 |
YPYL10 |
|
40000 |
0.1 |
0.1 |
A001 |
|
|
|
|
|
|
藥品乙類10% |
8000 |
YPYL10 |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.1 |
0.1 |
|
| 100003 |
藥品乙類20% |
01 |
|
2 |
YPYL20 |
|
40000 |
0.2 |
0.2 |
A001 |
|
|
|
|
|
|
藥品乙類20% |
8000 |
YPYL20 |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.2 |
0.2 |
|
| 100004 |
藥品乙類30% |
01 |
|
2 |
YPYL30 |
|
40000 |
0.3 |
0.3 |
A001 |
|
|
|
|
|
|
藥品乙類30% |
8000 |
YPYL30 |
|
0 |
0 |
0 |
2020-1-1 |
|
|
0.3 |
0.3 |
|
| 100005 |
藥品自費 |
01 |
|
3 |
YPZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
藥品自費 |
8000 |
YPZF |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| XA16AXS241A001 |
鹽酸沙丙蝶呤 |
01 |
|
2 |
YSSBDL |
|
40000 |
0 |
0 |
A001 |
|
|
|
|
|
|
鹽酸沙丙蝶呤口服常釋劑型?????? |
8000 |
YSSBDL |
|
0 |
1 |
1 |
2020-1-1 |
|
限四氫生物蝶呤缺乏癥 |
0 |
0 |
|
| ZFXA01ABF391S006 |
復方氯己定（自費） |
01 |
|
3 |
FFLJDZF |
|
40000 |
1 |
1 |
S006 |
|
|
|
|
|
|
復方氯己定含漱液 |
|
FFLJDHSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD08ACF391C001 |
復方氯己定（自費） |
01 |
|
3 |
FFLJDZF |
|
40000 |
1 |
1 |
C001 |
|
|
|
|
|
|
復方氯己定酊劑 |
|
FFLJDDJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BAL338B001 |
羅沙替丁醋酸酯（自費） |
01 |
|
3 |
LSTDCSZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
羅沙替丁醋酸酯注射劑 |
|
LSTDCSZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BAL338B014 |
羅沙替丁醋酸酯（自費） |
01 |
|
3 |
LSTDCSZZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
羅沙替丁醋酸酯凍干粉針 |
|
LSTDCSZDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCA081B001 |
埃索美拉唑（艾司奧美拉唑）（自費） |
01 |
|
3 |
ASMLZ(ASAMLZ)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
埃索美拉唑（艾司奧美拉唑）注射劑 |
|
ASMLZ(ASAMLZ)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCA084A012 |
艾普拉唑（自費） |
01 |
|
3 |
APLZZF |
|
40000 |
1 |
1 |
A012 |
|
|
|
|
|
|
艾普拉唑腸溶片 |
|
APLZCRP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCA211B001 |
奧美拉唑（自費） |
01 |
|
3 |
AMLZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
奧美拉唑注射劑 |
|
AMLZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCA211B003 |
奧美拉唑（自費） |
01 |
|
3 |
AMLZZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
奧美拉唑注射用無菌粉末 |
|
AMLZZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCA211B014 |
奧美拉唑（自費） |
01 |
|
3 |
AMLZZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
奧美拉唑凍干粉針 |
|
AMLZDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCL033B001 |
蘭索拉唑（自費） |
01 |
|
3 |
LSLZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
蘭索拉唑注射劑 |
|
LSLZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCL033B014 |
蘭索拉唑（自費） |
01 |
|
3 |
LSLZZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
蘭索拉唑凍干粉針 |
|
LSLZDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCP025B001 |
泮托拉唑（自費） |
01 |
|
3 |
PTLZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
泮托拉唑注射劑 |
|
PTLZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCP025B003 |
泮托拉唑（自費） |
01 |
|
3 |
PTLZZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
泮托拉唑注射用無菌粉末 |
|
PTLZZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCP025B014 |
泮托拉唑（自費） |
01 |
|
3 |
PTLZZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
泮托拉唑凍干粉針 |
|
PTLZDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BCL043B001 |
雷貝拉唑（自費） |
01 |
|
3 |
LBLZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
雷貝拉唑注射劑 |
|
LBLZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA03AXE020X003 |
二甲硅油（自費） |
01 |
|
3 |
EJGYZF |
|
40000 |
1 |
1 |
X003 |
|
|
|
|
|
|
二甲硅油口服乳劑 |
|
EJGYKFRJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA03AXX007X003 |
西甲硅油（自費） |
01 |
|
3 |
XJGYZF |
|
40000 |
1 |
1 |
X003 |
|
|
|
|
|
|
西甲硅油口服乳劑 |
|
XJGYKFRJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA03FAD173X002 |
多潘立酮（自費） |
01 |
|
3 |
DPLTZF |
|
40000 |
1 |
1 |
X002 |
|
|
|
|
|
|
多潘立酮口服混懸劑 |
|
DPLTKFHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAA202B001 |
昂丹司瓊（自費） |
01 |
|
3 |
ADSQZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
昂丹司瓊注射劑 |
|
ADSQZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAA202B002 |
昂丹司瓊（自費） |
01 |
|
3 |
ADSQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
昂丹司瓊注射液 |
|
ADSQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAD237B002 |
多拉司瓊（自費） |
01 |
|
3 |
DLSQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
多拉司瓊注射液 |
|
DLSQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAG064B001 |
格拉司瓊（自費） |
01 |
|
3 |
GLSQZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
格拉司瓊注射劑 |
|
GLSQZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAG064B002 |
格拉司瓊（自費） |
01 |
|
3 |
GLSQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
格拉司瓊注射液 |
|
GLSQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAG064B014 |
格拉司瓊（自費） |
01 |
|
3 |
GLSQZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
格拉司瓊凍干粉針 |
|
GLSQDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAP003B002 |
帕洛諾司瓊（自費） |
01 |
|
3 |
PLNSQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
帕洛諾司瓊注射液 |
|
PLNSQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAT122B001 |
托烷司瓊（自費） |
01 |
|
3 |
TWSQZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
托烷司瓊注射劑 |
|
TWSQZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAT122B002 |
托烷司瓊（自費） |
01 |
|
3 |
TWSQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
托烷司瓊注射液 |
|
TWSQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAT122B014 |
托烷司瓊（自費） |
01 |
|
3 |
TWSQZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
托烷司瓊凍干粉針 |
|
TWSQDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA04AAA078B002 |
阿扎司瓊（自費） |
01 |
|
3 |
AZSQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
阿扎司瓊注射液 |
|
AZSQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAC059B001 |
促肝細胞生長素（自費） |
01 |
|
3 |
CGXBSCSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
促肝細胞生長素注射劑 |
|
CGXBSCSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAC059B002 |
促肝細胞生長素（自費） |
01 |
|
3 |
CGXBSCSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
促肝細胞生長素注射液 |
|
CGXBSCSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAC059B014 |
促肝細胞生長素（自費） |
01 |
|
3 |
CGXBSCSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
促肝細胞生長素凍干粉針 |
|
CGXBSCSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAD195B002 |
多烯磷脂酰膽堿（自費） |
01 |
|
3 |
DXLZXDJZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
多烯磷脂酰膽堿注射液 |
|
DXLZXDJZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF632B001 |
復方甘草甜素（復方甘草酸苷）（自費） |
01 |
|
3 |
FFGCTS(FFGCSG)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
復方甘草甜素（復方甘草酸苷）注射劑 |
|
FFGCTS(FFGCSG)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF632B002 |
復方甘草甜素（復方甘草酸苷）（自費） |
01 |
|
3 |
FFGCTS(FFGCSG)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方甘草甜素（復方甘草酸苷）注射液 |
|
FFGCTS(FFGCSG)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF632B014 |
復方甘草甜素（復方甘草酸苷）（自費） |
01 |
|
3 |
FFGCTS(FFGCSG)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
復方甘草甜素（復方甘草酸苷）凍干粉針 |
|
FFGCTS(FFGCSG)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAG021B001 |
甘草酸二銨（自費） |
01 |
|
3 |
GCSEAZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
甘草酸二銨注射劑 |
|
GCSEAZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAG021B002 |
甘草酸二銨（自費） |
01 |
|
3 |
GCSEAZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
甘草酸二銨注射液 |
|
GCSEAZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAG021B003 |
甘草酸二銨（自費） |
01 |
|
3 |
GCSEAZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
甘草酸二銨注射用無菌粉末 |
|
GCSEAZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAG021B014 |
甘草酸二銨（自費） |
01 |
|
3 |
GCSEAZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
甘草酸二銨凍干粉針 |
|
GCSEADGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAG105A001 |
谷胱甘肽（自費） |
01 |
|
3 |
GGGTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
谷胱甘肽片劑 |
|
GGGTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAH032B001 |
還原型谷胱甘肽（自費） |
01 |
|
3 |
HYXGGGTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
還原型谷胱甘肽注射劑 |
|
HYXGGGTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAH032B014 |
還原型谷胱甘肽（自費） |
01 |
|
3 |
HYXGGGTZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
還原型谷胱甘肽凍干粉針 |
|
HYXGGGTDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAM076B001 |
門冬氨酸鳥氨酸（自費） |
01 |
|
3 |
MDASNASZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
門冬氨酸鳥氨酸注射劑 |
|
MDASNASZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAM076B002 |
門冬氨酸鳥氨酸（自費） |
01 |
|
3 |
MDASNASZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
門冬氨酸鳥氨酸注射液 |
|
MDASNASZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAS151A001 |
水飛薊素（自費） |
01 |
|
3 |
SFJSZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
水飛薊素片劑 |
|
SFJSPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAS151E001 |
水飛薊素（自費） |
01 |
|
3 |
SFJSZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
水飛薊素硬膠囊 |
|
SFJSYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAY144B002 |
異甘草酸鎂（自費） |
01 |
|
3 |
YGCSMZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
異甘草酸鎂注射液 |
|
YGCSMZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF258B001 |
復方二氯醋酸二異丙胺（自費） |
01 |
|
3 |
FFELCSEYBAZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
復方二氯醋酸二異丙胺注射劑 |
|
FFELCSEYBAZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF258B002 |
復方二氯醋酸二異丙胺（自費） |
01 |
|
3 |
FFELCSEYBAZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方二氯醋酸二異丙胺注射液 |
|
FFELCSEYBAZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF278B002 |
復方甘草酸單銨（自費） |
01 |
|
3 |
FFGCSDAZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方甘草酸單銨注射液 |
|
FFGCSDAZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF279B001 |
復方甘草酸單銨S（自費） |
01 |
|
3 |
FFGCSDASZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
復方甘草酸單銨S注射劑 |
|
FFGCSDASZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF279B002 |
復方甘草酸單銨S（自費） |
01 |
|
3 |
FFGCSDASZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方甘草酸單銨S注射液 |
|
FFGCSDASZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAF279B014 |
復方甘草酸單銨S（自費） |
01 |
|
3 |
FFGCSDASZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
復方甘草酸單銨S凍干粉針 |
|
FFGCSDASDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA05BAH094B001 |
核糖核酸Ⅲ（自費） |
01 |
|
3 |
HTHSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
核糖核酸Ⅲ注射劑 |
|
HTHSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA06ACJ197A001 |
聚卡波非鈣（自費） |
01 |
|
3 |
JKBFGZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
聚卡波非鈣片劑 |
|
JKBFGPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA06AXP121A001 |
普蘆卡必利（自費） |
01 |
|
3 |
PLKBLZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
普蘆卡必利片劑 |
|
PLKBLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07BCM081X002 |
蒙脫石（自費） |
01 |
|
3 |
MTSZF |
|
40000 |
1 |
1 |
X002 |
|
|
|
|
|
|
蒙脫石口服混懸劑 |
|
MTSKFHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07DAL281N001 |
洛哌丁胺（自費） |
01 |
|
3 |
LPDAZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
洛哌丁胺顆粒劑 |
|
LPDAKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAK083W001 |
枯草桿菌、腸球菌二聯活菌（自費） |
01 |
|
3 |
KCGJCQJELHJZF |
|
40000 |
1 |
1 |
W001 |
|
|
|
|
|
|
枯草桿菌、腸球菌二聯活菌口服常釋劑型 |
|
KCGJCQJELHJKFCSJX |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAS129E001 |
雙歧桿菌活菌（自費） |
01 |
|
3 |
SQGJHJZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
雙歧桿菌活菌硬膠囊 |
|
SQGJHJYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAS130A001 |
雙歧桿菌乳桿菌三聯活菌（自費） |
01 |
|
3 |
SQGJRGJSLHJZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
雙歧桿菌乳桿菌三聯活菌片劑 |
|
SQGJRGJSLHJPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAS233P001 |
雙歧桿菌三聯活菌（自費） |
01 |
|
3 |
SQGJSLHJZF |
|
40000 |
1 |
1 |
P001 |
|
|
|
|
|
|
雙歧桿菌三聯活菌口服散劑 |
|
SQGJSLHJKFSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAS131A001 |
雙歧桿菌四聯活菌（自費） |
01 |
|
3 |
SQGJSLHJZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
雙歧桿菌四聯活菌片劑 |
|
SQGJSLHJPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAL015A001 |
蠟樣芽孢桿菌活菌（自費） |
01 |
|
3 |
LYYBGJHJZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
蠟樣芽孢桿菌活菌片劑 |
|
LYYBGJHJPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAL015E001 |
蠟樣芽孢桿菌活菌（自費） |
01 |
|
3 |
LYYBGJHJZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
蠟樣芽孢桿菌活菌硬膠囊 |
|
LYYBGJHJYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAR055A001 |
乳酸菌素（自費） |
01 |
|
3 |
RSJSZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
乳酸菌素片劑 |
|
RSJSPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAR055A006 |
乳酸菌素（自費） |
01 |
|
3 |
RSJSZF |
|
40000 |
1 |
1 |
A006 |
|
|
|
|
|
|
乳酸菌素分散片 |
|
RSJSFSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAR055A017 |
乳酸菌素（自費） |
01 |
|
3 |
RSJSZF |
|
40000 |
1 |
1 |
A017 |
|
|
|
|
|
|
乳酸菌素薄膜衣片 |
|
RSJSBMYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAR055A025 |
乳酸菌素（自費） |
01 |
|
3 |
RSJSZF |
|
40000 |
1 |
1 |
A025 |
|
|
|
|
|
|
乳酸菌素素片 |
|
RSJSSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAL039A001 |
酪酸梭菌活菌（自費） |
01 |
|
3 |
LSSJHJZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
酪酸梭菌活菌片劑 |
|
LSSJHJPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAL039E001 |
酪酸梭菌活菌（自費） |
01 |
|
3 |
LSSJHJZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
酪酸梭菌活菌硬膠囊 |
|
LSSJHJYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAL039P001 |
酪酸梭菌活菌（自費） |
01 |
|
3 |
LSSJHJZF |
|
40000 |
1 |
1 |
P001 |
|
|
|
|
|
|
酪酸梭菌活菌口服散劑 |
|
LSSJHJKFSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ABC161B002 |
重組賴脯胰島素（自費） |
01 |
|
3 |
CZLFYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組賴脯胰島素注射液 |
|
CZLFYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ABG159B002 |
谷賴胰島素（自費） |
01 |
|
3 |
GLYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
谷賴胰島素注射液 |
|
GLYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ABL029B002 |
賴脯胰島素（自費） |
01 |
|
3 |
LFYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
賴脯胰島素注射液 |
|
LFYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ABM079B002 |
門冬胰島素（自費） |
01 |
|
3 |
MDYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
門冬胰島素注射液 |
|
MDYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ADJ136B002 |
精蛋白鋅重組賴脯胰島素混合（50R）（自費） |
01 |
|
3 |
JDBXCZLFYDSHH(50R)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
精蛋白鋅重組賴脯胰島素混合（50R）注射液 |
|
JDBXCZLFYDSHH(50R)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ADJ137B002 |
精蛋白鋅重組賴脯胰島素混合（25R）（自費） |
01 |
|
3 |
JDBXCZLFYDSHH(25R)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
精蛋白鋅重組賴脯胰島素混合（25R）注射液 |
|
JDBXCZLFYDSHH(25R)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ADM080B002 |
門冬胰島素30（自費） |
01 |
|
3 |
MDYDS30ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
門冬胰島素30注射液 |
|
MDYDS30ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10ADM147B002 |
門冬胰島素50（自費） |
01 |
|
3 |
MDYDS50ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
門冬胰島素50注射液 |
|
MDYDS50ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10AEC074B002 |
重組甘精胰島素（自費） |
01 |
|
3 |
CZGJYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組甘精胰島素注射液 |
|
CZGJYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10AED087B002 |
地特胰島素（自費） |
01 |
|
3 |
DTYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
地特胰島素注射液 |
|
DTYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10AEG025B002 |
甘精胰島素（自費） |
01 |
|
3 |
GJYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
甘精胰島素注射液 |
|
GJYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10AED318B002 |
德谷胰島素（自費） |
01 |
|
3 |
DGYDSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
德谷胰島素注射液 |
|
DGYDSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDE074A001 |
二甲雙胍維格列?、颍ㄗ再M） |
01 |
|
3 |
EJSGWGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
二甲雙胍維格列汀Ⅱ片劑 |
|
EJSGWGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDE075A001 |
二甲雙胍維格列?、螅ㄗ再M） |
01 |
|
3 |
EJSGWGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
二甲雙胍維格列汀Ⅲ片劑 |
|
EJSGWGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDL357A001 |
利格列汀二甲雙胍Ⅰ（自費） |
01 |
|
3 |
LGLTEJSGZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
利格列汀二甲雙胍Ⅰ片劑 |
|
LGLTEJSGPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDL358A001 |
利格列汀二甲雙胍Ⅱ（自費） |
01 |
|
3 |
LGLTEJSGZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
利格列汀二甲雙胍Ⅱ片劑 |
|
LGLTEJSGPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDX222A001 |
西格列汀二甲雙胍Ⅰ（自費） |
01 |
|
3 |
XGLTEJSGZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
西格列汀二甲雙胍Ⅰ片劑 |
|
XGLTEJSGPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDX223A001 |
西格列汀二甲雙胍Ⅱ（自費） |
01 |
|
3 |
XGLTEJSGZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
西格列汀二甲雙胍Ⅱ片劑 |
|
XGLTEJSGPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDS251A010 |
沙格列汀二甲雙胍Ⅰ（自費） |
01 |
|
3 |
SGLTEJSGZF |
|
40000 |
1 |
1 |
A010 |
|
|
|
|
|
|
沙格列汀二甲雙胍Ⅰ緩釋片 |
|
SGLTEJSGHSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDS252A010 |
沙格列汀二甲雙胍Ⅱ（自費） |
01 |
|
3 |
SGLTEJSGZF |
|
40000 |
1 |
1 |
A010 |
|
|
|
|
|
|
沙格列汀二甲雙胍Ⅱ緩釋片 |
|
SGLTEJSGHSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BDS253A010 |
沙格列汀二甲雙胍Ⅲ（自費） |
01 |
|
3 |
SGLTEJSGZF |
|
40000 |
1 |
1 |
A010 |
|
|
|
|
|
|
沙格列汀二甲雙胍Ⅲ緩釋片 |
|
SGLTEJSGHSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BHA283A001 |
阿格列?。ㄗ再M） |
01 |
|
3 |
AGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
阿格列汀片劑 |
|
AGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BHL343A001 |
利格列汀（自費） |
01 |
|
3 |
LGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
利格列汀片劑 |
|
LGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BHS231A001 |
沙格列?。ㄗ再M） |
01 |
|
3 |
SGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
沙格列汀片劑 |
|
SGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BHW104A001 |
維格列汀（自費） |
01 |
|
3 |
WGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
維格列汀片劑 |
|
WGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA10BHX202A001 |
西格列?。ㄗ再M） |
01 |
|
3 |
XGLTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
西格列汀片劑 |
|
XGLTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AXL154B001 |
硫辛酸（自費） |
01 |
|
3 |
LXSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
硫辛酸注射劑 |
|
LXSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AXL154B002 |
硫辛酸（自費） |
01 |
|
3 |
LXSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
硫辛酸注射液 |
|
LXSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CCA017A001 |
阿法骨化醇（自費） |
01 |
|
3 |
AFGHCZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
阿法骨化醇片劑 |
|
AFGHCPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CCA017E001 |
阿法骨化醇（自費） |
01 |
|
3 |
AFGHCZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
阿法骨化醇硬膠囊 |
|
AFGHCYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CCA017E002 |
阿法骨化醇（自費） |
01 |
|
3 |
AFGHCZF |
|
40000 |
1 |
1 |
E002 |
|
|
|
|
|
|
阿法骨化醇軟膠囊 |
|
AFGHCRJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CCA017X004 |
阿法骨化醇（自費） |
01 |
|
3 |
AFGHCZF |
|
40000 |
1 |
1 |
X004 |
|
|
|
|
|
|
阿法骨化醇口服滴劑 |
|
AFGHCKFDJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CCG111E002 |
骨化三醇（自費） |
01 |
|
3 |
GHSCZF |
|
40000 |
1 |
1 |
E002 |
|
|
|
|
|
|
骨化三醇軟膠囊 |
|
GHSCRJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CCG111B002 |
骨化三醇（自費） |
01 |
|
3 |
GHSCZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
骨化三醇注射液 |
|
GHSCZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAS153B001 |
水溶性維生素（自費） |
01 |
|
3 |
SRXWSSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
水溶性維生素注射劑 |
|
SRXWSSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAS153B003 |
水溶性維生素（自費） |
01 |
|
3 |
SRXWSSZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
水溶性維生素注射用無菌粉末 |
|
SRXWSSZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAS153B014 |
水溶性維生素（自費） |
01 |
|
3 |
SRXWSSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
水溶性維生素凍干粉針 |
|
SRXWSSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12AXT013A001 |
碳酸鈣D3（自費） |
01 |
|
3 |
TSGD3ZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
碳酸鈣D3片劑 |
|
TSGD3PJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12AXT013N001 |
碳酸鈣D3（自費） |
01 |
|
3 |
TSGD3ZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
碳酸鈣D3顆粒劑 |
|
TSGD3KLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA11CBW032X004 |
維生素AD（自費） |
01 |
|
3 |
WSSADZF |
|
40000 |
1 |
1 |
X004 |
|
|
|
|
|
|
維生素AD口服滴劑 |
|
WSSADKFDJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12CEX037A001 |
硒酵母（自費） |
01 |
|
3 |
XJMZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
硒酵母片劑 |
|
XJMPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12CEX037E001 |
硒酵母（自費） |
01 |
|
3 |
XJMZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
硒酵母硬膠囊 |
|
XJMYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12AXX128N001 |
小兒碳酸鈣D3（自費） |
01 |
|
3 |
XETSGD3ZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
小兒碳酸鈣D3顆粒劑 |
|
XETSGD3KLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ022B001 |
脂溶性維生素Ⅰ（自費） |
01 |
|
3 |
ZRXWSSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
脂溶性維生素Ⅰ注射劑 |
|
ZRXWSSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ022B002 |
脂溶性維生素Ⅰ（自費） |
01 |
|
3 |
ZRXWSSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
脂溶性維生素Ⅰ注射液 |
|
ZRXWSSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ022B003 |
脂溶性維生素Ⅰ（自費） |
01 |
|
3 |
ZRXWSSZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
脂溶性維生素Ⅰ注射用無菌粉末 |
|
ZRXWSSZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ023B001 |
脂溶性維生素Ⅱ（自費） |
01 |
|
3 |
ZRXWSSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
脂溶性維生素Ⅱ注射劑 |
|
ZRXWSSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ023B002 |
脂溶性維生素Ⅱ（自費） |
01 |
|
3 |
ZRXWSSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
脂溶性維生素Ⅱ注射液 |
|
ZRXWSSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ023B003 |
脂溶性維生素Ⅱ（自費） |
01 |
|
3 |
ZRXWSSZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
脂溶性維生素Ⅱ注射用無菌粉末 |
|
ZRXWSSZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12AAC067A001 |
醋酸鈣（自費） |
01 |
|
3 |
CSGZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
醋酸鈣片劑 |
|
CSGPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12AAC067E001 |
醋酸鈣（自費） |
01 |
|
3 |
CSGZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
醋酸鈣硬膠囊 |
|
CSGYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12CBL149A001 |
硫酸鋅（自費） |
01 |
|
3 |
LSXZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
硫酸鋅片劑 |
|
LSXPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12CBL149A018 |
硫酸鋅（自費） |
01 |
|
3 |
LSXZF |
|
40000 |
1 |
1 |
A018 |
|
|
|
|
|
|
硫酸鋅糖衣片 |
|
LSXTYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12CBL149X001 |
硫酸鋅（自費） |
01 |
|
3 |
LSXZF |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
硫酸鋅口服溶液劑 |
|
LSXKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12BAM074A001 |
門冬氨酸鉀鎂（自費） |
01 |
|
3 |
MDASJMZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
門冬氨酸鉀鎂片劑 |
|
MDASJMPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12BAM074A017 |
門冬氨酸鉀鎂（自費） |
01 |
|
3 |
MDASJMZF |
|
40000 |
1 |
1 |
A017 |
|
|
|
|
|
|
門冬氨酸鉀鎂薄膜衣片 |
|
MDASJMBMYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XAM074B001 |
門冬氨酸鉀鎂（自費） |
01 |
|
3 |
MDASJMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
門冬氨酸鉀鎂注射劑 |
|
MDASJMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XAM074B002 |
門冬氨酸鉀鎂（自費） |
01 |
|
3 |
MDASJMZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
門冬氨酸鉀鎂注射液 |
|
MDASJMZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XAM074B014 |
門冬氨酸鉀鎂（自費） |
01 |
|
3 |
MDASJMZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
門冬氨酸鉀鎂凍干粉針 |
|
MDASJMDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA12AAP077N001 |
葡萄糖酸鈣（自費） |
01 |
|
3 |
PTTSGZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
葡萄糖酸鈣顆粒劑 |
|
PTTSGKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AXF235A001 |
復方顛茄氫氧化鋁（自費） |
01 |
|
3 |
FFDQQYHLZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
復方顛茄氫氧化鋁片劑 |
|
FFDQQYHLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAF478A001 |
復方嗜酸乳桿菌（自費） |
01 |
|
3 |
FFSSRGJZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
復方嗜酸乳桿菌片劑 |
|
FFSSRGJPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02AXF501A005 |
復方碳酸鈣（自費） |
01 |
|
3 |
FFTSGZF |
|
40000 |
1 |
1 |
A005 |
|
|
|
|
|
|
復方碳酸鈣咀嚼片 |
|
FFTSGJJP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA09AAF535E001 |
復方消化酶（自費） |
01 |
|
3 |
FFXHMZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
復方消化酶硬膠囊 |
|
FFXHMYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA09AAF573P001 |
復方胰酶（自費） |
01 |
|
3 |
FFYMZF |
|
40000 |
1 |
1 |
P001 |
|
|
|
|
|
|
復方胰酶口服散劑 |
|
FFYMKFSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA07FAF604E005 |
復合乳酸菌（自費） |
01 |
|
3 |
FHRSJZF |
|
40000 |
1 |
1 |
E005 |
|
|
|
|
|
|
復合乳酸菌腸溶膠囊 |
|
FHRSJCRJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AXL178A001 |
鋁鎂顛茄（自費） |
01 |
|
3 |
LMDQZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
鋁鎂顛茄片劑 |
|
LMDQPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02ADL177X002 |
鋁鎂（自費） |
01 |
|
3 |
LMZF |
|
40000 |
1 |
1 |
X002 |
|
|
|
|
|
|
鋁鎂口服混懸劑 |
|
LMKFHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA02BAF350A001 |
復方雷尼替丁（自費） |
01 |
|
3 |
FFLNTDZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
復方雷尼替丁片劑 |
|
FFLNTDPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA03AXW064N001 |
胃鉍鎂（自費） |
01 |
|
3 |
WBMZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
胃鉍鎂顆粒劑 |
|
WBMKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AXW071B001 |
烏司他?。ㄗ再M） |
01 |
|
3 |
WSTDZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
烏司他丁注射劑 |
|
WSTDZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AXW071B002 |
烏司他?。ㄗ再M） |
01 |
|
3 |
WSTDZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
烏司他丁注射液 |
|
WSTDZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AAX051A012 |
腺苷蛋氨酸（自費） |
01 |
|
3 |
XGDASZF |
|
40000 |
1 |
1 |
A012 |
|
|
|
|
|
|
腺苷蛋氨酸腸溶片 |
|
XGDASCRP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AAX051B001 |
腺苷蛋氨酸（自費） |
01 |
|
3 |
XGDASZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
腺苷蛋氨酸注射劑 |
|
XGDASZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01BAT027B001 |
特利加壓素（自費） |
01 |
|
3 |
TLJYSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
特利加壓素注射劑 |
|
TLJYSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ABG047B021 |
肝素（自費） |
01 |
|
3 |
GSZF |
|
40000 |
1 |
1 |
B021 |
|
|
|
|
|
|
肝素封管液 |
|
GSFGY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACB040A001 |
貝前列素（自費） |
01 |
|
3 |
BQLSZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
貝前列素片劑 |
|
BQLSPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACB040A017 |
貝前列素（自費） |
01 |
|
3 |
BQLSZF |
|
40000 |
1 |
1 |
A017 |
|
|
|
|
|
|
貝前列素薄膜衣片 |
|
BQLSBMYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACL190A001 |
氯吡格雷（自費） |
01 |
|
3 |
LBGLZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
氯吡格雷片劑 |
|
LBGLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACS050A001 |
沙格雷酯（自費） |
01 |
|
3 |
SGLZZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
沙格雷酯片劑 |
|
SGLZPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACT038B001 |
替羅非班（自費） |
01 |
|
3 |
TLFBZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
替羅非班注射劑 |
|
TLFBZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACT038B002 |
替羅非班（自費） |
01 |
|
3 |
TLFBZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
替羅非班注射液 |
|
TLFBZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACT038B004 |
替羅非班（自費） |
01 |
|
3 |
TLFBZF |
|
40000 |
1 |
1 |
B004 |
|
|
|
|
|
|
替羅非班注射用濃溶液 |
|
TLFBZSYNRY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACT132B002 |
替羅非班氯化鈉（自費） |
01 |
|
3 |
TLFBLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
替羅非班氯化鈉注射液 |
|
TLFBLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACX010A001 |
西洛他唑（自費） |
01 |
|
3 |
XLTZZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
西洛他唑片劑 |
|
XLTZPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACX010A025 |
西洛他唑（自費） |
01 |
|
3 |
XLTZZF |
|
40000 |
1 |
1 |
A025 |
|
|
|
|
|
|
西洛他唑素片 |
|
XLTZSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACX010E001 |
西洛他唑（自費） |
01 |
|
3 |
XLTZZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
西洛他唑硬膠囊 |
|
XLTZYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACY271B002 |
依替巴肽（自費） |
01 |
|
3 |
YTBTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
依替巴肽注射液 |
|
YTBTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACY170A001 |
吲哚布芬（自費） |
01 |
|
3 |
YDBFZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
吲哚布芬片劑 |
|
YDBFPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ACT157A001 |
替格瑞洛（自費） |
01 |
|
3 |
TGRLZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
替格瑞洛片劑 |
|
TGRLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADA066B001 |
阿替普酶（自費） |
01 |
|
3 |
ATPMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
阿替普酶注射劑 |
|
ATPMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADJ103B001 |
降纖酶（自費） |
01 |
|
3 |
JXMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
降纖酶注射劑 |
|
JXMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADJ103B002 |
降纖酶（自費） |
01 |
|
3 |
JXMZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
降纖酶注射液 |
|
JXMZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADJ103B003 |
降纖酶（自費） |
01 |
|
3 |
JXMZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
降纖酶注射用無菌粉末 |
|
JXMZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADJ103B014 |
降纖酶（自費） |
01 |
|
3 |
JXMZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
降纖酶凍干粉針 |
|
JXMDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADX048B002 |
纖溶酶（自費） |
01 |
|
3 |
XRMZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
纖溶酶注射液 |
|
XRMZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01ADX048B014 |
纖溶酶（自費） |
01 |
|
3 |
XRMZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
纖溶酶凍干粉針 |
|
XRMDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AEA021B002 |
阿加曲班（自費） |
01 |
|
3 |
AJQBZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
阿加曲班注射液 |
|
AJQBZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AED251E001 |
達比加群酯（自費） |
01 |
|
3 |
DBJQZZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
達比加群酯硬膠囊 |
|
DBJQZYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AEB202B001 |
比伐蘆定（自費） |
01 |
|
3 |
BFLDZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
比伐蘆定注射劑 |
|
BFLDZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AFA281A001 |
阿哌沙班（自費） |
01 |
|
3 |
APSBZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
阿哌沙班片劑 |
|
APSBPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AFH075B002 |
磺達肝癸鈉（自費） |
01 |
|
3 |
HDGGNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
磺達肝癸鈉注射液 |
|
HDGGNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AFL056A001 |
利伐沙班（自費） |
01 |
|
3 |
LFSBZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
利伐沙班片劑 |
|
LFSBPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AXA223B001 |
奧扎格雷（自費） |
01 |
|
3 |
AZGLZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
奧扎格雷注射劑 |
|
AZGLZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AXA223B002 |
奧扎格雷（自費） |
01 |
|
3 |
AZGLZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
奧扎格雷注射液 |
|
AZGLZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AXA223B003 |
奧扎格雷（自費） |
01 |
|
3 |
AZGLZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
奧扎格雷注射用無菌粉末 |
|
AZGLZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AXA223B014 |
奧扎格雷（自費） |
01 |
|
3 |
AZGLZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
奧扎格雷凍干粉針 |
|
AZGLDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB01AXC127B002 |
參芎葡萄糖（自費） |
01 |
|
3 |
CXPTTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
參芎葡萄糖注射液 |
|
CXPTTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXB011B001 |
白眉蛇毒血凝酶（自費） |
01 |
|
3 |
BMSDXNMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
白眉蛇毒血凝酶注射劑 |
|
BMSDXNMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXJ095B014 |
尖吻蝮蛇血凝酶（自費） |
01 |
|
3 |
JWFSXNMZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
尖吻蝮蛇血凝酶凍干粉針 |
|
JWFSXNMDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXJ153B002 |
聚桂醇（自費） |
01 |
|
3 |
JGCZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
聚桂醇注射液 |
|
JGCZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXK018B001 |
卡絡磺鈉（腎上腺色腙）（自費） |
01 |
|
3 |
KLHN(SSXSZ)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
卡絡磺鈉（腎上腺色腙）注射劑 |
|
KLHN(SSXSZ)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXK018B002 |
卡絡磺鈉（腎上腺色腙）（自費） |
01 |
|
3 |
KLHN(SSXSZ)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
卡絡磺鈉（腎上腺色腙）注射液 |
|
KLHN(SSXSZ)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXK018B003 |
卡絡磺鈉（腎上腺色腙）（自費） |
01 |
|
3 |
KLHN(SSXSZ)ZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
卡絡磺鈉（腎上腺色腙）注射用無菌粉末 |
|
KLHN(SSXSZ)ZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXK018B014 |
卡絡磺鈉（腎上腺色腙）（自費） |
01 |
|
3 |
KLHN(SSXSZ)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
卡絡磺鈉（腎上腺色腙）凍干粉針 |
|
KLHN(SSXSZ)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXK096B002 |
卡絡磺鈉氯化鈉（自費） |
01 |
|
3 |
KLHNLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
卡絡磺鈉氯化鈉注射液 |
|
KLHNLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXM155B014 |
矛頭蝮蛇血凝酶（自費） |
01 |
|
3 |
MTFSXNMZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
矛頭蝮蛇血凝酶凍干粉針 |
|
MTFSXNMDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BDR011B001 |
人凝血酶原復合物（自費） |
01 |
|
3 |
RNXMYFHWZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人凝血酶原復合物注射劑 |
|
RNXMYFHWZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BDR011B014 |
人凝血酶原復合物（自費） |
01 |
|
3 |
RNXMYFHWZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人凝血酶原復合物凍干粉針 |
|
RNXMYFHWDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BBR019B001 |
人纖維蛋白原（自費） |
01 |
|
3 |
RXWDBYZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人纖維蛋白原注射劑 |
|
RXWDBYZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BBR019B003 |
人纖維蛋白原（自費） |
01 |
|
3 |
RXWDBYZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
人纖維蛋白原注射用無菌粉末 |
|
RXWDBYZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BBR019B014 |
人纖維蛋白原（自費） |
01 |
|
3 |
RXWDBYZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人纖維蛋白原凍干粉針 |
|
RXWDBYDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXS064B002 |
蛇毒血凝酶（自費） |
01 |
|
3 |
SDXNMZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
蛇毒血凝酶注射液 |
|
SDXNMZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BDC111B001 |
重組人凝血因子Ⅷ（自費） |
01 |
|
3 |
CZRNXYZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人凝血因子Ⅷ注射劑 |
|
CZRNXYZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BDC147B001 |
重組人凝血因子Ⅸ（自費） |
01 |
|
3 |
CZRNXYZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人凝血因子Ⅸ注射劑 |
|
CZRNXYZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXC117B002 |
重組人血小板生成素（自費） |
01 |
|
3 |
CZRXXBSCSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人血小板生成素注射液 |
|
CZRXXBSCSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB02BXA307A001 |
艾曲泊帕乙醇胺（自費） |
01 |
|
3 |
AQBPYCAZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
艾曲泊帕乙醇胺片劑 |
|
AQBPYCAPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03ABY199X001 |
右旋糖酐鐵（自費） |
01 |
|
3 |
YXTGTZF |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
右旋糖酐鐵口服溶液劑 |
|
YXTGTKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03AED181E001 |
多糖鐵復合物（自費） |
01 |
|
3 |
DTTFHWZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
多糖鐵復合物硬膠囊 |
|
DTTFHWYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03ACS058B002 |
山梨醇鐵（自費） |
01 |
|
3 |
SLCTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
山梨醇鐵注射液 |
|
SLCTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03ACZ012B001 |
蔗糖鐵（自費） |
01 |
|
3 |
ZTTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
蔗糖鐵注射劑 |
|
ZTTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03ACZ012B002 |
蔗糖鐵（自費） |
01 |
|
3 |
ZTTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
蔗糖鐵注射液 |
|
ZTTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03BAJ038B001 |
甲鈷胺（自費） |
01 |
|
3 |
JGAZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
甲鈷胺注射劑 |
|
JGAZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03BAJ038B002 |
甲鈷胺（自費） |
01 |
|
3 |
JGAZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
甲鈷胺注射液 |
|
JGAZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03BAJ038B014 |
甲鈷胺（自費） |
01 |
|
3 |
JGAZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
甲鈷胺凍干粉針 |
|
JGADGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03BAX052B001 |
腺苷鈷胺（自費） |
01 |
|
3 |
XGGAZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
腺苷鈷胺注射劑 |
|
XGGAZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03BAX052B014 |
腺苷鈷胺（自費） |
01 |
|
3 |
XGGAZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
腺苷鈷胺凍干粉針 |
|
XGGADGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03XAC103B002 |
重組人促紅素（CHO細胞）（自費） |
01 |
|
3 |
CZRCHS(CHOXB)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人促紅素（CHO細胞）注射液 |
|
CZRCHS(CHOXB)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03XAC103B003 |
重組人促紅素（CHO細胞）（自費） |
01 |
|
3 |
CZRCHS(CHOXB)ZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
重組人促紅素（CHO細胞）注射用無菌粉末 |
|
CZRCHS(CHOXB)ZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03XAC103B014 |
重組人促紅素（CHO細胞）（自費） |
01 |
|
3 |
CZRCHS(CHOXB)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人促紅素（CHO細胞）凍干粉針 |
|
CZRCHS(CHOXB)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB03XAC149B002 |
重組人促紅素-β（CHO細胞）（自費） |
01 |
|
3 |
CZRCHS-(CHOXB)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人促紅素-β（CHO細胞）注射液 |
|
CZRCHS-(CHOXB)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAH027B002 |
琥珀酰明膠（自費） |
01 |
|
3 |
HPXMJZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
琥珀酰明膠注射液 |
|
HPXMJZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAQ163B002 |
羥乙基淀粉（200/0.5）氯化鈉（自費） |
01 |
|
3 |
QYJDF(2000.5)LHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
羥乙基淀粉（200/0.5）氯化鈉注射液 |
|
QYJDF(2000.5)LHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAQ164B002 |
羥乙基淀粉（130/0.4）氯化鈉（自費） |
01 |
|
3 |
QYJDF(1300.4)LHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
羥乙基淀粉（130/0.4）氯化鈉注射液 |
|
QYJDF(1300.4)LHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAR021B001 |
人血白蛋白（自費） |
01 |
|
3 |
RXBDBZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人血白蛋白注射劑 |
|
RXBDBZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAR021B002 |
人血白蛋白（自費） |
01 |
|
3 |
RXBDBZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
人血白蛋白注射液 |
|
RXBDBZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAR021B005 |
人血白蛋白（自費） |
01 |
|
3 |
RXBDBZF |
|
40000 |
1 |
1 |
B005 |
|
|
|
|
|
|
人血白蛋白注射用溶液劑 |
|
RXBDBZSYRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAR021B014 |
人血白蛋白（自費） |
01 |
|
3 |
RXBDBZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人血白蛋白凍干粉針 |
|
RXBDBDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05AAJ157B002 |
聚明膠肽（自費） |
01 |
|
3 |
JMJTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
聚明膠肽注射液 |
|
JMJTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAF145B002 |
復方氨基酸（15AA）（自費） |
01 |
|
3 |
FFAJS(15AA)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方氨基酸（15AA）注射液 |
|
FFAJS(15AA)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAF142B002 |
復方氨基酸（自費） |
01 |
|
3 |
FFAJSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方氨基酸注射液 |
|
FFAJSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAF160B002 |
復方氨基酸（20AA）（自費） |
01 |
|
3 |
FFAJS(20AA)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方氨基酸（20AA）注射液 |
|
FFAJS(20AA)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAF162B002 |
復方氨基酸（6AA）（自費） |
01 |
|
3 |
FFAJS(6AA)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方氨基酸（6AA）注射液 |
|
FFAJS(6AA)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAF164B002 |
復方氨基酸（9AA）（自費） |
01 |
|
3 |
FFAJS(9AA)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方氨基酸（9AA）注射液 |
|
FFAJS(9AA)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAZ018B002 |
脂肪乳（C14-24）（自費） |
01 |
|
3 |
ZFR(C14-24)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
脂肪乳（C14-24）注射液 |
|
ZFR(C14-24)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAU005B002 |
ω-3魚油脂肪乳（自費） |
01 |
|
3 |
-3YYZFRZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
ω-3魚油脂肪乳注射液 |
|
-3YYZFRZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BAJ113B002 |
結構脂肪乳（C6-24）（自費） |
01 |
|
3 |
JGZFR(C6-24)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
結構脂肪乳（C6-24）注射液 |
|
JGZFR(C6-24)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BBG129B001 |
果糖（自費） |
01 |
|
3 |
GTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
果糖注射劑 |
|
GTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BBG129B002 |
果糖（自費） |
01 |
|
3 |
GTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
果糖注射液 |
|
GTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BBG146B002 |
果糖氯化鈉（自費） |
01 |
|
3 |
GTLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
果糖氯化鈉注射液 |
|
GTLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BBN080B002 |
鈉鉀鎂鈣葡萄糖（自費） |
01 |
|
3 |
NJMGPTTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
鈉鉀鎂鈣葡萄糖注射液 |
|
NJMGPTTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05BBC143B002 |
醋酸鈉林格（自費） |
01 |
|
3 |
CSNLGZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
醋酸鈉林格注射液 |
|
CSNLGZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XBB120B001 |
丙氨酰谷氨酰胺（自費） |
01 |
|
3 |
BAXGAXAZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
丙氨酰谷氨酰胺注射劑 |
|
BAXGAXAZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XBB120B002 |
丙氨酰谷氨酰胺（自費） |
01 |
|
3 |
BAXGAXAZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
丙氨酰谷氨酰胺注射液 |
|
BAXGAXAZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XAM073B002 |
門冬氨酸鉀（自費） |
01 |
|
3 |
MDASJZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
門冬氨酸鉀注射液 |
|
MDASJZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXB05XAF240B002 |
復方電解質（自費） |
01 |
|
3 |
FFDJZZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方電解質注射液 |
|
FFDJZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01BDY054B002 |
伊布利特（自費） |
01 |
|
3 |
YBLTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
伊布利特注射液 |
|
YBLTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01CXZ065B002 |
左西孟旦（自費） |
01 |
|
3 |
ZXMDZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
左西孟旦注射液 |
|
ZXMDZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01DAD024B001 |
單硝酸異山梨酯（自費） |
01 |
|
3 |
DXSYSLZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
單硝酸異山梨酯注射劑 |
|
DXSYSLZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01DAD024B002 |
單硝酸異山梨酯（自費） |
01 |
|
3 |
DXSYSLZZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
單硝酸異山梨酯注射液 |
|
DXSYSLZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01DAD024B014 |
單硝酸異山梨酯（自費） |
01 |
|
3 |
DXSYSLZZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
單硝酸異山梨酯凍干粉針 |
|
DXSYSLZDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01DXN039B014 |
尼可地爾（自費） |
01 |
|
3 |
NKDEZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
尼可地爾凍干粉針 |
|
NKDEDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBD015B002 |
丹參酮ⅡA（自費） |
01 |
|
3 |
DCTAZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
丹參酮ⅡA注射液 |
|
DCTAZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBG072B001 |
葛根素（自費） |
01 |
|
3 |
GGSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
葛根素注射劑 |
|
GGSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBG072B002 |
葛根素（自費） |
01 |
|
3 |
GGSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
葛根素注射液 |
|
GGSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBG072B014 |
葛根素（自費） |
01 |
|
3 |
GGSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
葛根素凍干粉針 |
|
GGSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBQ102A001 |
曲美他嗪（自費） |
01 |
|
3 |
QMTQZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
曲美他嗪片劑 |
|
QMTQPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBQ102E001 |
曲美他嗪（自費） |
01 |
|
3 |
QMTQZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
曲美他嗪硬膠囊 |
|
QMTQYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC01EBQ102A010 |
曲美他嗪（自費） |
01 |
|
3 |
QMTQZF |
|
40000 |
1 |
1 |
A010 |
|
|
|
|
|
|
曲美他嗪緩釋片 |
|
QMTQHSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC02ACK062V001 |
可樂定（自費） |
01 |
|
3 |
KLDZF |
|
40000 |
1 |
1 |
V001 |
|
|
|
|
|
|
可樂定貼劑 |
|
KLDTJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC02CAC046B001 |
川芎嗪（自費） |
01 |
|
3 |
CXQZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
川芎嗪注射劑 |
|
CXQZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC02CAC046B002 |
川芎嗪（自費） |
01 |
|
3 |
CXQZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
川芎嗪注射液 |
|
CXQZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC02CAC046B014 |
川芎嗪（自費） |
01 |
|
3 |
CXQZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
川芎嗪凍干粉針 |
|
CXQDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC03CAT115B001 |
托拉塞米（自費） |
01 |
|
3 |
TLSMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
托拉塞米注射劑 |
|
TLSMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC03CAT115B002 |
托拉塞米（自費） |
01 |
|
3 |
TLSMZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
托拉塞米注射液 |
|
TLSMZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC04AXF007B001 |
法舒地爾（自費） |
01 |
|
3 |
FSDEZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
法舒地爾注射劑 |
|
FSDEZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC04AXF007B002 |
法舒地爾（自費） |
01 |
|
3 |
FSDEZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
法舒地爾注射液 |
|
FSDEZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC04AFY101A012 |
胰激肽原酶（自費） |
01 |
|
3 |
YJTYMZF |
|
40000 |
1 |
1 |
A012 |
|
|
|
|
|
|
胰激肽原酶腸溶片 |
|
YJTYMCRP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC04AFY101B001 |
胰激肽原酶（自費） |
01 |
|
3 |
YJTYMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
胰激肽原酶注射劑 |
|
YJTYMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC04AFY101B014 |
胰激肽原酶（自費） |
01 |
|
3 |
YJTYMZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
胰激肽原酶凍干粉針 |
|
YJTYMDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC04AXX195B002 |
杏芎氯化鈉（自費） |
01 |
|
3 |
XXLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
杏芎氯化鈉注射液 |
|
XXLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05BAD165F002 |
多磺酸粘多糖（自費） |
01 |
|
3 |
DHSZDTZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
多磺酸粘多糖乳膏劑 |
|
DHSZDTRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05CAQ005B001 |
七葉皂苷（自費） |
01 |
|
3 |
YZGZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
七葉皂苷注射劑 |
|
YZGZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05CAQ005B014 |
七葉皂苷（自費） |
01 |
|
3 |
YZGZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
七葉皂苷凍干粉針 |
|
YZGDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05CAQ094B001 |
曲克蘆?。ㄗ再M） |
01 |
|
3 |
QKLDZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
曲克蘆丁注射劑 |
|
QKLDZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05CAQ094B002 |
曲克蘆丁（自費） |
01 |
|
3 |
QKLDZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
曲克蘆丁注射液 |
|
QKLDZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05CAQ094B014 |
曲克蘆?。ㄗ再M） |
01 |
|
3 |
QKLDZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
曲克蘆丁凍干粉針 |
|
QKLDDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC05CAF447B002 |
復方曲肽（自費） |
01 |
|
3 |
FFQTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
復方曲肽注射液 |
|
FFQTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09BXY230A001 |
依那普利葉酸（自費） |
01 |
|
3 |
YNPLYSZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
依那普利葉酸片劑 |
|
YNPLYSPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09CAA257A001 |
奧美沙坦酯（自費） |
01 |
|
3 |
AMSTZZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
奧美沙坦酯片劑 |
|
AMSTZPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09CAA257A017 |
奧美沙坦酯（自費） |
01 |
|
3 |
AMSTZZF |
|
40000 |
1 |
1 |
A017 |
|
|
|
|
|
|
奧美沙坦酯薄膜衣片 |
|
AMSTZBMYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09CAA257E001 |
奧美沙坦酯（自費） |
01 |
|
3 |
AMSTZZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
奧美沙坦酯硬膠囊 |
|
AMSTZYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09DAA212A001 |
奧美沙坦酯氫氯噻嗪（自費） |
01 |
|
3 |
AMSTZQLSQZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
奧美沙坦酯氫氯噻嗪片劑 |
|
AMSTZQLSQPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09DBA313A001 |
奧美沙坦酯氨氯地平（自費） |
01 |
|
3 |
AMSTZALDPZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
奧美沙坦酯氨氯地平片劑 |
|
AMSTZALDPPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC09DBT176A001 |
替米沙坦氨氯地平（自費） |
01 |
|
3 |
TMSTALDPZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
替米沙坦氨氯地平片劑 |
|
TMSTALDPPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXC10AXY097A001 |
依折麥布（自費） |
01 |
|
3 |
YZMBZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
依折麥布片劑 |
|
YZMBPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01AEE027S001 |
二硫化硒（自費） |
01 |
|
3 |
ELHXZF |
|
40000 |
1 |
1 |
S001 |
|
|
|
|
|
|
二硫化硒洗劑 |
|
ELHXXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01ACL079S004 |
聯苯芐唑（自費） |
01 |
|
3 |
LBBZZF |
|
40000 |
1 |
1 |
S004 |
|
|
|
|
|
|
聯苯芐唑外用溶液劑 |
|
LBBZWYRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01ACL079T001 |
聯苯芐唑（自費） |
01 |
|
3 |
LBBZZF |
|
40000 |
1 |
1 |
T001 |
|
|
|
|
|
|
聯苯芐唑搽劑 |
|
LBBZCJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01ACL079F002 |
聯苯芐唑（自費） |
01 |
|
3 |
LBBZZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
聯苯芐唑乳膏劑 |
|
LBBZRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01ACQ086F002 |
曲安奈德益康唑（自費） |
01 |
|
3 |
QANDYKZZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
曲安奈德益康唑乳膏劑 |
|
QANDYKZRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01ACT058F002 |
酮康唑（自費） |
01 |
|
3 |
TKZZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
酮康唑乳膏劑 |
|
TKZRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD01ACY162F002 |
益康唑（自費） |
01 |
|
3 |
YKZZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
益康唑乳膏劑 |
|
YKZRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD03AXC078P009 |
重組牛堿性成纖維細胞生長因子（自費） |
01 |
|
3 |
CZNJXCXWXBSCYZZF |
|
40000 |
1 |
1 |
P009 |
|
|
|
|
|
|
重組牛堿性成纖維細胞生長因子外用凍干制劑 |
|
CZNJXCXWXBSCYZWYDGZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD03AXC078U001 |
重組牛堿性成纖維細胞生長因子（自費） |
01 |
|
3 |
CZNJXCXWXBSCYZZF |
|
40000 |
1 |
1 |
U001 |
|
|
|
|
|
|
重組牛堿性成纖維細胞生長因子凝膠劑 |
|
CZNJXCXWXBSCYZNJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD03AXC105P009 |
重組人堿性成纖維細胞生長因子（自費） |
01 |
|
3 |
CZRJXCXWXBSCYZZF |
|
40000 |
1 |
1 |
P009 |
|
|
|
|
|
|
重組人堿性成纖維細胞生長因子外用凍干制劑 |
|
CZRJXCXWXBSCYZWYDGZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD03AXC105U001 |
重組人堿性成纖維細胞生長因子（自費） |
01 |
|
3 |
CZRJXCXWXBSCYZZF |
|
40000 |
1 |
1 |
U001 |
|
|
|
|
|
|
重組人堿性成纖維細胞生長因子凝膠劑 |
|
CZRJXCXWXBSCYZNJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD08ADP041F001 |
硼酸（自費） |
01 |
|
3 |
PSZF |
|
40000 |
1 |
1 |
F001 |
|
|
|
|
|
|
硼酸軟膏劑 |
|
PSRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD10AEG132F002 |
過氧苯甲酰（自費） |
01 |
|
3 |
GYBJXZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
過氧苯甲酰乳膏劑 |
|
GYBJXRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD10AEG132U001 |
過氧苯甲酰（自費） |
01 |
|
3 |
GYBJXZF |
|
40000 |
1 |
1 |
U001 |
|
|
|
|
|
|
過氧苯甲酰凝膠劑 |
|
GYBJXNJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD11AXB099F002 |
吡美莫司（自費） |
01 |
|
3 |
BMMSZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
吡美莫司乳膏劑 |
|
BMMSRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD11AXQ064F002 |
氫醌（自費） |
01 |
|
3 |
QKZF |
|
40000 |
1 |
1 |
F002 |
|
|
|
|
|
|
氫醌乳膏劑 |
|
QKRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXD11AXT002F001 |
他克莫司（自費） |
01 |
|
3 |
TKMSZF |
|
40000 |
1 |
1 |
F001 |
|
|
|
|
|
|
他克莫司軟膏劑 |
|
TKMSRGJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG02ADD082D003 |
地諾前列酮（自費） |
01 |
|
3 |
DNQLTZF |
|
40000 |
1 |
1 |
D003 |
|
|
|
|
|
|
地諾前列酮陰道栓 |
|
DNQLTYDS |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG02ADK026B002 |
卡前列素氨丁三醇（自費） |
01 |
|
3 |
KQLSADSCZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
卡前列素氨丁三醇注射液 |
|
KQLSADSCZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG02BAZ061Z007 |
左炔諾孕酮（自費） |
01 |
|
3 |
ZQNYTZF |
|
40000 |
1 |
1 |
Z007 |
|
|
|
|
|
|
左炔諾孕酮宮內節(jié)育系統(tǒng) |
|
ZQNYTGNJYXT |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG02CXA070B002 |
阿托西班（自費） |
01 |
|
3 |
ATXBZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
阿托西班注射液 |
|
ATXBZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG03EBQ136A001 |
炔雌醇環(huán)丙孕酮（自費） |
01 |
|
3 |
QCCHBYTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
炔雌醇環(huán)丙孕酮片劑 |
|
QCCHBYTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG03XBM095A001 |
米非司酮（自費） |
01 |
|
3 |
MFSTZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
米非司酮片劑 |
|
MFSTPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG03XBM095E001 |
米非司酮（自費） |
01 |
|
3 |
MFSTZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
米非司酮硬膠囊 |
|
MFSTYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG03XBM095E002 |
米非司酮（自費） |
01 |
|
3 |
MFSTZF |
|
40000 |
1 |
1 |
E002 |
|
|
|
|
|
|
米非司酮軟膠囊 |
|
MFSTRJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG03XBM142E001 |
米非司酮Ⅱ（自費） |
01 |
|
3 |
MFSTZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
米非司酮Ⅱ硬膠囊 |
|
MFSTYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG04BXF018A001 |
非那吡啶（自費） |
01 |
|
3 |
FNBDZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
非那吡啶片劑 |
|
FNBDPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG04BXF018E001 |
非那吡啶（自費） |
01 |
|
3 |
FNBDZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
非那吡啶硬膠囊 |
|
FNBDYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG04BXZ059B001 |
左卡尼汀（自費） |
01 |
|
3 |
ZKNTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
左卡尼汀注射劑 |
|
ZKNTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG04BXZ059B002 |
左卡尼?。ㄗ再M） |
01 |
|
3 |
ZKNTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
左卡尼汀注射液 |
|
ZKNTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXG04BXZ059B014 |
左卡尼汀（自費） |
01 |
|
3 |
ZKNTZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
左卡尼汀凍干粉針 |
|
ZKNTDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXA16AAZ059X001 |
左卡尼汀（自費） |
01 |
|
3 |
ZKNTZF |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
左卡尼汀口服溶液劑 |
|
ZKNTKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01ACC113B001 |
重組人生長激素（自費） |
01 |
|
3 |
CZRSCJSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人生長激素注射劑 |
|
CZRSCJSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01ACC113B002 |
重組人生長激素（自費） |
01 |
|
3 |
CZRSCJSZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人生長激素注射液 |
|
CZRSCJSZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01ACC113B014 |
重組人生長激素（自費） |
01 |
|
3 |
CZRSCJSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人生長激素凍干粉針 |
|
CZRSCJSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBA213B001 |
奧曲肽（自費） |
01 |
|
3 |
AQTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
奧曲肽注射劑 |
|
AQTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBA213B002 |
奧曲肽（自費） |
01 |
|
3 |
AQTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
奧曲肽注射液 |
|
AQTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBA213B003 |
奧曲肽（自費） |
01 |
|
3 |
AQTZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
奧曲肽注射用無菌粉末 |
|
AQTZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBA213B014 |
奧曲肽（自費） |
01 |
|
3 |
AQTZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
奧曲肽凍干粉針 |
|
AQTDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBS078B001 |
生長抑素（自費） |
01 |
|
3 |
SCYSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
生長抑素注射劑 |
|
SCYSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBS078B003 |
生長抑素（自費） |
01 |
|
3 |
SCYSZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
生長抑素注射用無菌粉末 |
|
SCYSZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH01CBS078B014 |
生長抑素（自費） |
01 |
|
3 |
SCYSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
生長抑素凍干粉針 |
|
SCYSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH05BXP123B002 |
帕立骨化醇（自費） |
01 |
|
3 |
PLGHCZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
帕立骨化醇注射液 |
|
PLGHCZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXH05BXX224A001 |
西那卡塞（自費） |
01 |
|
3 |
XNKSZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
西那卡塞片劑 |
|
XNKSPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01AAD193B001 |
多西環(huán)素（自費） |
01 |
|
3 |
DXHSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
多西環(huán)素注射劑 |
|
DXHSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01AAT140B001 |
替加環(huán)素（自費） |
01 |
|
3 |
TJHSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
替加環(huán)素注射劑 |
|
TJHSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CAA040X006 |
阿莫西林（自費） |
01 |
|
3 |
AMXLZF |
|
40000 |
1 |
1 |
X006 |
|
|
|
|
|
|
阿莫西林干混懸劑 |
|
AMXLGHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CAA040N001 |
阿莫西林（自費） |
01 |
|
3 |
AMXLZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
阿莫西林顆粒劑 |
|
AMXLKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CRP017B001 |
哌拉西林舒巴坦（自費） |
01 |
|
3 |
PLXLSBTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
哌拉西林舒巴坦注射劑 |
|
PLXLSBTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CRP017B003 |
哌拉西林舒巴坦（自費） |
01 |
|
3 |
PLXLSBTZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
哌拉西林舒巴坦注射用無菌粉末 |
|
PLXLSBTZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CRP017B013 |
哌拉西林舒巴坦（自費） |
01 |
|
3 |
PLXLSBTZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
哌拉西林舒巴坦無菌粉針 |
|
PLXLSBTWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CRP017B014 |
哌拉西林舒巴坦（自費） |
01 |
|
3 |
PLXLSBTZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
哌拉西林舒巴坦凍干粉針 |
|
PLXLSBTDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CRP018B001 |
哌拉西林他唑巴坦（自費） |
01 |
|
3 |
PLXLTZBTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
哌拉西林他唑巴坦注射劑 |
|
PLXLTZBTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01CRP018B014 |
哌拉西林他唑巴坦（自費） |
01 |
|
3 |
PLXLTZBTZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
哌拉西林他唑巴坦凍干粉針 |
|
PLXLTZBTDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DBT075B001 |
頭孢硫脒（自費） |
01 |
|
3 |
TBLMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢硫脒注射劑 |
|
TBLMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DBT075B011 |
頭孢硫脒（自費） |
01 |
|
3 |
TBLMZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢硫脒粉針劑 |
|
TBLMFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DBT075B013 |
頭孢硫脒（自費） |
01 |
|
3 |
TBLMZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢硫脒無菌粉針 |
|
TBLMWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT098B001 |
頭孢替安（自費） |
01 |
|
3 |
TBTAZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢替安注射劑 |
|
TBTAZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT098B013 |
頭孢替安（自費） |
01 |
|
3 |
TBTAZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢替安無菌粉針 |
|
TBTAWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT076B001 |
頭孢美唑（自費） |
01 |
|
3 |
TBMZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢美唑注射劑 |
|
TBMZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT076B003 |
頭孢美唑（自費） |
01 |
|
3 |
TBMZZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
頭孢美唑注射用無菌粉末 |
|
TBMZZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT076B011 |
頭孢美唑（自費） |
01 |
|
3 |
TBMZZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢美唑粉針劑 |
|
TBMZFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT076B013 |
頭孢美唑（自費） |
01 |
|
3 |
TBMZZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢美唑無菌粉針 |
|
TBMZWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT102B001 |
頭孢西?。ㄗ再M） |
01 |
|
3 |
TBXDZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢西丁注射劑 |
|
TBXDZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT102B003 |
頭孢西?。ㄗ再M） |
01 |
|
3 |
TBXDZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
頭孢西丁注射用無菌粉末 |
|
TBXDZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT102B011 |
頭孢西?。ㄗ再M） |
01 |
|
3 |
TBXDZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢西丁粉針劑 |
|
TBXDFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT102B013 |
頭孢西?。ㄗ再M） |
01 |
|
3 |
TBXDZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢西丁無菌粉針 |
|
TBXDWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT078B001 |
頭孢米諾（自費） |
01 |
|
3 |
TBMNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢米諾注射劑 |
|
TBMNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT078B003 |
頭孢米諾（自費） |
01 |
|
3 |
TBMNZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
頭孢米諾注射用無菌粉末 |
|
TBMNZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT078B011 |
頭孢米諾（自費） |
01 |
|
3 |
TBMNZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢米諾粉針劑 |
|
TBMNFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DCT078B013 |
頭孢米諾（自費） |
01 |
|
3 |
TBMNZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢米諾無菌粉針 |
|
TBMNWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDL014B001 |
拉氧頭孢（自費） |
01 |
|
3 |
LYTBZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
拉氧頭孢注射劑 |
|
LYTBZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT081B001 |
頭孢哌酮舒巴坦（自費） |
01 |
|
3 |
TBPTSBTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢哌酮舒巴坦注射劑 |
|
TBPTSBTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT081B003 |
頭孢哌酮舒巴坦（自費） |
01 |
|
3 |
TBPTSBTZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
頭孢哌酮舒巴坦注射用無菌粉末 |
|
TBPTSBTZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT081B011 |
頭孢哌酮舒巴坦（自費） |
01 |
|
3 |
TBPTSBTZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢哌酮舒巴坦粉針劑 |
|
TBPTSBTFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT081B013 |
頭孢哌酮舒巴坦（自費） |
01 |
|
3 |
TBPTSBTZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢哌酮舒巴坦無菌粉針 |
|
TBPTSBTWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT081B026 |
頭孢哌酮舒巴坦（自費） |
01 |
|
3 |
TBPTSBTZF |
|
40000 |
1 |
1 |
B026 |
|
|
|
|
|
|
頭孢哌酮舒巴坦注射用溶媒結晶 |
|
TBPTSBTZSYRMJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT082B001 |
頭孢哌酮他唑巴坦（自費） |
01 |
|
3 |
TBPTTZBTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢哌酮他唑巴坦注射劑 |
|
TBPTTZBTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT153B001 |
頭孢曲松舒巴坦（自費） |
01 |
|
3 |
TBQSSBTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢曲松舒巴坦注射劑 |
|
TBQSSBTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DDT095B001 |
頭孢他啶他唑巴坦（自費） |
01 |
|
3 |
TBTDTZBTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢他啶他唑巴坦注射劑 |
|
TBTDTZBTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET065B001 |
頭孢吡肟（自費） |
01 |
|
3 |
TBBWZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢吡肟注射劑 |
|
TBBWZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET065B011 |
頭孢吡肟（自費） |
01 |
|
3 |
TBBWZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢吡肟粉針劑 |
|
TBBWFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET065B013 |
頭孢吡肟（自費） |
01 |
|
3 |
TBBWZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢吡肟無菌粉針 |
|
TBBWWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET084B001 |
頭孢匹羅（自費） |
01 |
|
3 |
TBPLZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢匹羅注射劑 |
|
TBPLZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET084B002 |
頭孢匹羅（自費） |
01 |
|
3 |
TBPLZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
頭孢匹羅注射液 |
|
TBPLZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET084B003 |
頭孢匹羅（自費） |
01 |
|
3 |
TBPLZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
頭孢匹羅注射用無菌粉末 |
|
TBPLZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET084B011 |
頭孢匹羅（自費） |
01 |
|
3 |
TBPLZF |
|
40000 |
1 |
1 |
B011 |
|
|
|
|
|
|
頭孢匹羅粉針劑 |
|
TBPLFZJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DET084B013 |
頭孢匹羅（自費） |
01 |
|
3 |
TBPLZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
頭孢匹羅無菌粉針 |
|
TBPLWJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DFA194B001 |
氨曲南（自費） |
01 |
|
3 |
AQNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
氨曲南注射劑 |
|
AQNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DFA194B003 |
氨曲南（自費） |
01 |
|
3 |
AQNZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
氨曲南注射用無菌粉末 |
|
AQNZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DHE007B001 |
厄他培南（自費） |
01 |
|
3 |
ETPNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
厄他培南注射劑 |
|
ETPNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DHB084B001 |
比阿培南（自費） |
01 |
|
3 |
BAPNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
比阿培南注射劑 |
|
BAPNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DHM046B001 |
美羅培南（自費） |
01 |
|
3 |
MLPNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
美羅培南注射劑 |
|
MLPNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DHY002B001 |
亞胺培南西司他?。ㄗ再M） |
01 |
|
3 |
YAPNXSTDZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
亞胺培南西司他丁注射劑 |
|
YAPNXSTDZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DIF005A001 |
法羅培南（自費） |
01 |
|
3 |
FLPNZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
法羅培南片劑 |
|
FLPNPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DIF005E001 |
法羅培南（自費） |
01 |
|
3 |
FLPNZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
法羅培南硬膠囊 |
|
FLPNYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DIF005N001 |
法羅培南（自費） |
01 |
|
3 |
FLPNZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
法羅培南顆粒劑 |
|
FLPNKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01DIT091B001 |
頭孢噻利（自費） |
01 |
|
3 |
TBSLZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
頭孢噻利注射劑 |
|
TBSLZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01FFK120X006 |
克林霉素棕櫚酸酯（自費） |
01 |
|
3 |
KLMSZLSZZF |
|
40000 |
1 |
1 |
X006 |
|
|
|
|
|
|
克林霉素棕櫚酸酯干混懸劑 |
|
KLMSZLSZGHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAF078B001 |
氟羅沙星（自費） |
01 |
|
3 |
FLSXZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
氟羅沙星注射劑 |
|
FLSXZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAF078B002 |
氟羅沙星（自費） |
01 |
|
3 |
FLSXZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
氟羅沙星注射液 |
|
FLSXZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAF078B014 |
氟羅沙星（自費） |
01 |
|
3 |
FLSXZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
氟羅沙星凍干粉針 |
|
FLSXDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAJ009A001 |
吉米沙星（自費） |
01 |
|
3 |
JMSXZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
吉米沙星片劑 |
|
JMSXPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279A001 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
洛美沙星片劑 |
|
LMSXPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279A006 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
A006 |
|
|
|
|
|
|
洛美沙星分散片 |
|
LMSXFSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279A017 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
A017 |
|
|
|
|
|
|
洛美沙星薄膜衣片 |
|
LMSXBMYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279A018 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
A018 |
|
|
|
|
|
|
洛美沙星糖衣片 |
|
LMSXTYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279E001 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
洛美沙星硬膠囊 |
|
LMSXYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279B001 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
洛美沙星注射劑 |
|
LMSXZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAL279B002 |
洛美沙星（自費） |
01 |
|
3 |
LMSXZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
洛美沙星注射液 |
|
LMSXZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAM122A001 |
莫西沙星（自費） |
01 |
|
3 |
MXSXZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
莫西沙星片劑 |
|
MXSXPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAM122B002 |
莫西沙星（自費） |
01 |
|
3 |
MXSXZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
莫西沙星注射液 |
|
MXSXZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01MAM134B002 |
莫西沙星氯化鈉（自費） |
01 |
|
3 |
MXSXLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
莫西沙星氯化鈉注射液 |
|
MXSXLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XAQ121B001 |
去甲萬古霉素（自費） |
01 |
|
3 |
QJWGMSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
去甲萬古霉素注射劑 |
|
QJWGMSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XAT037B001 |
替考拉寧（自費） |
01 |
|
3 |
TKLNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
替考拉寧注射劑 |
|
TKLNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XAW001B001 |
萬古霉素（自費） |
01 |
|
3 |
WGMSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
萬古霉素注射劑 |
|
WGMSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XBD198B014 |
多粘菌素B（多粘菌素）（自費） |
01 |
|
3 |
DZJSB(DZJS)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
多粘菌素B（多粘菌素）凍干粉針 |
|
DZJSB(DZJS)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XCF045B001 |
夫西地酸（自費） |
01 |
|
3 |
FXDSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
夫西地酸注射劑 |
|
FXDSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XCF045B003 |
夫西地酸（自費） |
01 |
|
3 |
FXDSZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
夫西地酸注射用無菌粉末 |
|
FXDSZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XDZ082B002 |
左奧硝唑氯化鈉（自費） |
01 |
|
3 |
ZAXZLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
左奧硝唑氯化鈉注射液 |
|
ZAXZLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XXD215B001 |
達托霉素（自費） |
01 |
|
3 |
DTMSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
達托霉素注射劑 |
|
DTMSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XXL070A001 |
利奈唑胺（自費） |
01 |
|
3 |
LNZAZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
利奈唑胺片劑 |
|
LNZAPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ01XXL350B002 |
利奈唑胺葡萄糖（自費） |
01 |
|
3 |
LNZAPTTZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
利奈唑胺葡萄糖注射液 |
|
LNZAPTTZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02AAL085B017 |
兩性霉素B（自費） |
01 |
|
3 |
LXMSBZF |
|
40000 |
1 |
1 |
B017 |
|
|
|
|
|
|
兩性霉素B脂質體注射劑 |
|
LXMSBZZTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACF059A001 |
伏立康唑（自費） |
01 |
|
3 |
FLKZZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
伏立康唑片劑 |
|
FLKZPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACF059A006 |
伏立康唑（自費） |
01 |
|
3 |
FLKZZF |
|
40000 |
1 |
1 |
A006 |
|
|
|
|
|
|
伏立康唑分散片 |
|
FLKZFSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACF059E001 |
伏立康唑（自費） |
01 |
|
3 |
FLKZZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
伏立康唑硬膠囊 |
|
FLKZYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACF059X006 |
伏立康唑（自費） |
01 |
|
3 |
FLKZZF |
|
40000 |
1 |
1 |
X006 |
|
|
|
|
|
|
伏立康唑干混懸劑 |
|
FLKZGHXJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACF059B001 |
伏立康唑（自費） |
01 |
|
3 |
FLKZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
伏立康唑注射劑 |
|
FLKZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACF059B003 |
伏立康唑（自費） |
01 |
|
3 |
FLKZZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
伏立康唑注射用無菌粉末 |
|
FLKZZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACY061X008 |
伊曲康唑（自費） |
01 |
|
3 |
YQKZZF |
|
40000 |
1 |
1 |
X008 |
|
|
|
|
|
|
伊曲康唑口服液 |
|
YQKZKFY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02ACY061B002 |
伊曲康唑（自費） |
01 |
|
3 |
YQKZZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
伊曲康唑注射液 |
|
YQKZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02AXK012B001 |
卡泊芬凈（自費） |
01 |
|
3 |
KBFJZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
卡泊芬凈注射劑 |
|
KBFJZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ02AXM100B001 |
米卡芬凈（自費） |
01 |
|
3 |
MKFJZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
米卡芬凈注射劑 |
|
MKFJZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AES051W001 |
沙奎那韋（自費） |
01 |
|
3 |
SKNWZF |
|
40000 |
1 |
1 |
W001 |
|
|
|
|
|
|
沙奎那韋口服常釋劑型 |
|
SKNWKFCSJX |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFA014A001 |
阿德福韋酯（自費） |
01 |
|
3 |
ADFWZZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
阿德福韋酯片劑 |
|
ADFWZPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFA014A006 |
阿德福韋酯（自費） |
01 |
|
3 |
ADFWZZF |
|
40000 |
1 |
1 |
A006 |
|
|
|
|
|
|
阿德福韋酯分散片 |
|
ADFWZFSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFA014E001 |
阿德福韋酯（自費） |
01 |
|
3 |
ADFWZZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
阿德福韋酯硬膠囊 |
|
ADFWZYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE009B001 |
恩夫韋肽（自費） |
01 |
|
3 |
EFWTZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
恩夫韋肽注射劑 |
|
EFWTZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE011A001 |
恩曲他濱（自費） |
01 |
|
3 |
EQTBZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
恩曲他濱片劑 |
|
EQTBPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE011E001 |
恩曲他濱（自費） |
01 |
|
3 |
EQTBZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
恩曲他濱硬膠囊 |
|
EQTBYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE070A001 |
恩曲他濱替諾福韋（自費） |
01 |
|
3 |
EQTBTNFWZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
恩曲他濱替諾福韋片劑 |
|
EQTBTNFWPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE013A001 |
恩替卡韋（自費） |
01 |
|
3 |
ETKWZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
恩替卡韋片劑 |
|
ETKWPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE013A006 |
恩替卡韋（自費） |
01 |
|
3 |
ETKWZF |
|
40000 |
1 |
1 |
A006 |
|
|
|
|
|
|
恩替卡韋分散片 |
|
ETKWFSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFE013E001 |
恩替卡韋（自費） |
01 |
|
3 |
ETKWZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
恩替卡韋硬膠囊 |
|
ETKWYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFL008A001 |
拉米夫定（自費） |
01 |
|
3 |
LMFDZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
拉米夫定片劑 |
|
LMFDPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFL008A017 |
拉米夫定（自費） |
01 |
|
3 |
LMFDZF |
|
40000 |
1 |
1 |
A017 |
|
|
|
|
|
|
拉米夫定薄膜衣片 |
|
LMFDBMYP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFL008E001 |
拉米夫定（自費） |
01 |
|
3 |
LMFDZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
拉米夫定硬膠囊 |
|
LMFDYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFQ008K001 |
齊多夫定（自費） |
01 |
|
3 |
QDFDZF |
|
40000 |
1 |
1 |
K001 |
|
|
|
|
|
|
齊多夫定糖漿劑 |
|
QDFDTJJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFQ008X001 |
齊多夫定（自費） |
01 |
|
3 |
QDFDZF |
|
40000 |
1 |
1 |
X001 |
|
|
|
|
|
|
齊多夫定口服溶液劑 |
|
QDFDKFRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFQ008B001 |
齊多夫定（自費） |
01 |
|
3 |
QDFDZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
齊多夫定注射劑 |
|
QDFDZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFQ008B002 |
齊多夫定（自費） |
01 |
|
3 |
QDFDZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
齊多夫定注射液 |
|
QDFDZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFT031A001 |
替比夫定（自費） |
01 |
|
3 |
TBFDZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
替比夫定片劑 |
|
TBFDPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFT043A001 |
替諾福韋二吡呋酯（自費） |
01 |
|
3 |
TNFWEBFZZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
替諾福韋二吡呋酯片劑 |
|
TNFWEBFZPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AFT043E001 |
替諾福韋二吡呋酯（自費） |
01 |
|
3 |
TNFWEBFZZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
替諾福韋二吡呋酯硬膠囊 |
|
TNFWEBFZYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AGL341A001 |
利匹韋林（自費） |
01 |
|
3 |
LPWLZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
利匹韋林片劑 |
|
LPWLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AHA218E001 |
奧司他韋（自費） |
01 |
|
3 |
ASTWZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
奧司他韋硬膠囊 |
|
ASTWYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AHA218N001 |
奧司他韋（自費） |
01 |
|
3 |
ASTWZF |
|
40000 |
1 |
1 |
N001 |
|
|
|
|
|
|
奧司他韋顆粒劑 |
|
ASTWKLJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AHP119B002 |
帕拉米韋氯化鈉（自費） |
01 |
|
3 |
PLMWLHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
帕拉米韋氯化鈉注射液 |
|
PLMWLHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05ARQ009A001 |
齊多拉米雙夫定（自費） |
01 |
|
3 |
QDLMSFDZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
齊多拉米雙夫定片劑 |
|
QDLMSFDPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05ARL282A001 |
洛匹那韋利托那韋（自費） |
01 |
|
3 |
LPNWLTNWZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
洛匹那韋利托那韋片劑 |
|
LPNWLTNWPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXA011A001 |
阿比多爾（自費） |
01 |
|
3 |
ABDEZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
阿比多爾片劑 |
|
ABDEPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXA011A006 |
阿比多爾（自費） |
01 |
|
3 |
ABDEZF |
|
40000 |
1 |
1 |
A006 |
|
|
|
|
|
|
阿比多爾分散片 |
|
ABDEFSP |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXA011E001 |
阿比多爾（自費） |
01 |
|
3 |
ABDEZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
阿比多爾硬膠囊 |
|
ABDEYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXC047B001 |
穿琥寧（自費） |
01 |
|
3 |
CHNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
穿琥寧注射劑 |
|
CHNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXC047B002 |
穿琥寧（自費） |
01 |
|
3 |
CHNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
穿琥寧注射液 |
|
CHNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXC047B003 |
穿琥寧（自費） |
01 |
|
3 |
CHNZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
穿琥寧注射用無菌粉末 |
|
CHNZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ05AXC047B014 |
穿琥寧（自費） |
01 |
|
3 |
CHNZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
穿琥寧凍干粉針 |
|
CHNDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06AAA006B001 |
A型肉毒毒素（自費） |
01 |
|
3 |
AXRDDSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
A型肉毒毒素注射劑 |
|
AXRDDSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06AAA006B014 |
A型肉毒毒素（自費） |
01 |
|
3 |
AXRDDSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
A型肉毒毒素凍干粉針 |
|
AXRDDSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAJ215B001 |
靜注人免疫球蛋白（pH4）（自費） |
01 |
|
3 |
JZRMYQDB(PH4)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射劑 |
|
JZRMYQDB(PH4)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAJ215B002 |
靜注人免疫球蛋白（pH4）（自費） |
01 |
|
3 |
JZRMYQDB(PH4)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射液 |
|
JZRMYQDB(PH4)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAJ215B003 |
靜注人免疫球蛋白（pH4）（自費） |
01 |
|
3 |
JZRMYQDB(PH4)ZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射用無菌粉末 |
|
JZRMYQDB(PH4)ZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAJ215B005 |
靜注人免疫球蛋白（pH4）（自費） |
01 |
|
3 |
JZRMYQDB(PH4)ZF |
|
40000 |
1 |
1 |
B005 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）注射用溶液劑 |
|
JZRMYQDB(PH4)ZSYRYJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAJ215B014 |
靜注人免疫球蛋白（pH4）（自費） |
01 |
|
3 |
JZRMYQDB(PH4)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
靜注人免疫球蛋白（pH4）凍干粉針 |
|
JZRMYQDB(PH4)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAR008B001 |
人免疫球蛋白（自費） |
01 |
|
3 |
RMYQDBZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人免疫球蛋白注射劑 |
|
RMYQDBZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ06BAR008B002 |
人免疫球蛋白（自費） |
01 |
|
3 |
RMYQDBZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
人免疫球蛋白注射液 |
|
RMYQDBZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR030B001 |
人用狂犬病疫苗（Vero細胞）（自費） |
01 |
|
3 |
RYKQBYM(EROXB)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（Vero細胞）注射劑 |
|
RYKQBYM(EROXB)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR030B002 |
人用狂犬病疫苗（Vero細胞）（自費） |
01 |
|
3 |
RYKQBYM(EROXB)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
人用狂犬病疫苗（Vero細胞）注射液 |
|
RYKQBYM(EROXB)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR030B014 |
人用狂犬病疫苗（Vero細胞）（自費） |
01 |
|
3 |
RYKQBYM(EROXB)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人用狂犬病疫苗（Vero細胞）凍干粉針 |
|
RYKQBYM(EROXB)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR032B001 |
人用狂犬病疫苗（地鼠腎細胞）（自費） |
01 |
|
3 |
RYKQBYM(DSSXB)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（地鼠腎細胞）注射劑 |
|
RYKQBYM(DSSXB)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR032B002 |
人用狂犬病疫苗（地鼠腎細胞）（自費） |
01 |
|
3 |
RYKQBYM(DSSXB)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
人用狂犬病疫苗（地鼠腎細胞）注射液 |
|
RYKQBYM(DSSXB)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR032B014 |
人用狂犬病疫苗（地鼠腎細胞）（自費） |
01 |
|
3 |
RYKQBYM(DSSXB)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
人用狂犬病疫苗（地鼠腎細胞）凍干粉針 |
|
RYKQBYM(DSSXB)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR033B001 |
人用狂犬病疫苗（雞胚細胞）（自費） |
01 |
|
3 |
RYKQBYM(JPXB)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（雞胚細胞）注射劑 |
|
RYKQBYM(JPXB)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXJ07BGR077B001 |
人用狂犬病疫苗（人二倍體細胞）（自費） |
01 |
|
3 |
RYKQBYM(REBTXB)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
人用狂犬病疫苗（人二倍體細胞）注射劑 |
|
RYKQBYM(REBTXB)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01AXT041E001 |
替莫唑胺（自費） |
01 |
|
3 |
TMZAZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
替莫唑胺硬膠囊 |
|
TMZAYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01BAP030B001 |
培美曲塞（自費） |
01 |
|
3 |
PMQSZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
培美曲塞注射劑 |
|
PMQSZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01BAP030B014 |
培美曲塞（自費） |
01 |
|
3 |
PMQSZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
培美曲塞凍干粉針 |
|
PMQSDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01BBF066A001 |
氟達拉濱（自費） |
01 |
|
3 |
FDLBZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
氟達拉濱片劑 |
|
FDLBPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01BBF066B001 |
氟達拉濱（自費） |
01 |
|
3 |
FDLBZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
氟達拉濱注射劑 |
|
FDLBZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01BCD089B001 |
地西他濱（自費） |
01 |
|
3 |
DXTBZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
地西他濱注射劑 |
|
DXTBZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01CXB019B002 |
斑蝥酸鈉維生素B6（自費） |
01 |
|
3 |
BMSNWSSB6ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
斑蝥酸鈉維生素B6注射液 |
|
BMSNWSSB6ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01CXL035X003 |
欖香烯（自費） |
01 |
|
3 |
LXXZF |
|
40000 |
1 |
1 |
X003 |
|
|
|
|
|
|
欖香烯口服乳劑 |
|
LXXKFRJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01CXL035B002 |
欖香烯（自費） |
01 |
|
3 |
LXXZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
欖香烯注射液 |
|
LXXZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01CXL035B022 |
欖香烯（自費） |
01 |
|
3 |
LXXZF |
|
40000 |
1 |
1 |
B022 |
|
|
|
|
|
|
欖香烯乳狀注射液 |
|
LXXRZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01CXB018B002 |
斑蝥酸鈉（自費） |
01 |
|
3 |
BMSNZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
斑蝥酸鈉注射液 |
|
BMSNZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01DBY055B001 |
伊達比星（自費） |
01 |
|
3 |
YDBXZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
伊達比星注射劑 |
|
YDBXZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XCL075B002 |
利妥昔單抗（自費） |
01 |
|
3 |
LTXDKZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
利妥昔單抗注射液 |
|
LTXDKZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XEA274A001 |
?？颂婺幔ㄗ再M） |
01 |
|
3 |
AKTNZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
埃克替尼片劑 |
|
AKTNPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XEJ008A001 |
吉非替尼（自費） |
01 |
|
3 |
JFTNZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
吉非替尼片劑 |
|
JFTNPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XEY059A001 |
伊馬替尼（自費） |
01 |
|
3 |
YMTNZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
伊馬替尼片劑 |
|
YMTNPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XEY059E001 |
伊馬替尼（自費） |
01 |
|
3 |
YMTNZF |
|
40000 |
1 |
1 |
E001 |
|
|
|
|
|
|
伊馬替尼硬膠囊 |
|
YMTNYJN |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XED246A001 |
達沙替尼（自費） |
01 |
|
3 |
DSTNZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
達沙替尼片劑 |
|
DSTNPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XWP043B001 |
硼替佐米（自費） |
01 |
|
3 |
PTZMZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
硼替佐米注射劑 |
|
PTZMZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XXG011B001 |
甘氨雙唑鈉（自費） |
01 |
|
3 |
GASZNZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
甘氨雙唑鈉注射劑 |
|
GASZNZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XXG011B014 |
甘氨雙唑鈉（自費） |
01 |
|
3 |
GASZNZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
甘氨雙唑鈉凍干粉針 |
|
GASZNDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XXT165B002 |
銅綠假單胞菌（自費） |
01 |
|
3 |
TLJDBJZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
銅綠假單胞菌注射液 |
|
TLJDBJZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XXX138B002 |
小牛脾提取物（自費） |
01 |
|
3 |
XNPTQWZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
小牛脾提取物注射液 |
|
XNPTQWZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL01XXC073B001 |
重組改構人腫瘤壞死因子（自費） |
01 |
|
3 |
CZGGRZLHSYZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組改構人腫瘤壞死因子注射劑 |
|
CZGGRZLHSYZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL02BBA292A001 |
阿比特龍（自費） |
01 |
|
3 |
ABTLZF |
|
40000 |
1 |
1 |
A001 |
|
|
|
|
|
|
阿比特龍片劑 |
|
ABTLPJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03AAJ213B002 |
聚乙二醇化重組人粒細胞刺激因子（自費） |
01 |
|
3 |
JYECHCZRLXBCJYZZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
聚乙二醇化重組人粒細胞刺激因子注射液 |
|
JYECHCZRLXBCJYZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03AAC106B002 |
重組人粒細胞刺激因子（自費） |
01 |
|
3 |
CZRLXBCJYZZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人粒細胞刺激因子注射液 |
|
CZRLXBCJYZZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03AAC146B001 |
重組人粒細胞刺激因子（CHO細胞）（自費） |
01 |
|
3 |
CZRLXBCJYZ(CHOXB)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人粒細胞刺激因子（CHO細胞）注射劑 |
|
CZRLXBCJYZ(CHOXB)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03AAC108B001 |
重組人粒細胞巨噬細胞刺激因子（自費） |
01 |
|
3 |
CZRLXBJSXBCJYZZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人粒細胞巨噬細胞刺激因子注射劑 |
|
CZRLXBJSXBCJYZZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03AAC108B014 |
重組人粒細胞巨噬細胞刺激因子（自費） |
01 |
|
3 |
CZRLXBJSXBCJYZZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人粒細胞巨噬細胞刺激因子凍干粉針 |
|
CZRLXBJSXBCJYZDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABJ163B002 |
聚乙二醇干擾素α2a（自費） |
01 |
|
3 |
JYECGRS2AZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
聚乙二醇干擾素α2a注射液 |
|
JYECGRS2AZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABJ164B001 |
聚乙二醇干擾素α2b（自費） |
01 |
|
3 |
JYECGRS2BZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
聚乙二醇干擾素α2b注射劑 |
|
JYECGRS2BZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABJ164B002 |
聚乙二醇干擾素α2b（自費） |
01 |
|
3 |
JYECGRS2BZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
聚乙二醇干擾素α2b注射液 |
|
JYECGRS2BZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC094B001 |
重組人干擾素α1b（自費） |
01 |
|
3 |
CZRGRS1BZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人干擾素α1b注射劑 |
|
CZRGRS1BZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC094B002 |
重組人干擾素α1b（自費） |
01 |
|
3 |
CZRGRS1BZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人干擾素α1b注射液 |
|
CZRGRS1BZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC094B014 |
重組人干擾素α1b（自費） |
01 |
|
3 |
CZRGRS1BZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人干擾素α1b凍干粉針 |
|
CZRGRS1BDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC095B001 |
重組人干擾素α2a（自費） |
01 |
|
3 |
CZRGRS2AZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人干擾素α2a注射劑 |
|
CZRGRS2AZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC095B002 |
重組人干擾素α2a（自費） |
01 |
|
3 |
CZRGRS2AZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人干擾素α2a注射液 |
|
CZRGRS2AZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC095B014 |
重組人干擾素α2a（自費） |
01 |
|
3 |
CZRGRS2AZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人干擾素α2a凍干粉針 |
|
CZRGRS2ADGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC096B001 |
重組人干擾素α2a（酵母）（自費） |
01 |
|
3 |
CZRGRS2A(JM)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人干擾素α2a（酵母）注射劑 |
|
CZRGRS2A(JM)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC096B014 |
重組人干擾素α2a（酵母）（自費） |
01 |
|
3 |
CZRGRS2A(JM)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人干擾素α2a（酵母）凍干粉針 |
|
CZRGRS2A(JM)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC097B001 |
重組人干擾素α2b（自費） |
01 |
|
3 |
CZRGRS2BZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人干擾素α2b注射劑 |
|
CZRGRS2BZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC097B002 |
重組人干擾素α2b（自費） |
01 |
|
3 |
CZRGRS2BZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人干擾素α2b注射液 |
|
CZRGRS2BZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC097B014 |
重組人干擾素α2b（自費） |
01 |
|
3 |
CZRGRS2BZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人干擾素α2b凍干粉針 |
|
CZRGRS2BDGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC098B001 |
重組人干擾素α2b（假單胞菌）（自費） |
01 |
|
3 |
CZRGRS2B(JDBJ)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人干擾素α2b（假單胞菌）注射劑 |
|
CZRGRS2B(JDBJ)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC098B002 |
重組人干擾素α2b（假單胞菌）（自費） |
01 |
|
3 |
CZRGRS2B(JDBJ)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人干擾素α2b（假單胞菌）注射液 |
|
CZRGRS2B(JDBJ)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC098B003 |
重組人干擾素α2b（假單胞菌）（自費） |
01 |
|
3 |
CZRGRS2B(JDBJ)ZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
重組人干擾素α2b（假單胞菌）注射用無菌粉末 |
|
CZRGRS2B(JDBJ)ZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC099B001 |
重組人干擾素α2b（酵母）（自費） |
01 |
|
3 |
CZRGRS2B(JM)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人干擾素α2b（酵母）注射劑 |
|
CZRGRS2B(JM)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ABC099B014 |
重組人干擾素α2b（酵母）（自費） |
01 |
|
3 |
CZRGRS2B(JM)ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人干擾素α2b（酵母）凍干粉針 |
|
CZRGRS2B(JM)DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC084B001 |
重組人白介素-11（自費） |
01 |
|
3 |
CZRBJS-11ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人白介素-11注射劑 |
|
CZRBJS-11ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC084B003 |
重組人白介素-11（自費） |
01 |
|
3 |
CZRBJS-11ZF |
|
40000 |
1 |
1 |
B003 |
|
|
|
|
|
|
重組人白介素-11注射用無菌粉末 |
|
CZRBJS-11ZSYWJFM |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC084B014 |
重組人白介素-11（自費） |
01 |
|
3 |
CZRBJS-11ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人白介素-11凍干粉針 |
|
CZRBJS-11DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC085B001 |
重組人白介素-11（Ⅰ）（自費） |
01 |
|
3 |
CZRBJS-11()ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人白介素-11（Ⅰ）注射劑 |
|
CZRBJS-11()ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC158B001 |
重組人白介素-11（酵母）（自費） |
01 |
|
3 |
CZRBJS-11(JM)ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人白介素-11（酵母）注射劑 |
|
CZRBJS-11(JM)ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC086B001 |
重組人白介素-2（自費） |
01 |
|
3 |
CZRBJS-2ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人白介素-2注射劑 |
|
CZRBJS-2ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC086B002 |
重組人白介素-2（自費） |
01 |
|
3 |
CZRBJS-2ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人白介素-2注射液 |
|
CZRBJS-2ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC086B013 |
重組人白介素-2（自費） |
01 |
|
3 |
CZRBJS-2ZF |
|
40000 |
1 |
1 |
B013 |
|
|
|
|
|
|
重組人白介素-2無菌粉針 |
|
CZRBJS-2WJFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC086B014 |
重組人白介素-2（自費） |
01 |
|
3 |
CZRBJS-2ZF |
|
40000 |
1 |
1 |
B014 |
|
|
|
|
|
|
重組人白介素-2凍干粉針 |
|
CZRBJS-2DGFZ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC128B001 |
重組人白介素-2（Ⅰ）（自費） |
01 |
|
3 |
CZRBJS-2()ZF |
|
40000 |
1 |
1 |
B001 |
|
|
|
|
|
|
重組人白介素-2（Ⅰ）注射劑 |
|
CZRBJS-2()ZSJ |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
| ZFXL03ACC087B002 |
重組人白介素-2（125Ala）（自費） |
01 |
|
3 |
CZRBJS-2(125ALA)ZF |
|
40000 |
1 |
1 |
B002 |
|
|
|
|
|
|
重組人白介素-2（125Ala）注射液 |
|
CZRBJS-2(125ALA)ZSY |
|
0 |
1 |
1 |
2020-1-1 |
|
|
1 |
1 |
|
